From Genes to Medicines: Unraveling the Biosynthesis and Biogenesis of Secondary Metabolites

Abstract

This article provides a comprehensive exploration of the biosynthesis and biogenesis of secondary metabolites, crucial compounds with vast pharmaceutical and industrial applications. Tailored for researchers, scientists, and drug development professionals, it synthesizes foundational knowledge with cutting-edge methodologies. The scope spans from the core biochemical pathways and ecological functions of secondary metabolites to advanced genome mining and multi-omics techniques for their discovery. It further addresses critical challenges in optimizing production and offers rigorous frameworks for validating and comparing biosynthetic gene clusters, serving as a strategic guide for accelerating natural product-based drug discovery.

The Chemical Language of Life: Fundamentals of Secondary Metabolite Biosynthesis

Secondary metabolites are low-molecular-weight organic compounds produced by plants and microbes under specific conditions which, unlike primary metabolites, are not directly involved in the fundamental processes of growth, development, or reproduction [1]. These specialized compounds serve crucial ecological functions in defense, protection, and signaling for the organisms that produce them, while also providing immense value to humans as pharmaceuticals, chemical feedstocks, and cosmetic ingredients [1] [2] [3]. The complex biosynthetic pathways of many secondary metabolites remain only partially understood, presenting both a challenge and opportunity for research aimed at harnessing their full potential in therapeutic applications [4]. This review examines the core definitions, biosynthetic origins, and advanced research methodologies characterizing these compounds, framed within the context of contemporary biosynthesis and biogenesis research.

Defining Characteristics and Ecological Significance

Fundamental Distinctions from Primary Metabolism

Secondary metabolites diverge from primary metabolites in several key aspects. While primary metabolites such as amino acids, nucleotides, and carbohydrates are ubiquitous across all plant species and essential for basic cellular functions, secondary metabolites exhibit restricted taxonomic distribution, often being species-specific or produced only under particular environmental conditions [1]. Their production is typically temporally and spatially regulated, accumulating during specific developmental stages or in specialized tissues and organs [5]. From an evolutionary perspective, secondary metabolites represent adaptive traits that enhance an organism's survival and fitness in specific ecological contexts rather than supporting core physiological processes.

Major Classes and Chemical Diversity

The structural diversity of secondary metabolites can be categorized into several major classes based on their biosynthetic origins and chemical structures, each with distinct biological activities and ecological functions, as summarized in Table 1.

Table 1: Major Classes of Plant Secondary Metabolites and Their Functions

Class	Biosynthetic Origin	Representative Compounds	Ecological Functions	Human Applications
Phenolics	Shikimate/Phenylpropanoid pathways	Flavonoids, Lignans, Tannins	UV protection, antioxidant, structural support	Antioxidants, nutraceuticals, anti-inflammatory agents
Terpenoids	Mevalonic acid (MVA) or Methylerythritol phosphate (MEP) pathways	Artemisinin, Taxol, Carotenoids	Defense against herbivores, attraction of pollinators	Antimalarials, anticancer drugs, fragrances
Alkaloids	Various amino acid precursors	Morphine, Quinine, Caffeine	Defense against herbivores and microbes	Analgesics, antimalarials, stimulants
Specialized Metabolites	Combined pathways	Acylphloroglucinolated catechins, Pilosanol-type molecules	Species-specific defense mechanisms	Potential pharmaceutical lead compounds [6]

Ecological Roles and Defense Functions

Secondary metabolites constitute a sophisticated chemical defense arsenal that enables plants to interact with and adapt to their environment. They function as phytoprotectants against herbivores, pathogens, and competing plants through toxic, repellent, or antinutritive effects [1]. Additionally, they provide protection from abiotic stresses including UV radiation, extreme temperatures, and drought through antioxidant activity and reactive oxygen species scavenging [1]. Beyond defense, they facilitate ecological interactions such as attracting pollinators and seed dispersers through pigments and volatiles, and mediating symbiotic relationships with soil microorganisms [3].

Biosynthesis and Regulatory Mechanisms

Fundamental Biosynthetic Pathways

The production of secondary metabolites in plants originates from several primary metabolic pathways that provide the basic carbon skeletons and precursor molecules, as illustrated in Figure 1. The shikimic acid pathway converts simple carbohydrates into aromatic amino acids (phenylalanine, tyrosine, tryptophan) that serve as precursors for phenolic compounds, alkaloids, and indole derivatives. The malonic acid pathway, although less common in higher plants, produces polyketides through sequential condensation of acetyl-CoA units. The mevalonic acid (MVA) and methylerythritol phosphate (MEP) pathways generate isoprenoid precursors (isopentenyl pyrophosphate and dimethylallyl pyrophosphate) for terpenoid biosynthesis, while various amino acid precursors form the backbone structures for alkaloid diversity.

Diagram Title: Secondary Metabolite Biosynthetic Pathways

Light-Mediated Regulation of Biosynthesis

Light serves as a key environmental factor regulating the synthesis of plant secondary metabolites through multidimensional mechanisms [1]. Different light qualities achieve differential biological regulation through specialized photoreceptor systems, with UV radiation activating the UVR8 photoreceptor pathway to enhance phenolic and flavonoid production, blue light influencing phenylpropanoid metabolism through cryptochrome-mediated networks, and red light modulating terpenoid production via phytochrome-mediated hormonal signaling [1]. The molecular mechanisms of UV light regulation are detailed in Figure 2.

Diagram Title: UV Light Regulation of Secondary Metabolism

Light intensity dynamically modulates secondary metabolite accumulation by affecting photosynthetic efficiency and energy allocation, while photoperiod coordinates metabolic rhythms through circadian clock genes [1]. These light-responsive mechanisms constitute a chemical defense strategy that enables plants to adapt to their environment while providing critical targets for directed regulation of medicinal components and functional nutrients.

Advanced Research Methodologies

Analytical Approaches for Metabolite Identification

Modern research on secondary metabolites employs sophisticated analytical technologies for compound discovery and characterization. Liquid chromatography/mass spectrometry (LC/MS) has emerged as a powerful platform, with high-resolution MS (HRMS) analyzers such as quadrupole time-of-flight (qTOF) and orbitrap providing enhanced m/z resolution, dynamic range, and sensitivity for structural elucidation [6]. Figure 3 illustrates a representative workflow for LC/MS data processing to identify novel secondary metabolites.

Diagram Title: LC/MS Metabolite Discovery Workflow

Protocols for processing LC/MS data include multiple critical steps to extract meaningful information from complex natural product extracts. Raw MS spectra undergo noise filtering to remove unwanted signals, followed by deisotoping to simplify spectral interpretation [6]. Processed MS spectra are then clustered based on similarity scoring between consecutive scans to generate Representative MS Spectra (RMS) corresponding to single metabolites [6]. These RMS are subsequently used for dereplication studies to identify known compounds and highlight novel metabolites of interest, with approaches such as the Fresh Compound Index (FCI) scoring system evaluating structural novelty against in-house databases [6].

Statistical Experimental Design for Optimization

Statistical experimental designs (Design of Experiments, DoE) provide powerful approaches for optimizing secondary metabolite production in plant cell suspension cultures (PCSCs), overcoming limitations of traditional one-factor-at-a-time (OFAT) methodologies [2]. These approaches enable researchers to systematically investigate the effects of multiple factors and their interactions on metabolite yield in a cost-efficient manner, significantly enhancing the productivity of plant cell cultures for pharmaceutical, chemical feedstock, and cosmetic applications [2]. Factorial designs allow simultaneous examination of multiple factors such as nutrient composition, hormone levels, and elicitor concentrations, reducing the total number of experiments required while providing comprehensive information about factor interactions [2].

Systems and Synthetic Biology Approaches

Advanced systems and synthetic biology tools are revolutionizing the characterization and engineering of plant metabolic pathways, as summarized in Table 2. These methodologies enable researchers to unravel complex biosynthetic networks and enhance the production of valuable natural products through directed genetic manipulation [4].

Table 2: Advanced Research Methods for Secondary Metabolite Pathway Analysis

Method Category	Specific Techniques	Applications	Key Advantages
Systems Biology	Co-expression analysis, Gene cluster identification, Genome-wide association studies (GWAS)	Identification of candidate genes in biosynthetic pathways, Elucidation of regulatory networks	Unbiased discovery of pathway components, Identification of natural genetic variants
Metabolite Profiling	LC-MS, GC-MS, NMR-based metabolomics	Comprehensive chemical phenotyping, Tracking metabolic flux	Simultaneous analysis of numerous metabolites, Quantitative assessment of pathway activity
Computational Approaches	Deep learning algorithms, In silico fragmentation prediction, Database mining	Novel compound prediction, Spectral interpretation, Dereplication	Accelerated identification process, Prediction of previously uncharacterized metabolites
Protein Complex Analysis	Metabolon engineering, Protein-protein interaction studies	Optimization of metabolic channeling, Enhancement of pathway efficiency	Recreation of efficient biosynthetic complexes, Increased metabolic flux to target compounds

Future directions in metabolic engineering include metabolon engineering to optimize metabolic channeling, artificial intelligence integration for pathway prediction and optimization, and development of sustainable production strategies underscoring the potential for cheaper and greener production of plant natural products [4].

Experimental Protocols for Key Methodologies

Principle: Exposure to ultraviolet radiation, particularly UV-B (280-315 nm), activates plant defense mechanisms leading to increased biosynthesis of protective secondary metabolites including flavonoids, phenolics, and terpenoids [1].

Protocol:

• Plant Material Preparation: Utilize uniform, healthy plants or in vitro cultures at consistent developmental stages (e.g., 4-6 week old Arabidopsis plants or established cell suspension cultures).
• UV Treatment Setup: Position UV-B lamps (e.g., fluorescent UV-B tubes emitting at 312 nm) at appropriate distance to achieve desired fluence rate (typically 0.5-5 W m⁻²), measured with a UV radiometer.
• Elicitation Procedure: Expose plant material to UV-B radiation for controlled duration (e.g., 15 minutes to 4 hours depending on species sensitivity). For enhanced effect, follow UV treatment with dark incubation period (e.g., 36 hours) to facilitate metabolite accumulation [1].
• Harvest and Analysis: Collect plant material immediately or at designated time points post-elicitation. Flash-freeze in liquid nitrogen and store at -80°C until metabolite extraction and analysis.

Key Considerations: Include appropriate controls (non-UV exposed plants), monitor for potential UV stress damage, and optimize exposure duration and intensity for specific plant species [1].

LC/MS-Based Metabolite Discovery from Natural Products

Principle: High-resolution mass spectrometry coupled with liquid chromatography enables comprehensive profiling of secondary metabolites in complex plant extracts, facilitating discovery of novel compounds [6].

Protocol:

• Sample Preparation: Homogenize plant tissue (e.g., 100 mg fresh weight) in extraction solvent (e.g., 80% methanol, 1 mL). Sonicate for 15 minutes and centrifuge at 14,000 × g for 10 minutes. Collect supernatant for analysis.
• LC Conditions: Utilize reversed-phase chromatography (e.g., C18 column, 2.1 × 100 mm, 1.8 μm) with mobile phase A (water with 0.1% formic acid) and B (acetonitrile with 0.1% formic acid). Apply gradient elution (e.g., 5-95% B over 20 minutes) at flow rate of 0.3 mL/min.
• MS Analysis: Operate high-resolution mass spectrometer (e.g., Q-TOF or Orbitrap) in data-independent acquisition (DIA) mode with electrospray ionization in both positive and negative modes. Set mass range to m/z 100-1500 with resolution >30,000.
• Data Processing:
  • Noise Filtering: Remove ion peaks with intensity below predetermined threshold (e.g., <1000 counts) and m/z values below 100 [6].
  • Deisotoping: Eliminate isotopic peaks to simplify spectra using algorithm-based approaches.
  • Spectral Clustering: Group consecutive MS spectra with similarity scores above threshold (e.g., 0.90-0.95) using modified dot-product method to generate Representative MS Spectra (RMS) [6].
  • Deconvolution: Apply filters to separate co-eluted metabolites when consecutive spectra show different base peak ions or convex downward patterns.
• Dereplication and Novelty Assessment: Compare RMS against in-house or public databases. Calculate Fresh Compound Index (FCI) to grade structural novelty [6].

Essential Research Reagents and Materials

Table 3: Research Reagent Solutions for Secondary Metabolite Studies

Reagent/Category	Specific Examples	Function/Application	Technical Considerations
Chromatography Supplies	C18 reversed-phase columns, HILIC columns, Solid-phase extraction cartridges	Metabolite separation, sample clean-up	Column chemistry selection critical for compound classes; SPE enables fractionation
Mass Spectrometry Reagents	Formic acid, Ammonium acetate, Acetonitrile (LC-MS grade), Methanol (LC-MS grade)	Mobile phase modifiers, solvent systems	High-purity reagents essential for sensitive MS detection; acid modifiers improve ionization
Plant Culture Materials	Murashige and Skoog (MS) medium, Phytohormones (auxins, cytokinins), Elicitors (methyl jasmonate, salicylic acid)	Plant tissue culture, metabolite induction	Hormone balance critical for cell growth vs. production; elicitors enhance defense compounds
Molecular Biology Tools	RNA isolation kits, cDNA synthesis kits, qPCR reagents, Gateway cloning systems	Gene expression analysis, pathway engineering	Quality RNA essential for transcriptomics; modular cloning enables pathway assembly
Chemical Standards	Authentic standards (e.g., rutin, quercetin, artemisinin), Stable isotope-labeled internal standards	Metabolite identification and quantification	Necessary for definitive compound identification; isotope standards enable precise quantification
Specialized Light Sources	UV-B lamps (312 nm), LED arrays with specific wavelengths, Photoperiod-controlled growth chambers	Light quality studies, photoregulation research	Precise wavelength control essential for photoreceptor studies; intensity must be calibrated

Secondary metabolites represent a vast reservoir of chemical diversity with profound ecological significance and substantial application potential in medicine and biotechnology. Their definition as compounds "beyond primary needs" underscores their specialized roles in environmental adaptation and defense rather than core physiological functions. Advanced research methodologies spanning analytical chemistry, statistical design, and molecular biology are rapidly accelerating our understanding of their complex biosynthetic pathways and regulatory mechanisms. The integration of systems and synthetic biology approaches, coupled with sophisticated analytical platforms, promises to unlock previously inaccessible chemical diversity, enabling sustainable production of valuable plant natural products for pharmaceutical and industrial applications. As research in this field continues to evolve, the fundamental definition of secondary metabolites as strategic chemical solutions to ecological challenges provides a robust framework for future discovery and innovation.

Secondary metabolites are low-molecular-weight organic compounds produced by plants and microorganisms under specific conditions. While not directly involved in fundamental growth and developmental processes, they play crucial roles in plant defense, protection, and regulation, while also serving as critical resources in pharmaceutical and industrial applications [1]. The biosynthesis of these compounds proceeds through several conserved metabolic pathways, with the shikimic acid, acetate-mevalonate, and acetate-malonate pathways representing three fundamental routes for aromatic compounds, terpenoids, and fatty acids/polyketides, respectively [7] [8] [9]. Understanding these pathways at a mechanistic level provides researchers with the foundational knowledge necessary to manipulate metabolic fluxes for enhanced production of valuable compounds through metabolic engineering and synthetic biology approaches [10]. This technical guide examines the enzymatic steps, regulation, and experimental methodologies for these core biosynthetic pathways within the context of secondary metabolite research.

Pathway Fundamentals and Comparative Analysis

Shikimic Acid Pathway

The shikimate pathway is a seven-step metabolic pathway used by bacteria, archaea, fungi, algae, some protozoans, and plants for the biosynthesis of folates and aromatic amino acids (tryptophan, phenylalanine, and tyrosine). This pathway is not found in mammals, making it an attractive target for antimicrobial and herbicide development [7]. The pathway begins with the substrates phosphoenol pyruvate (PEP) and erythrose-4-phosphate (E4P), which undergo condensation catalyzed by DAHP synthase to form 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP). Through a series of enzymatic transformations, this compound is ultimately converted to chorismate, a key branch point metabolite that serves as the precursor for the three aromatic amino acids and multiple secondary metabolites [7] [10].

The shikimate pathway represents the primary route for the biosynthesis of aromatic compounds in nature, with its intermediate shikimic acid serving as the key raw material for synthesis of the influenza antiviral drug oseltamivir (Tamiflu) [10]. Other important pharmaceutical intermediates produced via this pathway and its branches include quinic acid, gallic acid, pyrogallol, and catechol. Modern pharmacological studies have revealed that shikimic acid derivatives exhibit anti-tumor, anti-thrombosis, anti-inflammatory, anti-virus, and analgesic properties [10].

Acetate-Mevalonate Pathway

The mevalonate pathway, also known as the isoprenoid pathway or HMG-CoA reductase pathway, is an essential metabolic pathway present in eukaryotes, archaea, and some bacteria [8]. This pathway begins with acetyl-CoA and proceeds through a series of condensation and reduction steps to produce the five-carbon building blocks isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP). These isoprenoid precursors are used to synthesize a diverse class of over 30,000 biomolecules including cholesterol, vitamin K, coenzyme Q10, and all steroid hormones [8].

The mevalonate pathway is best known as the target of statins, a class of cholesterol-lowering drugs that inhibit HMG-CoA reductase. The pathway is regulated through multiple mechanisms including transcriptional control by SREBP proteins, translational regulation, and enzyme phosphorylation [8]. Plants and most bacteria possess an alternative pathway for isoprenoid synthesis called the methylerythritol phosphate (MEP) or non-mevalonate pathway, which produces the same IPP and DMAPP outputs through entirely different enzymatic reactions [8].

Acetate-Malonate Pathway

The acetate-malonate pathway includes the synthesis of fatty acids and aromatic compounds with the help of secondary metabolites [9]. The main precursors of this pathway are acetyl-CoA and malonyl-CoA, with the end products being saturated or unsaturated fatty acids or polyketides. Polyketides are secondary metabolites which further synthesize aromatic compounds through the polyketide pathway and represent an important class of therapeutic compounds including antibiotics, antifungals, and immunosuppressants [9].

In plants, the acetate-malonate pathway operates at the interface of central and lipid metabolism while also supporting the phenylpropanoid pathway of flavonoid biosynthesis [11]. The pathway provides malonyl-CoA moieties for the C2 elongation reaction catalyzed by chalcone synthase, which combines with phenylpropanoid pathway products to form the basic flavonoid backbone structure. Research in Arabidopsis thaliana has demonstrated that this pathway is transcriptionally coregulated with flavonoid biosynthetic genes and is essential for normal flavonoid accumulation [11].

Table 1: Comparative Analysis of Major Biosynthetic Pathways

Feature	Shikimic Acid Pathway	Acetate-Mevalonate Pathway	Acetate-Malonate Pathway
Primary Function	Biosynthesis of aromatic amino acids and phenolic compounds	Production of isoprenoid precursors	Synthesis of fatty acids and polyketides
Initial Substrates	Phosphoenol pyruvate (PEP) and erythrose-4-phosphate (E4P)	Acetyl-CoA	Acetyl-CoA and malonyl-CoA
Key Intermediate	Shikimic acid	Mevalonic acid	Malonyl-CoA
End Products	Phenylalanine, tyrosine, tryptophan, folates, plant phenolics	IPP, DMAPP, sterols, carotenoids, terpenes	Fatty acids, flavonoids, polyketides
Organism Distribution	Bacteria, archaea, fungi, algae, plants, some protozoans	Eukaryotes, archaea, some bacteria	Universal
Pharmaceutical Significance	Tamiflu precursor, antibacterial targets	Statin targets, steroid hormones	Antibiotics, flavonoids with health benefits
Key Regulatory Enzymes	DAHP synthase, shikimate kinase	HMG-CoA reductase	Acetyl-CoA carboxylase

Table 2: Key Enzymes and Their Functions in Biosynthetic Pathways

Pathway	Enzyme	Reaction Catalyzed	Regulatory Features
Shikimic Acid	DAHP synthase	Condenses PEP and E4P to form DAHP	Feedback inhibited by aromatic amino acids
	Shikimate dehydrogenase	Reduces 3-dehydroshikimate to shikimate	Constitutively expressed in E. coli
	EPSP synthase	Couples shikimate-3-phosphate with PEP to form EPSP	Inhibited by glyphosate herbicide
Acetate-Mevalonate	HMG-CoA synthase	Condenses acetoacetyl-CoA with acetyl-CoA to form HMG-CoA	Transcriptional regulation by SREBP
	HMG-CoA reductase	Reduces HMG-CoA to mevalonate	Rate-limiting step; statin target
	Mevalonate-5-kinase	Phosphorylates mevalonate to mevalonate-5-phosphate	Consumes ATP
Acetate-Malonate	Acetyl-CoA carboxylase	Carboxylates acetyl-CoA to malonyl-CoA	Postulated to be essential for flavonoid biosynthesis
	Ketoacyl-CoA thiolase (KAT5)	Converts lipids to acetyl-CoA in peroxisomes	Coexpressed with flavonoid genes
	Chalcone synthase	Combines p-coumaroyl-CoA with malonyl-CoA for C2 elongation	Key entry point to flavonoid biosynthesis

Experimental Methodologies and Protocols

Metabolic Engineering of the Shikimate Pathway

Background: Metabolic engineering of the shikimate pathway has significantly improved the yield of shikimic acid and its derivatives. Escherichia coli serves as the most commonly used bacterium in the metabolic engineering of this pathway and its branches due to its well-characterized genetics and metabolism [10].

Protocol for Enhanced Shikimic Acid Production:

• Strain Construction: Begin with an appropriate E. coli host strain (e.g., K-12 derivatives). Genetically modify the strain to overexpress key shikimate pathway genes including aroG (encoding DAHP synthase feedback-resistant to phenylalanine inhibition), aroB (encoding DHQ synthase), and aroE (encoding shikimate dehydrogenase) [10].

• Branch Pathway Disruption: Knock out genes encoding shikimate kinase (aroL and aroK) to prevent conversion of shikimic acid to shikimate-3-phosphate, thereby accumulating shikimic acid. Additionally, disrupt the shiA gene encoding shikimate transporters to prevent shikimic acid uptake from the extracellular environment [10].

• Precursor Supply Enhancement: Modify central carbon metabolism to increase availability of the precursors phosphoenol pyruvate (PEP) and erythrose-4-phosphate (E4P). This can be achieved by overexpressing transketolase (tktA) to enhance E4P supply and employing PEP synthase (ppsA) overexpression or eliminating PEP-dependent phosphotransferase system (PTS) sugar transport to increase PEP availability [10].

• Fermentation Conditions: Cultivate engineered strains in defined mineral media with glucose as the carbon source. Maintain temperature at 30-37°C with appropriate aeration. Monitor shikimic acid accumulation throughout the fermentation process [10].

• Product Analysis: Quantify shikimic acid production using high-performance liquid chromatography (HPLC) with UV detection or LC-MS/MS for precise quantification [10].

Investigating the Acetate Pathway for Flavonoid Biosynthesis

Background: The acetate pathway, also known as the polyketide pathway, provides malonyl-CoA for flavonoid biosynthesis. This pathway operates at the interface of central and lipid metabolism and supports the phenylpropanoid pathway [11].

Protocol for Assessing Acetate Pathway Mutants:

• Mutant Selection: Identify or generate mutant lines for key acetate pathway enzymes using T-DNA insertion mutants or artificial microRNA (amiRNA) strategies. Key targets include ketoacyl-CoA thiolase (KAT5), enoyl-CoA hydratase (ECH), 3-hydroxyacyl-CoA dehydrogenase (HCD), and cytosolic acetyl-CoA carboxylase (ACC) [11].

• Metabolite Profiling: Employ a hierarchical metabolomics approach covering primary metabolites, secondary metabolites, and lipids. For primary metabolites, use GC-MS analysis of polar extracts. For secondary metabolites (flavonoids), utilize LC-MS/MS with multiple reaction monitoring for specific flavonoid compounds [11].

• Lipid Analysis: Extract lipids using appropriate organic solvents (e.g., chloroform:methanol mixtures) and analyze using LC-MS with electrospray ionization for comprehensive lipid profiling [11].

• Gene Expression Analysis: IsRNA from plant tissues and perform quantitative RT-PCR to measure expression levels of key structural genes of the flavonoid pathway (e.g., CHS, CHI, F3H) and acetate pathway genes [11].

• Data Integration: Correlate metabolic phenotypes with gene expression patterns to establish the role of specific acetate pathway enzymes in flavonoid biosynthesis and lipid metabolism [11].

Light-Mediated Regulation of Secondary Metabolite Pathways

Background: Light serves as a key environmental factor regulating the synthesis of plant secondary metabolites through multidimensional regulatory mechanisms. Different light qualities activate or suppress specific metabolic pathways via signal transduction networks mediated by specialized photoreceptors [1].

Protocol for Light Quality Experiments:

• Light Treatment Setup: Establish controlled environment growth chambers with specific light quality treatments using LED systems. Key treatments include:

  • UV-B light (280-315 nm) for activating phenolic and flavonoid biosynthesis
  • Blue light (450-495 nm) mediated by cryptochrome and phototropin receptors
  • Red light (620-750 nm) acting through phytochrome receptors [1]

• Plant Material and Growth Conditions: Use uniform plant materials (e.g., seedlings or tissue cultures) of species known for secondary metabolite production (e.g., Artemisia argyi, Taxus wallichiana). Maintain consistent light intensity and photoperiod across treatments except for the quality being tested [1].

• Sample Collection and Extraction: Harvest plant tissues at multiple time points following light exposure. Immediately freeze in liquid nitrogen and store at -80°C. Extract metabolites using appropriate solvents (e.g., methanol for phenolics, hexane for terpenoids) [1].

• Transcriptional Analysis: Isolate RNA from light-treated tissues and perform RNA-seq or qRT-PCR to monitor expression of pathway genes and transcription factors. Key targets include HY5, MYB transcription factors, and structural genes of relevant pathways [1].

• Metabolite Quantification: Analyze specific secondary metabolites using HPLC, GC-MS, or LC-MS/MS. For shikimate pathway-related compounds, focus on phenylpropanoids and flavonoids. For mevalonate pathway, analyze terpenoid profiles [1].

Pathway Visualization and Regulation

Shikimic Acid Pathway Engineering Strategy

Diagram 1: Shikimic acid pathway with engineering targets. Key engineering strategies include overexpression of DAHP synthase (AroG/F/H) and knockout of shikimate kinase (AroL/K) to accumulate shikimic acid.

Mevalonate Pathway Regulation

Diagram 2: Mevalonate pathway regulation. The rate-limiting HMG-CoA reductase step is targeted by statins, with transcriptional regulation by SREBP. Some organisms utilize an alternative MEP pathway.

Acetate-Malonate Pathway in Flavonoid Biosynthesis

Diagram 3: Acetate-malonate pathway in flavonoid biosynthesis. The pathway provides malonyl-CoA for chalcone synthase, which combines with phenylpropanoid pathway products to form flavonoid precursors.

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Research Reagents for Biosynthetic Pathway Studies

Reagent/Category	Specific Examples	Function/Application	Research Context
Key Enzymes	DAHP synthase (AroG/F/H), HMG-CoA reductase, Chalcone synthase (CHS)	Pathway catalysis and regulation studies	Protein purification, enzyme kinetics, inhibitor screening
Inhibitors	Glyphosate (EPSP synthase inhibitor), Statins (HMG-CoA reductase inhibitors)	Pathway perturbation studies	Mechanism of action studies, flux control analysis
Analytical Standards	Shikimic acid, mevalonolactone, malonyl-CoA, naringenin	Metabolite quantification and method validation	HPLC, LC-MS/MS calibration, absolute quantification
Expression Vectors	pET system for E. coli, plant binary vectors	Heterologous gene expression	Pathway engineering, enzyme characterization
Antibodies	Anti-HMGCR, anti-ACC, anti-MYB transcription factors	Protein detection and quantification	Western blotting, immunoprecipitation, localization studies
Mutant Collections	Arabidopsis T-DNA lines, E. coli knockout collections	Gene function analysis	Phenotypic screening, metabolomic profiling
Light Sources	UV-B lamps, specific wavelength LED systems	Photoregulation studies	Light quality experiments, photoreceptor studies
Oxaziclomefone	Oxaziclomefone|Herbicide for Research Use	Oxaziclomefone is a selective herbicide that inhibits cell expansion in grasses. This product is for laboratory research use only (RUO) and is not intended for personal use.	Bench Chemicals
Methyl Orsellinate	Methyl 2,4-Dihydroxy-6-methylbenzoate|Methyl Orsellinate	Methyl 2,4-dihydroxy-6-methylbenzoate (Methyl Orsellinate) is a lichen metabolite for cancer, antifungal, and inflammation research. This product is for Research Use Only (RUO). Not for human or veterinary use.	Bench Chemicals

The shikimic acid, acetate-mevalonate, and acetate-malonate pathways represent fundamental biosynthetic routes that interface between primary metabolism and specialized secondary metabolite production. Each pathway possesses distinct regulatory mechanisms, enzymatic components, and biotechnological applications. Contemporary research employs sophisticated metabolic engineering strategies, comprehensive metabolomic profiling, and light-mediated regulation to manipulate these pathways for enhanced production of valuable compounds. The continued elucidation of regulatory networks and rate-limiting steps across these interconnected pathways will further advance our ability to engineer microbial and plant systems for pharmaceutical and industrial applications, particularly through the integration of synthetic biology approaches with traditional metabolic engineering.

Secondary metabolites (SMs) represent a vast reservoir of structurally complex molecules with profound impacts on human health, agriculture, and ecology. These compounds are synthesized by bacteria, fungi, and plants through specialized metabolic pathways. Biosynthetic gene clusters (BGCs) encode the enzymatic machinery for SM production, typically featuring core synth(et)ase genes surrounded by accessory tailoring enzymes, regulators, and transporters [12]. Among these core enzymes, polyketide synthases (PKSs), nonribosomal peptide synthetases (NRPSs), and terpene cyclases (TCs) serve as the fundamental architects of chemical diversity, generating an astonishing array of molecular scaffolds from simple building blocks [13] [14]. These enzymatic systems provide the foundational carbon frameworks that tailoring enzymes subsequently modify, yielding the structural complexity characteristic of natural products.

The engineering of these enzymatic pathways through combinatorial biosynthesis has emerged as a powerful strategy for generating novel compounds with enhanced or new biological activities [14]. This technical guide examines the core machinery of PKS, NRPS, and terpene cyclase enzymes, detailing their mechanisms, experimental characterization, and engineering approaches, framed within the context of contemporary secondary metabolite research.

Polyketide Synthases (PKS): Molecular Assembly Lines

Architectural Domains and Classification

Polyketide synthases are multifunctional enzymes that assemble polyketide backbones through sequential decarboxylative Claisen condensations of acyl-CoA precursors, analogous to fatty acid synthesis but with far greater product diversity [13]. Fungal PKSs are typically iterative type I enzymes that carry multiple catalytic domains on a single polypeptide and reuse their active sites for multiple catalytic cycles [15]. These mega-enzymes are classified into three major categories based on their domain composition and reduction level:

• Non-reducing PKS (NR-PKS): Contain starter unit acyl carrier protein transacylase (SAT), ketosynthase (KS), acyltransferase (AT), product template (PT), acyl carrier protein (ACP), and thioesterase (TE) domains. They produce unreduced, aromatic polyketides [15] [14].
• Partially-reducing PKS (PR-PKS): Lack full reductive capacity but may contain ketoreductase (KR) domains [14].
• Highly-reducing PKS (HR-PKS): Contain KS, AT, ACP, and multiple reductive domains (KR, dehydratase (DH), enoyl reductase (ER)) that generate highly reduced, often chiral, polyketide chains [15] [14].

Table 1: Core Domains in Fungal Polyketide Synthases

Domain	Function	Present in PKS Type
SAT (Starter unit ACP transacylase)	Selects and loads starter unit	NR-PKS
KS (Ketosynthase)	Catalyzes chain elongation	All types
AT (Acyltransferase)	Selects and loads extender unit	All types
ACP (Acyl Carrier Protein)	Carries growing polyketide chain	All types
PT (Product Template)	Controls polyketide cyclization	NR-PKS
KR (Ketoreductase)	Reduces ketone to alcohol	HR-PKS, PR-PKS
DH (Dehydratase)	Eliminates water to form alkene	HR-PKS
ER (Enoylreductase)	Reduces alkene to alkane	HR-PKS
TE (Thioesterase)	Releases final product	NR-PKS, some HR-PKS

Representative Biosynthetic Pathways and Engineering

The collaboration between different PKS types enables the synthesis of complex benzenediol lactones. For example, the phytotoxin aldaulactone from Alternaria dauci is synthesized by the collaborative action of a highly-reducing PKS (HR-PKS) and a non-reducing PKS (NR-PKS) [15]. The HR-PKS (AdPKS7) synthesizes a reduced polyketide that is transferred to the NR-PKS (AdPKS8), which performs additional elongations and cyclizations to form the benzenediol lactone scaffold [15].

Engineering PKS enzymes through domain swapping has proven effective for generating novel compounds. Swapping the product template (PT) domain from ApdA (in asperthecin biosynthesis) into PKS4 (in bikaverin biosynthesis) resulted in the production of a novel α-pyranoanthraquinone [14]. Similarly, swapping both PT and TE domains between different NR-PKS systems has yielded novel macrocyclic compounds, including the unexpected polyketide 1-(7,9,10-trihydroxy-1-oxo-1H-benzo[g]isochromen-3-yl)pentane-2,4-dione [14].

Figure 1: PKS Classification and Engineering Workflow. Fungal polyketide synthases are categorized based on their reductive capabilities and domain architecture, with engineering strategies enabling diversification of polyketide products.

Nonribosomal Peptide Synthetases (NRPS): Template-Independent Peptide Assembly

Modular Organization and Mechanism

Nonribosomal peptide synthetases are multimodular enzymatic assembly lines that synthesize structurally diverse peptides without direct mRNA templating. Each NRPS module is responsible for incorporating one amino acid building block into the growing peptide chain, with the number and order of modules determining the final peptide sequence [15]. The core domains within each NRPS module include:

• Adenylation (A) domain: Selects and activates the specific amino acid substrate through adenylation.
• Peptidyl Carrier Protein (PCP) domain: Shuttles the activated amino acid as a thioester using a phosphopantetheine prosthetic group.
• Condensation (C) domain: Catalyzes peptide bond formation between adjacent modules.

Additional specialized domains include epimerization (E) domains that convert L-amino acids to D-configurations, methyltransferase (MT) domains that install N-methyl groups, and various termination domains (thioesterase TE or reductase R) that release the final product [15] [14].

Hybrid NRPS Systems and Unconventional Mechanisms

Many natural products arise from hybrid NRPS systems that incorporate polyketide and terpenoid elements. The flavunoidine pathway from Aspergillus flavus exemplifies collaboration between NRPS and terpene cyclases, where a single-module NRPS (FlvI) esterifies 5,5-dimethyl-L-pipecolate to an oxygenated sesquiterpene core [16]. This hybrid TC/NRPS cluster produces alkaloidal terpenoids with cage-like tetracyclic structures previously unknown in nature [16].

Unconventional NRPS mechanisms continue to be discovered. In Mortierella alpina, NRPS enzymes with atypical epimerase/condensation domains produce cyclic peptides like malpinin acetylated hexapeptides and malpibaldin cyclic pentapeptides [17]. These systems highlight the evolutionary diversity of NRPS machinery across fungal lineages.

Table 2: Experimental Characterization of NRPS Selectivity

A-domain Specificity	Representative Amino Acid	Non-Proteinogenic Examples	Product Example
Aliphatic	L-Valine, L-Leucine	D-forms, N-methylated	Cyclosporine A
Aromatic	L-Tryptophan, L-Phenylalanine	Hydroxylated, chlorinated	Echinocandin
Acidic	L-Glutamate, L-Aspartate	Adenylate-forming reductases	β-lactam antibiotics
Unusual	L-Ornithine, L-Pipecolate	Dimethylcadaverine	Flavunoidine [16]

Terpene Cyclases: Architectural Masters of Molecular Complexity

Cyclization Mechanisms and Structural Diversity

Terpene cyclases transform linear, achiral polyprenyl pyrophosphates into an immense variety of carbocyclic skeletons with exquisite stereochemical control. Using farnesyl pyrophosphate (FPP, C15) or geranylgeranyl pyrophosphate (GGPP, C20) as substrates, these enzymes generate mono-, sesqui-, and diterpenes through carbocation-mediated cyclization cascades [13] [17]. The catalytic mechanism involves substrate ionization to generate reactive carbocation intermediates that undergo precise cyclization, rearrangement, and termination steps, all controlled within the enzyme's active site.

The flavunoidine biosynthetic pathway demonstrates sophisticated terpene cyclase collaboration. In Aspergillus flavus, two distinct terpene cyclases work sequentially: FlvE produces (+)-acoradiene, a sesquiterpene hydrocarbon, which is then remodeled by a second TC (FlvF) and cytochrome P450 oxygenases to generate a tetracyclic, cage-like core structure [16]. This exemplifies how terpene cyclases can generate unprecedented molecular architectures.

Distribution Across Fungal Lineages

Terpenoid biosynthesis dominates the secondary metabolite landscape across diverse fungal lineages. Genomic analyses reveal that terpene clusters represent the most abundant class of predicted BGCs in early-diverging Mucoromycotina, with diverse domain compositions suggesting highly variable products [17] [18]. In the Hypoxylaceae family, terpene cyclases contribute significantly to the remarkable chemical diversity observed, with species-specific BGCs generating unique terpenoid scaffolds [12].

Experimental Protocols and Methodologies

Genome Mining and Cluster Identification

The systematic identification of biosynthetic gene clusters employs integrated bioinformatics pipelines:

• Genome Sequencing and Assembly: Obtain high-quality genome sequences using long-read technologies (e.g., Oxford Nanopore, PacBio) to achieve contiguity (N50 > 1 Mbp preferred) sufficient for complete cluster capture [12].

• Gene Prediction and Annotation: Employ tools like GLIMMERHMM for ab initio gene prediction, complemented by transcriptomic evidence for accurate exon-intron boundary definition [17].

• BGC Identification: Utilize antiSMASH with ClusterFinder extension to predict BGC boundaries and classify cluster types based on core biosynthetic genes [19] [17].

• Comparative Analysis: Process predicted BGCs with BiG-SCAPE to organize into Gene Cluster Families (GCFs) based on content and architecture, revealing evolutionary relationships [19] [12].

• Heterologous Expression: Clone entire BGCs into fungal expression hosts (e.g., Aspergillus nidulans) to confirm cluster functionality and characterize metabolic output [16].

Pathway Elucidation through Gene Inactivation

Systematic dissection of individual gene functions follows this workflow:

• Targeted Gene Knockout: Replace target genes with selectable markers using homologous recombination or CRISPR/Cas9 systems [16].

• Metabolite Profiling: Compare metabolic profiles of wild-type and knockout strains using LC-HRMS and MS/MS molecular networking to identify missing compounds [16].

• Intermediate Isolation: Purify and structurally characterize pathway intermediates that accumulate in knockout mutants [16].

• Enzyme Reconstitution: Heterologously express and purify individual enzymes for in vitro biochemical characterization using appropriate substrates [16].

• Feeding Experiments: Supplement knockout strains with putative intermediates to establish precursor-product relationships and pathway sequence [16].

Figure 2: Experimental Workflow for BGC Characterization. Integrated approaches combining bioinformatics, genetics, and metabolomics enable comprehensive dissection of secondary metabolic pathways.

The Scientist's Toolkit: Essential Research Reagents and Methods

Table 3: Key Reagents and Resources for PKS, NRPS, and Terpene Cyclase Research

Reagent/Resource	Function/Application	Example Uses
antiSMASH	BGC identification and annotation	Predicts cluster types and boundaries based on core biosynthetic genes [19] [17]
BiG-SCAPE	Comparative analysis of BGCs	Groups BGCs into Gene Cluster Families based on similarity [12]
Heterologous Host Systems	Cluster expression and validation	Aspergillus nidulans, Saccharomyces cerevisiae for pathway reconstitution [16]
LC-HRMS/MS	Metabolite profiling and identification	Structural characterization of natural products and intermediates [16] [19]
Gene Knockout Tools	CRISPR/Cas9, homologous recombination	Functional characterization of individual cluster genes [16]
In vitro Enzyme Assays	Biochemical characterization	Substrate specificity and kinetic analysis of purified enzymes [16]
MIBIG Database	Repository of known BGCs	Reference for comparative analysis of novel clusters [17]
Allyl methyl sulfide	Allyl methyl sulfide, CAS:10152-76-8, MF:C4H8S, MW:88.17 g/mol	Chemical Reagent
Picolinafen	Picolinafen, CAS:137641-05-5, MF:C19H12F4N2O2, MW:376.3 g/mol	Chemical Reagent

The enzymatic machinery of PKS, NRPS, and terpene cyclases represents nature's sophisticated toolkit for generating chemical diversity. These core biosynthetic systems employ distinct yet complementary strategies to construct complex molecular scaffolds from simple building blocks. Combinatorial biosynthesis approaches that engineer these systems through domain swapping, module fusion, and pathway recombination are rapidly advancing our ability to access novel chemical space [14].

Future research directions will focus on elucidating the structural basis of enzyme specificity and mechanism, unlocking the vast majority of orphan BGCs with unknown products, and developing increasingly precise genome editing tools for pathway engineering [12] [14]. As genomic and metabolomic technologies continue to advance, our understanding of these remarkable enzymatic systems will deepen, accelerating the discovery and engineering of valuable natural products for therapeutic and industrial applications.

Secondary metabolites (SMs) represent a vast array of plant-synthesized compounds that, while not essential for primary growth and development, are indispensable for survival and ecological interactions [20]. These compounds provide plants, as sessile organisms, with a chemical toolkit to defend against biotic and abiotic stresses, facilitate communication, and adapt to environmental challenges [21] [22]. The biosynthesis of these metabolites is tightly regulated through sophisticated pathways and is often induced or enhanced under stress conditions, enabling plants to tolerate stressful environments [20]. Understanding the ecological roles of SMs is crucial for fundamental plant science and has significant implications for developing stress-resistant crops and discovering novel pharmaceutical compounds [20] [23]. This review provides an in-depth analysis of the defense, signaling, and adaptive functions of secondary metabolites, framed within the context of their biosynthesis and biogenesis.

Classes of Secondary Metabolites and Their Defense Functions

Secondary metabolites are broadly classified into several major categories based on their chemical structures and biosynthetic origins. Each class encompasses a diverse array of compounds with specific ecological roles, particularly in plant defense.

Table 1: Major Classes of Secondary Metabolites and Their Defense Roles

Metabolite Class	Biosynthetic Pathway	Key Subclasses	Primary Ecological Functions
Terpenoids/Terpenes [21] [22]	Mevalonic Acid (MVA) & Methylerythritol Phosphate (MEP) pathways [21]	Monoterpenes (C10), Sesquiterpenes (C15), Diterpenes (C20), Triterpenes (C30) [21]	Antimicrobial and antioxidant activities; herbivore deterrence; membrane stabilization; thermal stress tolerance [21] [22]
Phenolics [21] [22]	Shikimic Acid pathway [22]	Phenolic acids, Flavonoids, Lignin, Tannins, Coumarins [22]	Structural defense (lignin, suberin); potent antioxidant activity; neutralization of Reactive Oxygen Species (ROS) [21] [22]
Alkaloids [20] [21]	Derived from amino acids	Indole alkaloids, tropane alkaloids, etc. [20]	Toxicity to herbivores and pathogens; acting as natural pesticides and feeding deterrents [22]
Nitrogen- and Sulfur-Containing Compounds [21] [22]	Various	Glucosinolates, Alkaloids, Cyanogenic glycosides, Thionine, Defensins [21] [22]	Chemical deterrence against herbivores and pathogens; disruption of microbial integrity; anti-ROS activity [21] [22]

The production of these SMs is not constant but is dynamically regulated by environmental factors. For instance, abiotic stresses like drought, salinity, and extreme temperatures, as well as biotic stresses from pathogens and herbivores, act as elicitors, triggering sophisticated biosynthetic and signaling networks that lead to the accumulation of defensive compounds [20] [21] [22]. This induced defense mechanism allows plants to allocate resources efficiently, producing necessary chemical defenses only when threatened.

Signaling Molecules and the Regulation of Secondary Metabolism

The biosynthesis of secondary metabolites in response to environmental stimuli is coordinated by a complex network of signaling molecules. These molecules act as messengers, integrating stress signals and activating the transcriptional and biochemical pathways responsible for SM production.

Table 2: Key Signaling Molecules in Secondary Metabolite Biosynthesis

Signaling Molecule	Nature	Role in SM Biosynthesis & Stress Response
Nitric Oxide (NO) [21]	Gaseous free radical	Modulates enzyme activity and transcription factors; influences SM biosynthetic pathways; provides adaptation under adverse conditions [21].
Hydrogen Sulfide (Hâ‚‚S) [21]	Gaseous molecule	Mitigates abiotic stress by counteracting ROS accumulation; enhances bioactive compound production [21].
Methyl Jasmonate (MeJA) [21]	Plant hormone derivative	Elicits production of broad categories of SMs (e.g., rosmarinic acid, terpenoids, indole alkaloids); increases expression of biosynthetic transcription factors and genes [21].
Hydrogen Peroxide (Hâ‚‚Oâ‚‚) [21]	Reactive Oxygen Species	Acts as a signaling molecule in stress responses; involved in network of molecules that promote metabolic adjustments and SM accumulation [21].
Calcium (Ca²⁺) [21]	Ion	Integral role in stress responses and SM production; works in a network with other signaling molecules [21].

The following diagram illustrates the crosstalk between environmental stress, key signaling molecules, and the induction of secondary metabolite biosynthesis pathways:

A critical mechanism by which these signaling molecules exert their effect is through the activation of specific transcription factors such as MYB, bHLH, and WRKY [20]. For example, the WRKY transcription factor is a central regulator that influences the production of alkaloids like taxol in Taxus chinensis and artemisinin in Artemisia annua [21]. This coordinated signaling network ensures that the plant's chemical defense is precisely tailored to the specific environmental challenge.

Methodologies for Studying Secondary Metabolites

Research into the biosynthesis and ecological roles of secondary metabolites relies on a combination of advanced analytical, molecular, and biochemical techniques.

Analytical Techniques for Metabolite Profiling

The comprehensive identification and quantification of SMs are foundational to the field. Key methodologies include:

• Liquid Chromatography-Mass Spectrometry (LC/MS) [23] [24]: This is a core technique for the guided isolation and purification of secondary metabolites. It allows researchers to separate complex mixtures and identify compounds based on their mass-to-charge ratio. It is routinely used for metabolic profiling to compare SM composition across different plant accessions or under varying stress conditions [23] [24].
• Nuclear Magnetic Resonance (NMR) Spectroscopy [23]: NMR is the definitive method for determining the precise chemical structure of isolated compounds. A full suite of experiments, including 1H, 13C, 1H–1H COSY, HSQC, and HMBC, is used to elucidate molecular structures and confirm absolute configurations [23].

Molecular and Genetic Techniques

Understanding the regulatory networks behind SM biosynthesis requires molecular approaches:

• Gene Expression Analysis: Studying the expression levels of genes involved in biosynthetic pathways (e.g., for transcription factors like WRKY or enzymes like DXS in the terpenoid pathway) under different stress conditions or in response to signaling molecules [21].
• Multivariate Statistical Analysis: Advanced statistical tools such as Principal Component Analysis (PCA) and Hierarchical Cluster Analysis (HCA) are employed to analyze complex metabolite data sets. These methods can identify key biomarkers that differentiate genetic accessions and reveal correlations between specific metabolites (e.g., guayulins and rubber) [24].

Experimental Protocols for Key Analyses

Protocol: LC/MS-Guided Isolation of Secondary Metabolites from Fungal Culture [23]

• Fermentation and Extraction: Culture the source organism (e.g., Penicillium brevicompactum) in an appropriate liquid medium. After a defined period, separate the mycelia from the broth. Extract the secondary metabolites from the mycelia using an organic solvent like ethyl acetate or methanol, and concentrate under vacuum.
• LC/MS Profiling: Re-dissolve the crude extract and analyze by LC/MS. Use the mass spectral data to guide the fractionation process towards target compounds or compounds with novel masses.
• Chromatographic Purification: Subject the crude extract to successive chromatographic separations. This typically involves:
  • Step 1: Open Column Chromatography. Fractionate the extract using a normal-phase (e.g., silica gel) or reversed-phase (e.g., C18) column with a stepwise or gradient elution of solvents of increasing polarity.
  • Step 2: Preparative HPLC. Further purify individual fractions using preparative high-performance liquid chromatography (HPLC) with a reversed-phase column to obtain pure compounds.
• Structural Elucidation: Analyze pure compounds using NMR spectroscopy (1H, 13C, and 2D experiments like COSY, HSQC, HMBC) and HR-ESIMS to determine their planar and absolute structures.

Protocol: Multivariate Analysis of Metabolite Data for Biomarker Discovery [24]

• Data Collection: Over multiple growing seasons or experiments, compile a comprehensive dataset of metabolite contents (e.g., 82 metabolites across 27 accessions) measured under standardized conditions.
• Data Normalization: Normalize the data to ensure comparability across different metabolites and accessions.
• Statistical Processing:
  • Principal Component Analysis (PCA): Perform PCA to reduce the dimensionality of the data and visualize natural groupings among accessions. Identify which metabolites contribute most to the variance between groups.
  • Hierarchical Cluster Analysis (HCA): Use HCA to cluster accessions and metabolites based on their abundance profiles, revealing patterns and relationships.
  • Spearman Correlation: Calculate correlation coefficients between different metabolites to identify strong positive or negative relationships (e.g., between guayulin A and rubber content).
• Interpretation: Use the results to identify specific metabolites that serve as strong biomarkers for genetic classification or that are strongly linked to traits of economic importance.

The Scientist's Toolkit: Research Reagent Solutions

The following table details key reagents, materials, and tools essential for experimental research in secondary metabolite biosynthesis and function.

Table 3: Essential Research Reagents and Materials for Secondary Metabolite Research

Item/Biological Material	Function/Application	Example/Description
Model Producer Organisms	Source of diverse secondary metabolites for isolation and study.	Penicillium brevicompactum MSW10-1 (marine fungus) [23]; Parthenium argentatum (Guayule) [24].
Signaling Molecule Elicitors	To experimentally induce SM biosynthesis pathways in vivo or in vitro.	Sodium nitroprusside (NO donor); NaHS (Hâ‚‚S donor); Methyl Jasmonate (MeJA); Hydrogen Peroxide (Hâ‚‚Oâ‚‚) [21].
Chromatography Media	For separation and purification of secondary metabolites from crude extracts.	Silica gel, C18 reversed-phase silica for column chromatography; analytical and preparative C18 HPLC columns [23].
Deuterated Solvents	Essential for NMR spectroscopy for structural elucidation of purified compounds.	Deuterated chloroform (CDCl₃), Deuterated dimethyl sulfoxide (DMSO-d₆), Deuterated methanol (CD₃OD) [23].
Cell-based Bioassay Systems	For functional evaluation of isolated SMs for biological activity (e.g., therapeutic potential).	HepG2 liver cancer cells for assessing inhibition of hepatic lipogenesis [23]; primary mouse hepatocytes.
cudraflavone B	Cudraflavone B - Premium PF|CAS 19275-49-1
kaempferol 3-O-sophoroside	kaempferol 3-O-sophoroside, CAS:19895-95-5, MF:C27H30O16, MW:610.5 g/mol	Chemical Reagent

Secondary metabolites are central regulators of plant defense, signaling, and environmental adaptation. Their biosynthesis, orchestrated by a complex network of stress-induced signaling molecules and transcription factors, equips plants to survive in a dynamic and challenging environment. The ecological roles of terpenes, phenolics, alkaloids, and sulfur/nitrogen-containing compounds are diverse, ranging from direct toxicity against herbivores to antioxidant activity and structural reinforcement. Modern research, leveraging advanced analytical techniques like LC/MS and NMR alongside multivariate statistical analysis, continues to unravel the complexity of these compounds and their regulatory networks. This deep understanding paves the way for harnessing SMs to improve crop resilience through genetic engineering and to discover novel compounds for pharmaceutical applications, thereby contributing to agricultural sustainability and human health.

The escalating crisis of antimicrobial resistance and the persistent challenge of neoplastic diseases necessitate a continuous pipeline of novel therapeutic agents. Within this context, the symbiotic relationship between medicinal plants and their associated endophytic actinomycetes represents a frontier in the discovery of bioactive secondary metabolites. Secondary metabolites are organic compounds not directly involved in normal growth, development, or reproduction but are crucial for ecological interactions and defense [25] [26]. Actinomycetes, Gram-positive bacteria with high guanine-cytosine content in their DNA, are prolific producers of these compounds, accounting for approximately 45-50% of all discovered bioactive microbial metabolites [25] [27]. Notably, the single genus Streptomyces is responsible for 76% of these compounds, underscoring its dominance in this field [27].

Medicinal plants, shaped by long-term evolutionary pressures, produce a diverse array of unique secondary metabolites. Their endophytic actinomycetes, residing symbiotically within the plant tissues, have adapted to this chemically rich environment and often possess the genetic machinery to produce analogous or entirely novel bioactive compounds [27]. This synergistic relationship creates a powerful dual source for drug leads. However, a significant challenge lies in the fact that under standard laboratory conditions, many of the biosynthetic gene clusters (BGCs) in actinomycetes remain "silent" or "cryptic" [28] [29]. This whitepaper delves into the biodiversity, bioactive potential, and advanced genomic strategies required to unlock the full potential of these natural powerhouses within the broader context of biosynthesis and biogenesis research.

Actinomycetes and medicinal plants are not uniformly distributed; their diversity and chemical potential are heavily influenced by their ecological niches.

2.1 Actinomycetes in Diverse Habitats Actinomycetes exhibit remarkable ecological adaptability, thriving in environments ranging from common soils to extreme habitats. This diversity is a key source of chemical novelty, as summarized in Table 1.

Table 1: Habitat-Specific Diversity of Actinomycetes and Their Bioactive Compounds

Habitat	Examples of Actinomycete Genera	Reported Bioactivities
Terrestrial Soil	Streptomyces, Nocardia	Antibiotics, antimicrobials [25]
Rhizosphere Soil	Streptomyces	Antifungal agents, plant growth promotion [25]
Marine Ecosystems	Salinispora, Micromonospora	Novel antibiotics, anticancer agents [25] [30]
Medicinal Plants (Endophytic)	Streptomyces, Micromonospora, Nocardia, Brevibacterium, Leifsonia	Broad-spectrum antimicrobial, anticancer [25] [27] [31]
Extreme Environments (e.g., Hypersaline, Desert)	Streptomyces albidoflavus, S. griseoflavus	Antibacterial, antifungal [25]

The isolation of rare genera like Brevibacterium, Microbacterium, and Leifsonia xyli from medicinal plants such as Mirabilis jalapa and Clerodendrum colebrookianum highlights that these plants are reservoirs of untapped microbial diversity [31].

2.2 Endophytic Actinomycetes in Medicinal Plants Endophytic actinomycetes colonize the internal tissues of plants without causing disease. Their distribution within the plant is not random; they are most frequently isolated from roots, followed by stems, with leaves yielding the fewest isolates [27]. This likely reflects the soil as the primary source of colonization. The choice of isolation media is critical for capturing this diversity, with Starch Casein Nitrate Agar (SCNA), Tap Water Yeast Extract Agar (TWYE), and Humic Acid Vitamin B (HV) agar being among the most effective [27] [31].

Experimentation and Analytical Methodologies

A standardized, rigorous protocol is essential for the isolation, identification, and screening of endophytic actinomycetes.

3.1 Protocol for Isolation and Screening of Endophytic Actinomycetes

• 1. Sample Collection and Surface Sterilization: Collect fresh, healthy plant organs (roots, stems, leaves). Wash in running tap water and subject to sequential surface sterilization: immersion in 70% ethanol (3 min), followed by 0.4% sodium hypochlorite (1 min), and another rinse in 70% ethanol (2 min), concluding with three sterile distilled water washes [31].
• 2. Efficacy Validation: To confirm surface sterilization efficacy, imprint the sterilized tissue on an agar plate and inoculate the last wash water onto a control plate. The absence of microbial growth confirms that isolated microbes are true endophytes [27] [31].
• 3. Isolation and Cultivation: Aseptically macerate the surface-sterilized tissue and plate onto selective media like SCNA or AIA. Supplement media with antifungal agents (e.g., cycloheximide, 50-100 µg/mL) and antibacterial agents (e.g., nalidixic acid, 60 µg/mL) to inhibit the growth of fungi and fast-growing bacteria, respectively [27] [31]. Incubate plates at 26-28°C for 15-30 days.
• 4. Purification and Morphological Identification: Sub-culture distinct colonies showing actinomycete morphology (e.g., compact, filamentous, with aerial hyphae). Preliminary identification is based on characteristics of aerial and substrate mycelia, sporulation, and pigment production [31].
• 5. Molecular Identification: Extract genomic DNA and amplify the 16S rRNA gene for sequencing. This allows for accurate phylogenetic classification. For deeper genomic analysis, Whole Genome Sequencing can be performed [28].
• 6. Screening for Bioactivity: Conduct initial antimicrobial screening using the agar well diffusion method. Culture actinomycete isolates in broth, harvest cell-free supernatant, and place it in wells seeded with test pathogens (e.g., Staphylococcus aureus, Escherichia coli, Candida albicans) [31]. The presence of an inhibition zone indicates antimicrobial activity.

3.2 The Scientist's Toolkit: Essential Research Reagents Table 2: Key Reagents for Isolation and Characterization of Endophytic Actinomycetes

Reagent / Solution	Function / Application
Surface Sterilants (70% Ethanol, NaOCl)	Eliminates epiphytic microorganisms from plant tissue surfaces [27] [31].
Selective Media (SCNA, AIA, TWYE)	Provides nutrients selective for actinomycete growth while suppressing other microbes [27] [31].
Antifungal Agents (Nystatin, Cycloheximide)	Inhibits fungal contamination in culture plates [27].
Antibacterial Agents (Nalidixic Acid)	Suppresses the growth of Gram-negative bacteria during isolation [31].
Genomic DNA Extraction Kit	For obtaining high-quality DNA for PCR and sequencing [28].
16S rRNA PCR Primers	Amplification of the conserved 16S rRNA gene for phylogenetic analysis [31].

Key Bioactive Compounds and Their Biosynthetic Pathways

Actinomycetes are a primary source of clinically indispensable compounds. Their secondary metabolites are synthesized by massive enzyme complexes encoded by BGCs, which are often silent under laboratory conditions.

4.1 Major Classes of Bioactive Metabolites

• Antitumor Compounds: Many clinically used chemotherapeutics are derived from actinomycetes. Doxorubicin and Mitomycin C are potent antitumor antibiotics that function by intercalating into DNA and causing cross-linking, respectively, thereby disrupting DNA replication and transcription and inducing apoptosis [26] [32].
• Antimicrobial Compounds: The "Golden Age of Antibiotics" was built upon discoveries from actinomycetes. Streptomycin (from S. griseus), oxytetracycline, and erythromycin are classic examples that target bacterial protein synthesis [26] [32].
• Other Bioactivities: Metabolites like avermectin exhibit broad-spectrum antiparasitic activity, while others show antioxidant, antihyperglycemic, and anti-inflammatory properties [26] [32].

4.2 Activating Silent Biosynthetic Gene Clusters Genome mining has revealed that a typical Streptomyces genome harbors 25-50 BGCs, yet up to 90% remain silent in standard lab cultures [28] [29]. Several innovative strategies are employed to awaken this cryptic potential, with coculture being a particularly effective method that mimics natural ecological competition.

Diagram 1: Strategies to activate silent gene clusters for novel compound discovery. Adapted from [29] and [28].

Data Presentation: Quantitative Analysis of Bioactivity

Systematic screening provides quantitative evidence of the bioactivity potential inherent in actinomycetes, especially those isolated from medicinal plants.

Table 3: Quantitative Summary of Bioactive Potential from Select Studies

Study Focus	Isolation Source / Strategy	Key Quantitative Findings	Identified Bioactivities
Endophytic Actinomycetes from Medicinal Plants [31]	7 medicinal plants from India	42 total isolates; 22 (52.3%) showed antimicrobial activity. Highest isolation rate from roots (52.3%).	Broad-spectrum antimicrobial activity against human pathogens; presence of PKS-I and NRPS biosynthetic genes.
Genomic Potential of Actinomycetes [28]	211 genomes from diverse environments (mangroves, soil, marine sponges)	All 211 genomes met high-quality standards (≥95% completeness, <5% contamination). 32 strains were potential new species.	Dataset reveals extensive, unexplored smBGC diversity for novel compound discovery.
Antitumor Metabolites Review (2019-2024) [26] [32]	Systematic literature review	87 eligible studies identified diverse structural classes: polyketides, non-ribosomal peptides, alkaloids, and terpenoids.	Potent anticancer properties via apoptosis induction, proliferation inhibition, and disruption of tumor microenvironment.

The alliance between medicinal plants and endophytic actinomycetes constitutes a formidable and largely untapped reservoir for the biogenesis of novel secondary metabolites. The path forward requires an integrated, multidisciplinary approach. First, the exploration of underexplored and extreme ecosystems must be intensified to isolate novel actinomycete taxa. Second, high-throughput genome mining must become standard practice to map the vast landscape of silent BGCs. Finally, innovative activation strategies, particularly coculture and precision genetic engineering, are critical to translate genetic potential into chemical reality. By leveraging these advanced methodologies, researchers can systematically mine these powerhouses of bioactive compounds, paving the way for the next generation of therapeutics to address pressing global health challenges.

Harnessing Modern Technologies for Metabolite Discovery and Production

Genome Mining and In Silico Prediction of Biosynthetic Gene Clusters (BGCs)

In the context of secondary metabolites research, natural products represent an unparalleled source of bioactive compounds, many of which have found critical applications in medicine as antibiotics, anticancer agents, and immunosuppressants [33] [34]. These chemically diverse compounds are synthesized by bacteria, fungi, plants, and other organisms through genetically encoded biosynthetic pathways, typically organized as biosynthetic gene clusters (BGCs) [35] [33]. The emerging field of genome mining has revolutionized natural product discovery by leveraging computational tools to identify and characterize BGCs directly from genomic data, thereby uncovering the vast cryptic metabolic potential that far exceeds what is observed under laboratory conditions [36] [33].

This technical guide examines the core principles, methodologies, and tools for in silico prediction of BGCs, framing these computational approaches within the broader thesis of secondary metabolite biogenesis and their applications in drug discovery. As the pharmaceutical industry faces challenges including antibiotic resistance and high rediscovery rates of known compounds, genome mining provides a powerful strategy to prioritize novel chemical entities for experimental characterization [35] [37].

Computational Tools for BGC Identification and Analysis

The exponential growth of genomic sequencing data has propelled the development of sophisticated bioinformatic tools that identify BGCs based on our understanding of biosynthetic logic [33]. These tools primarily rely on homology to characterized pathways or employ machine learning approaches to detect novel BGC classes.

Table 1: Major Computational Tools for BGC Prediction and Analysis

Tool Name	Primary Algorithm	Key Features	Application Scope
antiSMASH [38] [39]	Hidden Markov Models (HMMs)	Identifies BGCs, compares to known clusters, predicts core structures	Generalist: Multiple BGC classes
PRISM [37] [38]	HMMs + Chemical graph-based prediction	Predicts secondary metabolite structures from BGC sequences	Generalist: Focus on structural prediction
DeepBGC [37] [38]	Bidirectional LSTM + Random Forest	Uses machine learning for BGC identification and product class prediction	Generalist: BGC identification & classification
GECCO [38]	Conditional Random Fields	Identifies BGCs using feature selection based on Fisher's exact test	Generalist: Particularly for bacterial genomes
BAGEL4 [38]	Protein motif search + BLAST	Specialized for bacteriocin identification	Class-specific: RiPPs (Bacteriocins)
RODEO [38]	HMM + Heuristic scoring + SVM	Identifies lasso peptide BGCs and predicts precursor peptides	Class-specific: RiPPs (Lasso peptides)
ARTS 2.0 [38]	HMMs + Genomic context analysis	Identifies antibiotic resistance genes within BGCs	Target-based: Antibiotic discovery
ClusterFinder [38]	Two-state HMM	Probabilistic identification of BGCs based on biosynthetic signatures	Generalist: Broad BGC detection

Specialized Databases for BGC Analysis

Table 2: Key Databases for BGC and Natural Product Research

Database	Content Scope	Key Features	Utility in Genome Mining
MIBiG [37] [39]	Curated BGCs with known products	Minimum information standard for BGC annotation	Reference database for known BGCs
ABC-HuMi [38]	BGCs from human microbiome	Interactive platform for five human body sites	Human microbiome-focused discovery
sBGC-hm [38]	BGCs from human gut microbiome	Specialized catalog of gut-derived BGCs	Gastrointestinal microbiome research
IMG/ABC [34]	Microbial BGCs from diverse environments	Large-scale database linking BGCs to metabolites	Comparative analysis across ecosystems

Experimental Methodologies and Workflows

Core Genome Mining Protocol

A standard workflow for BGC discovery integrates multiple computational tools to progress from raw genomic data to prioritized candidates for experimental validation [39]. The following protocol outlines key steps for comprehensive BGC analysis:

• Genome Acquisition and Preparation: Obtain genomic sequences in FASTA or GenBank format. For metagenomic studies, this step involves assembly of metagenome-assembled genomes (MAGs) from sequencing reads [38] [40].

• BGC Identification: Process genomic data through BGC prediction tools, with antiSMASH serving as the most widely adopted platform for initial detection [39]. antiSMASH identifies BGCs based on HMM profiles of core biosynthetic enzymes and additional features including Pfam domains and cluster boundaries [38].

• Feature Extraction and Annotation: Decompose identified BGCs into features describing gene components and biosynthetic capabilities. This includes:

  • Protein family (Pfam) domains and sub-PFAM domains using sequence similarity networks [37]
  • Resistance Gene Identifier (RGI) analysis to detect potential self-resistance genes [37]
  • Annotation of polyketide synthase (PKS) and nonribosomal peptide synthetase (NRPS) monomer predictions [37]

• Comparative Analysis and Prioritization: Compare identified BGCs against reference databases (e.g., MIBiG) to assess novelty [39]. Tools like BiG-SCAPE and BiG-FAM facilitate clustering of BGCs into Gene Cluster Families (GCFs) based on sequence similarity, enabling evolutionary analyses and prioritization of divergent clusters [38].

• Structure and Activity Prediction: For prioritized BGCs, utilize tools like PRISM to predict encoded chemical structures [38]. Machine learning classifiers can predict bioactivity (e.g., antibacterial, antifungal) directly from BGC features, achieving accuracies up to 80% for certain activity classes [37].

Targeted Genome Mining Approaches

Beyond general BGC detection, specialized mining strategies leverage particular genetic elements to discover compounds with desired properties:

• Resistance Gene-Based Mining: This approach targets BGCs containing self-resistance genes, particularly effective for antibiotic discovery. Genes conferring resistance through target duplication or modification are often co-localized with their corresponding biosynthetic machinery [33]. The ARTS 2.0 tool specializes in identifying BGCs with resistance genes through detection of physical proximity, gene duplication, and horizontal gene transfer events [38].

• Phylogeny-Guided Mining: This strategy focuses on taxonomic groups known for prolific metabolite production or understudied phyla with biosynthetic potential. For example, Planctomycetota have been found to contain numerous divergent BGCs, indicating untapped chemical diversity [40].

• Metabolomics-Integrated Mining: Coupling genomic data with mass spectrometry (MS) through tools like NPLinker and NPOmix enables connection of BGCs to their metabolic products, facilitating dereplication and structural elucidation [38] [33].

Diagram 1: Comprehensive workflow for genome mining and BGC prediction, integrating both general and specialized approaches.

Machine Learning in BGC Prediction and Bioactivity Assessment

The application of artificial intelligence, particularly machine learning (ML) and deep learning algorithms, has significantly enhanced both the speed and precision of BGC mining [35]. ML approaches address critical bottlenecks in natural product discovery, particularly in predicting the biological activity of encoded compounds prior to costly experimental characterization [37].

Machine Learning Framework for Bioactivity Prediction

A robust ML framework for BGC bioactivity prediction involves the following methodological components [37]:

• Training Dataset Assembly: Curate a high-quality dataset of known BGCs paired with their experimentally determined bioactivities. The MIBiG database serves as an essential resource, supplemented with literature-derived activity annotations [37]. Activities are typically recorded as binary values (active/inactive) for specific biological effects (e.g., antibacterial, antifungal, cytotoxic).

• Feature Engineering: Represent BGCs as feature vectors based on:

  • Pfam domain counts and sub-PFAM classifications via sequence similarity networks
  • smCOG annotations and CDs motifs
  • PKS/NRPS monomer predictions
  • Resistance genes identified through RGI analysis This process typically generates thousands of features (e.g., 1809 features for 1003 BGCs) [37].

• Classifier Training and Optimization: Train multiple binary classifiers (e.g., Random Forest, Support Vector Machines, Logistic Regression) using scikit-learn or similar libraries. Optimize parameters through 10-fold cross-validation to maximize balanced accuracy, particularly important for imbalanced datasets where certain activity classes may be underrepresented [37].

• Performance Validation: Evaluate classifiers using balanced accuracy metrics and receiver operator characteristic (ROC) analysis. Reported accuracies reach 74-80% for antibacterial and combined antifungal/antitumor/cytotoxic activities, though performance varies by activity class [37].

Diagram 2: Machine learning pipeline for predicting natural product bioactivity directly from BGC sequences.

Table 3: Essential Research Reagent Solutions for Genome Mining

Resource Category	Specific Tools/Platforms	Function in BGC Research
BGC Prediction Software	antiSMASH, DeepBGC, GECCO, PRISM	Identifies BGCs in genomic data using HMMs and machine learning algorithms [38] [39]
Specialized Prediction Tools	BAGEL4 (bacteriocins), RODEO (lasso peptides), TrRiPP (RiPPs)	Detects specific classes of natural products using class-specific algorithms [38]
Reference Databases	MIBiG, IMG/ABC, ABC-HuMi	Provides curated reference BGCs for comparison and annotation [37] [38] [39]
Analysis & Visualization	BiG-SCAPE, BiG-FAM, GATOR-GC	Enables comparative analysis of BGCs, deduplication, and evolutionary studies [41] [38]
Metabolomics Integration	NPLinker, NPOmix, Pep2Path	Connects BGCs to metabolites through mass spectrometry data [38]
Programming Libraries	scikit-learn, Python biopython	Facilitates custom machine learning model development and bioinformatics analysis [37]

Genome mining represents a transformative approach in secondary metabolite research, enabling systematic exploration of the vast biosynthetic potential encoded in microbial genomes [35] [33]. The integration of machine learning with bioinformatics tools has significantly advanced our ability to not only identify BGCs but also predict their chemical products and biological activities, thereby addressing key bottlenecks in natural product discovery [35] [37]. As these computational methods continue to evolve, they will undoubtedly deepen our understanding of secondary metabolite biogenesis and accelerate the development of novel therapeutic agents to address pressing medical needs, including antimicrobial resistance [35] [34]. For researchers in this field, maintaining current knowledge of the rapidly expanding toolkit of databases, algorithms, and integrative approaches is essential for harnessing the full potential of genome mining in both basic research and drug development pipelines.

The biosynthesis and biogenesis of secondary metabolites (SMs) represent a frontier in plant science and drug discovery. These compounds, crucial for plant adaptation and human therapeutics, are produced through complex enzymatic pathways that remain largely uncharacterized [42]. Traditional single-omics approaches have provided only partial insights, constrained by their requirement for prior knowledge and inability to capture system-level dynamics [42] [43]. The integration of genomics, transcriptomics, and metabolomics has emerged as a transformative paradigm, enabling de novo prediction of metabolic pathways and unprecedented understanding of SM biosynthesis through simultaneous analysis of biological layers [42] [44] [45].

This technical guide examines current methodologies, computational frameworks, and experimental protocols for multi-omics integration, with specific focus on applications in secondary metabolite research. We present standardized workflows, comparative tool analyses, and practical implementation guidelines to enable researchers to effectively leverage these approaches for elucidating biosynthetic pathways.

Computational Frameworks and Tools for Multi-Omics Integration

Methodological Approaches to Data Integration

Multi-omics integration strategies can be categorized into distinct methodological frameworks, each with specific strengths for secondary metabolite research:

Statistical and Correlation-based Methods: These approaches identify relationships between omics layers through correlation metrics. Mutual rank (MR)-based correlation maximizes highly correlated metabolite-transcript associations while reducing false positives [42] [43]. Weighted Gene Correlation Network Analysis (WGCNA) identifies modules of co-expressed, highly correlated genes and links them to metabolite profiles [46]. Correlation networks transform pairwise associations into graphical representations where nodes represent biological entities and edges reflect correlation thresholds [46].

Knowledge-Based Integration: Tools like MEANtools implement systematic unsupervised workflows that leverage reaction rules and metabolic structures from databases like RetroRules and LOTUS to predict candidate metabolic pathways de novo [42] [43]. This approach assesses whether observed mass differences between metabolites can be explained by reactions catalyzed by transcript-associated enzyme families.

Multivariate and Machine Learning Approaches: Multi-Omics Factor Analysis (MOFA+) uses latent factors to capture variation across different omics modalities, offering low-dimensional interpretation [47]. Deep learning methods like graph convolutional networks (MoGCN) reduce dimensionality using autoencoders while preserving essential features [47].

Table 1: Comparative Analysis of Multi-Omics Integration Tools

Tool/Method	Integration Approach	Key Features	Applications in SM Research
MEANtools	Knowledge-based	Uses reaction rules from RetroRules, structure matching with LOTUS database	Predicts candidate metabolic pathways de novo; correctly identified 5/7 steps in tomato falcarindiol pathway [42]
MOFA+	Statistical/multivariate	Unsupervised factor analysis, latent factors capture cross-omics variation	Feature selection for subtype classification; identified 121 relevant pathways in breast cancer study [47]
MoGCN	Deep learning	Graph convolutional networks with autoencoders for dimensionality reduction	Cancer subtype identification; selected features with biological relevance [47]
xMWAS	Correlation networks	Pairwise association with PLS components, community detection	Identifies highly interconnected omics communities [46]
PRISM 4	Genome mining	Predicts chemical structures from biosynthetic gene clusters	Links genomic loci to antibiotic structures; predicts natural product-like molecules [48]

Pathway Prediction and Network Analysis

Network-based integration methods abstract interactions among various omics into biological network models, aligning with the inherent organization of biological systems [49]. These approaches can be categorized into:

• Network propagation/diffusion methods that spread information across network structures
• Similarity-based approaches that identify patterns based on topological measures
• Graph neural networks that learn complex network representations
• Network inference models that reconstruct regulatory relationships [49]

For secondary metabolite research, these methods facilitate the identification of biosynthetic gene clusters, prediction of pathway completeness, and reconstruction of metabolic networks from multi-omics data.

Experimental Design and Workflow Implementation

Standardized Multi-Omics Workflow

A robust multi-omics workflow for secondary metabolite research encompasses several critical phases:

Experimental Design Considerations: Effective studies require paired transcriptomic-metabolomic datasets across multiple conditions, tissues, or timepoints. Research on Nicotiana tabacum demonstrated the importance of sampling at critical developmental stages (vigorous growth, topping, and harvest stages) to capture dynamic metabolic shifts [45]. Similarly, stress induction experiments (e.g., salt-alkali stress in Curcuma wenyujin) reveal responsive pathways and associated metabolites [50].

Sample Preparation and Data Generation:

• Metabolite Profiling: For comprehensive coverage, implement non-targeted metabolomics using UPLC-MS/MS with both positive and negative ionization modes [45] [50]. Extraction protocols should optimize for secondary metabolite classes of interest (e.g., 70% methanol with internal standards for tobacco leaf metabolites [45]).
• Transcriptome Sequencing: RNA sequencing should follow quality control standards (A260/A280: 1.8-2.1, A260/A230: 1.9-2.4, concentration >200 ng/μL) with library preparation specifically designed for the organism [50].

Data Processing and Integration:

• Metabolomics data processing includes peak alignment, retention time correction, and normalization against quality control samples [45].
• Transcriptomics data requires quality filtering, trimming, and alignment to reference genomes [45].
• Integration occurs through correlation analysis, network construction, or simultaneous analysis via computational frameworks.

MEANtools Protocol for Pathway Prediction

MEANtools represents a cutting-edge approach for unsupervised metabolic pathway prediction [42] [43]. Implementation involves:

Input Data Requirements:

• Mass feature table with m/z values, retention times, and abundance across samples
• Transcript expression matrix from RNA-seq
• Public database resources (RetroRules, LOTUS) for reaction rules and metabolite structures

Execution Steps:

• Data Formatting and Annotation: Format input data and annotate metabolites by matching masses to LOTUS database, considering possible adducts [42].
• Correlation Analysis: Calculate mutual rank-based correlations between mass features and transcripts across samples [42] [43].
• Reaction Rule Application: Apply RetroRules database to assess whether chemical differences between correlated metabolites can be explained by transcript-associated enzyme families [42] [43].
• Network Construction: Generate reaction networks where nodes represent mass signatures and edges represent enzymatic reactions [43].
• Pathway Prediction: Identify connected metabolite-transcript sets that represent candidate biosynthetic pathways [42].

Validation: In the falcarindiol biosynthetic pathway in tomato, MEANtools correctly anticipated five out of seven characterized steps, demonstrating strong predictive capability [42].

Applications in Secondary Metabolite Research

Case Studies in Plant Specialized Metabolism

Multi-omics integration has driven significant advances in understanding plant secondary metabolism:

Tobacco Leaf Development: Integrated transcriptomic and metabolomic analysis across three developmental stages (vigorous growth, topping, and harvest) identified 25 unigenes with stage-specific expression strongly associated with flavonoid accumulation [45]. The research revealed coordinated regulation where early developmental stages showed upregulated chalcone synthase (CHS) and chalcone isomerase (CHI) expression correlating with enhanced flavonoid backbone biosynthesis, while later stages exhibited increased dihydroflavonol 4-reductase (DFR) and anthocyanidin synthase (ANS) expression consistent with anthocyanin accumulation [45].

Curcuma wenyujin Response to Stress: Transcriptome and metabolome profiling under salt-alkali stress identified 438 differentially expressed genes and 166 significantly differentially accumulated metabolites [50]. Key candidate genes CwPER5 and CwBGLU32 were identified as likely regulators of metabolite synthesis under stress conditions, with enriched pathways including biosynthesis of secondary metabolites, zeatin biosynthesis, and ABC transporters [50].

Tomato Falcarindiol Biosynthesis: MEANtools application correctly predicted five out of seven steps in the falcarindiol biosynthetic pathway, demonstrating the power of unsupervised computational approaches for elucidating previously uncharacterized pathways [42].

Biomedical and Pharmaceutical Applications

Beyond plant metabolism, multi-omics integration has profound implications for drug discovery and development:

Antibiotic Discovery: PRISM 4 enables comprehensive prediction of secondary metabolite structure and biological activity from microbial genome sequences, generating accurate structure predictions for 1,157 of 1,230 detected biosynthetic gene clusters [48]. This approach has been used to chart secondary metabolite biosynthesis in over 10,000 bacterial genomes, revealing thousands of encoded antibiotics [48].

Radiation Response Mechanisms: Integrated transcriptomics and metabolomics in total-body irradiation models identified dysregulated amino acids, phospholipids, and carnitine derivatives alongside dysregulated genes (Nos2, Hmgcs2, Oxct2a) [44]. Joint pathway analysis revealed alterations in amino acid, carbohydrate, lipid, nucleotide, and fatty acid metabolism following radiation exposure [44].

Cancer Subtyping and Treatment: Multi-omics integration significantly enhances breast cancer subtype identification, with MOFA+ outperforming deep learning approaches in feature selection accuracy (F1 score: 0.75) and biological pathway identification (121 relevant pathways compared to 100 from MOGCN) [47].

Research Reagent Solutions and Technical Requirements

Table 2: Essential Research Reagents and Platforms for Multi-Omics Studies

Category	Specific Tools/Reagents	Function/Application	Technical Considerations
Sequencing Platforms	BGISEQ-500, Illumina platforms	Transcriptome sequencing	Minimum 20M reads/sample, quality thresholds (Q30 > 80%)
Mass Spectrometry	Agilent 6545 QTOF/MS, Orbitrap systems	Metabolite profiling	Positive and negative ionization modes, m/z range 50-1000
Chromatography	Waters ACQUITY UPLC HSS T3 C18 column	Metabolite separation	Mobile phases: water + 0.1% formic acid, acetonitrile + 0.1% formic acid
RNA Extraction	TriZol method	RNA isolation	Quality requirements: A260/A280 1.8-2.1, concentration >200 ng/μL
Computational Resources	MEANtools, PRISM 4, MOFA+, xMWAS	Data integration and analysis	Database dependencies: RetroRules, LOTUS, KEGG, MetaNetX
Specialized Reagents	Sodium hydrogen carbonate, Sodium carbonate	Stress induction	Salt-alkali stress studies: 240-480 mmol/L concentration range

Challenges and Future Directions

Despite significant advances, multi-omics integration faces several challenges that require methodological innovation:

Data Heterogeneity and Complexity: Multi-omics datasets differ in type, scale, and source, often with thousands of variables and limited samples [49] [46]. Biological datasets are complex, noisy, and heterogeneous, with potential measurement errors or unknown biological deviations [49]. Future development should focus on incorporating temporal and spatial dynamics while improving model interpretability [49].

Computational Scalability: Network-based methods struggle with computational efficiency when handling large-scale multi-omics datasets [49]. Maintaining biological interpretability while increasing model complexity remains challenging [49].

Method Selection and Standardization: The field lacks standardized frameworks for evaluating and comparing different integration methods, making appropriate approach selection difficult [49]. Establishing standardized evaluation frameworks would significantly advance the field.

Integration with Synthetic Biology: Multi-omics insights are increasingly driving metabolic engineering approaches. For instance, cytoplasmic engineering in Nicotiana benthamiana has enabled production of miltiradiene, a key intermediate of tanshinones, providing an alternative platform for synthetic biology research on high-value plant specialized metabolites [51].

As multi-omics technologies continue to evolve, their integration will play an increasingly central role in unraveling the complex biosynthetic networks underlying secondary metabolite production, ultimately accelerating drug discovery and development efforts across pharmaceutical and biotechnology sectors.

Elucidating the biosynthetic pathways of secondary metabolites is a cornerstone of pharmacognosy and drug discovery. These pathways represent the complex biochemical routes through which living plants, acting as biosynthetic laboratories, convert primary metabolites into structurally diverse and biologically active compounds [52]. Understanding these pathways is essential for the sustainable production, yield optimization, and bioengineering of plant-based pharmaceuticals. The investigation of biosynthetic pathways employs a suite of sophisticated techniques designed to trace the journey of precursor molecules into final metabolic products. Among the most powerful are tracer techniques and mutant strain analysis, which allow researchers to dissect these biochemical processes with high precision [52]. Tracer techniques utilize labeled compounds to follow the sequential steps in a biosynthetic pathway, while mutant strain analysis leverages genetic modifications to identify pathway intermediates and enzymes. When integrated, these methods provide a comprehensive framework for pathway elucidation, forming the methodological backbone of modern research on the biogenesis of secondary metabolites. This guide details the core principles, experimental protocols, and data interpretation strategies that define these cornerstone techniques.

Tracer Techniques: Principles and Applications

Tracer technique can be defined as a method which utilizes a labelled compound to find out or to trace the different intermediates and various steps in biosynthetic pathways in plants, at a given rate and time [52]. This approach relies on introducing a labeled precursor into a biological system, where it joins the general metabolic pool and undergoes the same biochemical reactions as its unlabeled counterpart, thereby illuminating the pathway's sequence.

Significance and Selection of Tracers

The significance of tracer techniques stems from their high sensitivity, applicability to living systems, and the wide range of available isotopes that provide accurate results with proper methodology [52]. The selection of an appropriate tracer is critical and depends on several factors. The starting concentration must withstand dilution during metabolism, the tracer must have a sufficiently long half-life for the experiment, and it should be harmless to the biological system while actively participating in the synthesis [52]. Furthermore, the tracer must be highly pure and remain bound throughout the entire biosynthetic process to ensure reliable results.

Types of Isotopes and Detection Methods

Tracers are broadly categorized into radioactive and stable isotopes, each with distinct detection methodologies. The table below summarizes the commonly used isotopes and their corresponding detection techniques:

Table 1: Types of Tracers and Detection Methods

Isotope Type	Examples	Common Applications	Detection Instruments
Radioactive Isotopes	¹⁴C, ³H, ³⁵S, ³²P [52]	Biological investigation (C, H); metabolic studies (S, P); protein, alkaloid, and amino acid studies (labelled N) [52]	Geiger-Muller (GM) Counters, Liquid Scintillation Chambers, Autoradiography [52]
Stable Isotopes	²H, ¹³C, ¹⁵N, ¹⁸O [52]	Labelling compounds as potential biosynthetic intermediates [52]	Mass Spectrometry, NMR Spectrophotometry [52]

The choice between radioactive and stable isotopes depends on the specific research question, available instrumentation, and safety considerations. For instance, ¹⁴C-labeled glucose is frequently used for determining glucose in biological systems, while labeled nitrogen is preferred for studies on nitrogen and amino acids [52].

Experimental Protocol for Tracer Techniques

A robust tracer experiment follows a structured, three-step workflow: preparation and introduction of the labeled compound, followed by separation and detection.

Step 1: Preparation of Labeled Compounds

Labeled compounds can be produced biosynthetically or via organic synthesis. A common biosynthetic method involves growing plants in an atmosphere of ¹⁴CO₂, which leads to the incorporation of the radioactive carbon into all carbon compounds [52]. Alternatively, organic synthesis can be employed, as illustrated by the preparation of labeled acetic acid: CH₃MgBr + ¹⁴CO₂ → CH₃¹⁴COOHMgBr + H₂O → CH₃¹⁴COOH + Mg(OH)Br [52]. Commercially available tracers, such as tritium (³H)-labeled compounds, are also widely used [52].

The method of introducing the tracer into the plant or tissue must be carefully selected based on the biological system and the experiment's goals. Common techniques include [52]:

• Root Feeding & Stem Feeding: Direct uptake through the vascular system.
• Direct Injection: Precise injection into specific tissues.
• Floating Method: Incubating tissue segments on a solution containing the tracer.
• Spray Technique: Foliar application of the tracer solution.
• Wick Feeding: Continuous supply via a wick inserted into the plant.

Step 3: Separation, Detection, and Data Interpretation

After a suitable metabolic period, the labeled compounds are separated, purified, and their radioactivity is determined using instruments like GM counters, liquid scintillation counters, or through autoradiography [52]. Advanced data interpretation employs several powerful autoradiographic methods:

• Precursor-Product Sequence: A presumed labeled precursor is fed to the plant, and the constituent of interest is isolated after a time period. Radioactivity in the final product confirms the precursor's role [52]. This method has been applied to the biogenesis of morphine and ergot alkaloids.
• Double and Multiple Labelling: This method uses a specifically labeled precursor (e.g., labeled at specific atomic positions), and the recovered product is degraded to determine the fate of each label. It provides evidence for the biochemical mechanism of incorporation and has been extensively used in studying morphine alkaloids [52].
• Competitive Feeding: This technique helps identify possible intermediates that the plant normally uses. The plant is fed a labeled precursor along with an unlabeled putative intermediate. If the unlabeled compound dilutes the radioactivity in the final product, it is confirmed as a normal intermediate. This has been used to elucidate the biogenesis of hemlock alkaloids [52].
• Sequential Analysis: The plant is grown in ¹⁴COâ‚‚ and analyzed at sequential time intervals to determine the order in which various correlated compounds become labeled. This method was crucial in elucidating the carbon pathway in photosynthesis and determining the sequence of alkaloid formation in opium, hemlock, and tobacco [52].

Mutant Strain Analysis in Pathway Elucidation

Mutant strain analysis is a powerful genetic approach for dissecting biosynthetic pathways. The core principle involves inactivating specific genes and comparing the metabolic profiles of the mutant organism with the wild-type to identify pathway-dependent molecules.

Principle of Comparative Metabolomics

This method leverages the fact that secondary metabolic pathways can often be cleanly deleted from a cell without preventing growth. By comparing the metabolomes of controls, wild-type organisms, and pathway mutant organisms, researchers can map molecular features that are dependent on a functional pathway of interest [53]. The absence of a final metabolite in a knockout mutant, coupled with the accumulation of a putative intermediate, provides strong evidence for that compound's role in the pathway.

Experimental Protocol for Mutant Analysis

The following workflow outlines the key steps in a pathway-targeted metabolomics study using mutant strains [53]:

• Culture Growth and Extraction:

  • Grow biological replicates of wild-type and mutant strains under defined conditions. For bacteria, this typically involves inoculation in a minimal or rich medium, often with inducers like IPTG for gene cluster expression [53].
  • After a designated growth period, extract the whole culture metabolome (cells plus supernatant) using an organic solvent like ethyl acetate.
  • Centrifuge the samples, transfer the organic layer, and evaporate it to dryness under reduced pressure. Store the extracts at -20°C until analysis.

• LC-MS Analysis and Data Processing:

  • Reconstitute the dried extracts in a suitable solvent like methanol for Liquid Chromatography-Mass Spectrometry (LC-MS) analysis [53].
  • Acquire high-resolution mass spectrometry (HRMS) data for all samples. Use chemometric software (e.g., Agilent Mass Profiler Professional) to perform a comparative analysis between the wild-type and mutant sample groups.
  • This differential analysis yields a unique list of molecular features (potential pathway-specific intermediates and products) that are present in the wild-type but absent in the mutant.

• Pathway-Targeted MS/MS and Molecular Networking:

  • Using the unique list of molecular features, perform targeted tandem MS (MS/MS) to acquire fragmentation data.
  • Input this MS/MS data into a molecular networking platform (e.g., Global Natural Products Social Molecular Networking, GNPS). This software clusters related molecules based on similar fragmentation patterns, visually representing the structural relationships within a pathway [53].
  • The resulting molecular network allows researchers to assess experimental perturbations and guide the discovery of novel natural products.

Integrated Workflow and Visualization

The synergy between tracer techniques and mutant strain analysis creates a powerful, multi-faceted approach for definitive pathway elucidation. Mutant analysis can identify a set of candidate pathway intermediates, while tracer feeding experiments can confirm the sequence and kinetics of their conversion.

Experimental Workflow Diagram

The diagram below illustrates the integrated workflow for biosynthetic pathway elucidation, combining both tracer and mutant strain techniques.

Research Reagent Solutions

The following table details key reagents and materials essential for conducting these elucidation experiments.

Table 2: Essential Research Reagents for Pathway Elucidation

Reagent / Material	Function / Application	Example Usage
Isotopically Labeled Compounds (e.g., [U-¹³C₁₃]-L-Cys, ¹⁴C-glucose) [52] [53]	To trace the incorporation of atoms and the flow of metabolites through biosynthetic pathways.	Fed to plant or microbial cultures to confirm precursor-product relationships and determine sequence [52].
M9 Minimal Medium [53]	A defined growth medium that allows for precise control of nutrient sources, essential for isotope labeling studies.	Used for growing bacterial cultures in stable isotope labeling experiments to ensure proper incorporation of the label [53].
IPTG (Isopropyl β-D-1-thiogalactopyranoside) [53]	A molecular biology reagent used to induce expression from the lac operon and other inducible promoters.	Used to trigger the expression of a biosynthetic gene cluster in a heterologous host or engineered strain [53].
LC-MS Grade Solvents (Methanol, Acetonitrile, Water with 0.1% Formic Acid) [53]	High-purity solvents for liquid chromatography and mass spectrometry to minimize background noise and ion suppression.	Used as the mobile phase and for sample reconstitution in UHPLC-Q-TOF MS analysis [53].
C18 Reverse-Phase UHPLC Column [53]	A chromatography column used to separate complex mixtures of metabolites based on hydrophobicity prior to mass spectrometry.	Critical for the separation of secondary metabolites from a crude organic extract during LC-MS analysis [53].

The strategic integration of tracer techniques and mutant strain analysis provides a robust framework for deconstructing the complex biosynthetic pathways of secondary metabolites. Tracer techniques offer the dynamic, temporal resolution to track molecular flux, while mutant analysis provides the genetic evidence to pinpoint essential pathway components. Together, they enable researchers to move from a simple list of candidate compounds to a validated, sequential biochemical map. The continuous advancement of detection technologies, particularly high-resolution mass spectrometry and sophisticated data analysis platforms like molecular networking, is further enhancing the power and throughput of these methods. By applying this integrated methodological approach, researchers can accelerate the discovery and engineering of novel natural products, paving the way for new therapeutics and a deeper understanding of plant biochemistry.

Heterologous Expression and Metabolic Engineering in Prokaryotic Systems

Within the broader thesis on the biosynthesis and biogenesis of secondary metabolites, the ability to produce these complex molecules in scalable and genetically tractable systems is paramount. Many native producers, such as plants or slow-growing actinomycetes, are unsuitable for industrial-scale production. Heterologous expression—the transfer of genetic material from a native host into a surrogate—coupled with metabolic engineering provides a powerful solution. Prokaryotic systems, primarily E. coli and Streptomyces species, offer rapid growth, well-characterized genetics, and established fermentation protocols, making them ideal chassis organisms for the sustainable production of high-value secondary metabolites like antibiotics, anticancer agents, and fragrances.

Prokaryotic Chassis Organisms: A Comparative Analysis

The selection of an appropriate prokaryotic host is the foundational step. The table below compares the two most prevalent chassis organisms.

Table 1: Comparison of Key Prokaryotic Chassis Organisms

Feature	Escherichia coli	Streptomyces spp.
Genetic Tools	Extensive, standardized (e.g., T7/pET systems, CRISPRi/a)	Well-developed, but more complex (e.g., BAC libraries, CRISPR)
Growth Rate	Very fast (doubling time ~20 min)	Slow (doubling time ~2-6 hours)
Post-Translational Modifications	Limited, lacks eukaryotic PTMs	Capable of some complex PTMs; secretes proteins efficiently
GC Content Compatibility	Low GC (~50%)	High GC (~70-74%), ideal for actinobacterial genes
Native Secondary Metabolism	Minimal, low background	Extensive, can interfere but also provides precursors
Typical Metabolite Targets	Simple polyketides, terpenoids, non-ribosomal peptides (NRPs)	Complex polyketides (PKS), NRPs, antibiotics
Titer Example (Representative)	Amorphadiene: ~27 g/L	Unnatural polyketide: ~1.2 g/L

Core Experimental Workflow and Methodologies

The general pipeline for heterologous expression and engineering involves multiple, iterative steps.

Diagram 1: Heterologous Expression Workflow

Protocol: Gibson Assembly for Vector Construction

This method allows for the seamless assembly of multiple DNA fragments, such as a biosynthetic gene cluster (BGC) and an expression vector.

• Principle: Using a 5' exonuclease, DNA polymerase, and DNA ligase to chew back, overlap, and join DNA fragments in a single, isothermal reaction.
• Reagents:
  • DNA Fragments: Purified, linearized vector backbone and insert(s) with 20-40 bp homologous overlaps.
  • Gibson Assembly Master Mix (commercially available).
  • Chemically competent E. coli cells.
• Procedure:
  • Set up the reaction: Mix ~100 ng of vector with a 2:1 molar ratio of insert(s) in a final volume of 10-20 µL containing 1x Gibson Master Mix.
  • Incubate at 50°C for 15-60 minutes.
  • Transform 2-5 µL of the assembly reaction into 50 µL of chemically competent E. coli cells via heat shock.
  • Plate on selective media and incubate overnight at 37°C.
  • Screen colonies by colony PCR and/or restriction digest to confirm correct assembly.

Protocol: Fed-Batch Fermentation for Metabolite Production

Optimized fermentation is critical for achieving high titers.

• Principle: A batch process is initiated, and nutrients are fed into the bioreactor to maintain optimal growth and product formation without causing catabolite repression or inhibition.
• Reagents:
  • Defined Mineral Salt Medium.
  • Carbon Source Feed (e.g., 500 g/L Glucose).
  • Inducer (e.g., IPTG for T7 systems).
  • Antifoam Agent.
• Procedure:
  • Inoculate a single colony into a small volume of liquid medium and grow overnight.
  • Transfer the seed culture to the bioreactor containing the batch medium.
  • Monitor and control parameters: pH (~7.0), dissolved oxygen (>30%), temperature (e.g., 30-37°C).
  • Once the initial carbon source is depleted (evidenced by a spike in dissolved oxygen), initiate the carbon feed at a controlled exponential or constant rate.
  • Induce gene expression at the optimal cell density (OD600).
  • Continue fermentation for 24-120 hours, sampling periodically for metabolite and biomass analysis.

Metabolic Engineering Strategies

Once heterologous production is achieved, metabolic engineering is applied to overcome bottlenecks and increase yield. The strategy involves manipulating central metabolism to channel flux toward the target pathway.

Diagram 2: Metabolic Engineering for Precursor Supply

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Reagents for Heterologous Expression in Prokaryotes

Reagent	Function	Example & Notes
Expression Vectors	Carries the target gene cluster for replication and expression.	pET系列 (Inducible T7 promoter for E. coli); pSET152 (Integrative vector for Streptomyces).
DNA Assembly Master Mix	Seamlessly joins multiple DNA fragments.	NEBuilder HiFi DNA Assembly Mix; Gibson Assembly Master Mix.
CRISPR-Cas9 System	Enables precise gene knock-outs, knock-ins, and edits.	Alt-R S.p. Cas9 Nuclease; host-specific CRISPR plasmids.
Inducers	Controls the timing and level of gene expression.	Isopropyl β-d-1-thiogalactopyranoside (IPTG) for lac-based systems; anhydrotetracycline for tet systems.
Chassis Strains	Genetically engineered host organisms.	E. coli BL21(DE3) (T7 polymerase, protease deficient); S. coelicolor M1152 (minimal secondary metabolism).
Lysis Reagents	Breaks open cells to analyze metabolite production.	BugBuster Master Mix for gentle extraction; bead-beating for tough cells.
Analytical Standards	For accurate identification and quantification of metabolites.	Commercially available standards for precursors (e.g., mevalonic acid) or target molecules.
4-Chloroguaiacol	4-Chloroguaiacol, CAS:16766-30-6, MF:C7H7ClO2, MW:158.58 g/mol	Chemical Reagent
Bis(2,2'-bipyridine)iron(II)	Bis(2,2'-bipyridine)iron(II), CAS:15552-69-9, MF:C20H16FeN4+2, MW:368.2 g/mol	Chemical Reagent

The biogenesis of plant secondary metabolites represents a cornerstone of modern therapeutic development, serving as a primary reservoir for antimicrobial and anticancer agents [4]. Despite their immense importance, the complex biosynthetic pathways of many plant-derived compounds remain only partially understood, hindering their full clinical potential [4]. This whitepaper provides an in-depth technical guide for researchers and drug development professionals on translating biosynthetic gene cluster (BGC) discoveries into viable clinical candidates. By integrating systems and synthetic biology approaches with advanced computational mining tools, we outline a structured framework for elucidating cryptic metabolic pathways, engineering biosynthetic capabilities, and advancing natural products through the drug development pipeline. The convergence of multi-omics technologies, artificial intelligence, and metabolic engineering now enables unprecedented opportunities for discovering and optimizing novel therapeutic agents from plant systems.

Biosynthetic Gene Cluster Discovery and Characterization

Bioinformatics Tools for BGC Mining

The initial phase of clinical translation involves comprehensive identification and annotation of BGCs within plant genomes. Specialized bioinformatics platforms enable researchers to detect gene clusters encoding pathways for polyketides, non-ribosomal peptides, terpenoids, and ribosomally synthesized and post-translationally modified peptides (RiPPs) [54].

Table 1: Computational Tools for BGC Identification and Analysis

Tool Name	Primary Function	BGC Types Detected	Key Features
antiSMASH/plantiSMASH	Comprehensive BGC detection	PKS, NRPS, Terpenes, RiPPs	Most widely used; plant-specific version available [54]
PRISM	Structural prediction of natural products	NRPS, PKS, RiPPs	Predicts chemical structures from genomic data [54]
BAGEL	RiPP identification	Bacteriocins, lanthipeptides	Specialized for ribosomally synthesized peptides [54]
ARTS	BGC prioritization & resistance gene detection	Various BGCs	Identifies potential antibiotic resistance targets [54]
RODEO	RiPP analysis and classification	RiPPs	Rapid ORF description and evaluation online [54]
BiG-SCAPE	BGC comparison & networking	Various BGCs	Builds sequence similarity networks and gene cluster families [54]
PhytoClust	Plant-specific BGC detection	Plant secondary metabolites	Dedicated to plant genomes [54]
CASSIS/SMIPS	Eukaryotic gene cluster prediction	Fungal & plant BGCs	Motif-based approach for cluster boundary prediction [54]
ClusterFinder	Putative BGC detection	Novel BGCs	Probabilistic approach for genomic and metagenomic data [54]
EvoMining	Divergent BGC discovery	Evolutionarily novel BGCs	Identifies duplicates of primary metabolism enzymes in BGCs [54]

Experimental Validation of BGC Function

Following computational identification, BGCs require experimental validation to confirm their association with bioactive compound production. Key methodologies include:

Gene Expression Correlation Analysis: Correlating BGC gene expression with metabolite production under various conditions, such as light exposure, which regulates secondary metabolite synthesis through photoreceptor-mediated signaling networks [1]. For instance, UV-B radiation activates the UVR8 photoreceptor, promoting combination with COP1 and activating HY5 transcription factor, subsequently inducing expression of key enzymes in the phenylpropanoid pathway like PAL and CHS [1].

Heterologous Expression: Transferring entire BGCs into amenable host organisms (e.g., Saccharomyces cerevisiae, Escherichia coli) to confirm compound production. The standardized workflow involves: (1) BGC isolation via Gibson assembly or yeast recombination, (2) vector assembly with appropriate promoters and terminators, (3) transformation into heterologous host, (4) cultivation under optimized conditions, and (5) metabolite extraction and analysis via LC-MS/MS.

Gene Knockout/Knockdown: Utilizing CRISPR-Cas9 or RNAi to disrupt candidate genes within putative BGCs followed by metabolite profiling to identify pathway disruptions. Protocol: Design sgRNAs targeting core biosynthetic genes; transform plant tissue via Agrobacterium-mediated transformation; select and regenerate edited lines; analyze metabolite profiles of wild-type versus mutant lines via UPLC-QTOF-MS.

Diagram 1: BGC Discovery Workflow (83 characters)

Pathway Elucidation and Engineering Strategies

Systems Biology Approaches for Pathway Characterization

Comprehensive elucidation of secondary metabolic pathways requires integration of multi-omics datasets to construct predictive models of metabolic networks. Advanced methodologies include:

Co-expression Analysis: Identifying coordinately regulated genes across multiple conditions (e.g., different light qualities, elicitor treatments) to infer pathway components. Implementation: Generate RNA-seq data from 12+ conditions; calculate Pearson correlation coefficients between all gene pairs; construct co-expression networks using WGCNA; identify modules highly correlated with metabolite abundance.

Metabolite Profiling: Utilizing LC-MS/MS and NMR spectroscopy to comprehensively characterize metabolic changes associated with BGC activation. Protocol: Extract metabolites from plant tissue using 80% methanol; analyze via UPLC-QTOF-MS in both positive and negative ionization modes; annotate compounds using databases like GNPS; perform statistical analysis to identify differentially accumulated metabolites.

Protein Complex Identification: Characterizing metabolons—transient enzyme complexes that channel intermediates through biosynthetic pathways—via co-immunoprecipitation and proximity labeling techniques. Detailed method: Express tagged versions of biosynthetic enzymes in plant systems; perform cross-linking co-IP with formaldehyde; identify interacting partners via mass spectrometry; validate interactions with BiFC or SPR.

Table 2: Key Research Reagents for BGC Characterization

Reagent/Category	Specific Examples	Function/Application
Cloning Systems	Gibson Assembly, Golden Gate, Yeast Recombination	BGC assembly for heterologous expression
Expression Vectors	pET, pRSF, pCDF, plant binary vectors	BGC expression in heterologous hosts
Host Organisms	S. cerevisiae, E. coli, Nicotiana benthamiana	Heterologous expression platforms
Chromatography	UPLC, HPLC, LC-MS/MS systems	Metabolite separation and identification
Mass Spectrometry	QTOF, Orbitrap, Triple Quadrupole MS	High-resolution metabolite detection
Gene Editing	CRISPR-Cas9, TALENs, RNAi constructs	BGC validation via gene knockout
Antibodies	Anti-FLAG, Anti-HA, Anti-GFP	Protein detection and co-IP experiments
Elicitors	Methyl jasmonate, Salicylic acid, UV light	BGC activation for expression studies

Synthetic Biology Strategies for Pathway Optimization

Engineering optimized production systems requires sophisticated synthetic biology approaches that extend beyond simple heterologous expression:

Metabolon Engineering: Strategically fusing sequential enzymes in pathways to enhance metabolic flux through substrate channeling. Implementation: Design fusion constructs with flexible linkers between catalytic domains; express in plant or microbial systems; measure intermediate diffusion and overall pathway flux compared to non-fused controls.

Dynamic Regulation: Implementing synthetic genetic circuits that respond to metabolic status to balance precursor supply and product accumulation. Circuit design: Identify key pathway intermediates that indicate metabolic imbalance; develop biosensors (e.g., transcription factor-based) that respond to these intermediates; connect to regulatory elements controlling rate-limiting enzymes; validate in production hosts.

Deep Learning Integration: Utilizing neural networks to predict enzyme kinetics, substrate specificity, and metabolic flux for in silico pathway optimization. Implementation: Curate training datasets of enzyme sequences with kinetic parameters; train convolutional neural networks or LSTM models; predict optimal enzyme variants for specific metabolic contexts; validate predictions experimentally.

Diagram 2: Pathway Engineering Strategies (65 characters)

Mechanisms of Action of Plant-Derived Antimicrobial and Anticancer Agents

Antimicrobial Peptides with Dual Functionality

Cationic antimicrobial peptides (AMPs) represent a promising class of plant-derived compounds exhibiting both antibacterial and anticancer activities [55]. These peptides typically contain 5-40 amino acid residues with a net positive charge (+2 to +9) and substantial hydrophobic character (~30% or more) [55]. Their mechanism of action involves electrostatic attraction to negatively charged components of bacterial and cancer cell membranes, followed by membrane disruption through various models:

Carpet Model: AMPs assemble on the membrane surface and disrupt membrane integrity via detergent-type action when reaching threshold concentration [55].

Barrel-Stave Model: Peptides insert into membranes with transmembrane orientation and aggregate to form traditional ion-channel pores [55].

Toroidal-Pore Model: Peptides locate near head group regions with parallel orientation to bilayer surface, inducing curvature strain that leads to pore formation [55].

The selectivity of AMPs for bacterial and cancer cells versus normal mammalian cells derives from membrane composition differences. Bacterial membranes contain negatively charged lipids (phosphatidylglycerol, cardiolipin), while cancer cells frequently expose anionic phosphatidylserine on their outer leaflets [55]. In contrast, healthy mammalian membranes are predominantly zwitterionic (phosphatidylcholine, sphingomyelin) and contain cholesterol that stabilizes membrane structure [55].

Light-Regulated Biosynthesis of Bioactive Compounds

Light quality serves as a crucial environmental factor regulating the production of anticancer and antimicrobial compounds in plants [1]. Specific photoreceptor systems activate distinct biosynthetic pathways:

UV Light: UV-B (280-315 nm) activates UVR8 photoreceptors that dissociate from COP1, leading to HY5 transcription factor stabilization and subsequent upregulation of phenylpropanoid pathway genes (PAL, C4H, 4CL, CHS, CHI) [1]. This enhances production of flavonoids, phenolics, and anthocyanins with demonstrated bioactivities.

Blue Light: Perceived through cryptochrome and phototropin receptors, blue light influences phenylpropanoid metabolism via HY5 and MYB transcription factors, modulating production of antioxidant compounds [1].

Red Light: Mediated by phytochromes, red light modulates terpenoid production through hormonal signaling pathways, altering endogenous jasmonate and salicylate levels that regulate defensive compound biosynthesis [1].

Table 3: Light Quality Effects on Bioactive Compound Production

Light Quality	Photoreceptor	Transcription Factors	Bioactive Compounds Enhanced	Example Plant Systems
UV-B (280-315 nm)	UVR8	HY5, MYB12, MYB111	Flavonoids, Phenolics, Anthocyanins	Brassica napus, Morus alba [1]
UV-A (315-400 nm)	Cryptochrome?	HY5, bHLH	Gallotannins, Ellagitannins	Ocimum basilicum, Eucalyptus camaldulensis [1]
Blue Light	Cryptochrome, Phototropin	HY5, MYB	Phenolic Acids, Flavonoids	Lactuca sativa, Artemisia spp. [1]
Red Light	Phytochrome	PIFs, HY5	Terpenoids, Alkaloids	Various medicinal plants [1]

Diagram 3: Light Regulation of Biosynthesis (63 characters)

Preclinical Development and Translation

Assessment of Therapeutic Potential

Advancing BGC-derived compounds to clinical application requires rigorous preclinical evaluation of their therapeutic properties:

Cytotoxicity Screening: Evaluate selective toxicity against cancer cells versus normal mammalian cells. Standard protocol: Treat cancer cell lines (e.g., MCF-7, A549, HeLa) and normal cell lines (e.g., MCF-10A, HEK293) with compound gradients for 48-72 hours; assess viability via MTT or resazurin assays; calculate selectivity index (IC50 normal/IC50 cancer). AMPs with selectivity indices >3 demonstrate promising therapeutic windows [55].

Membrane Permeabilization Assays: Quantify membrane disruption mechanisms using dye leakage experiments. Methodology: Prepare lipid vesicles mimicking bacterial (PG/CL), cancer (PS/PC), and normal (PC/SM/cholesterol) membranes; load with self-quenching dyes (calcein, carboxyfluorescein); treat with compounds; measure fluorescence dequenching over time; calculate percentage membrane disruption.

Resistance Development Assessment: Compare resistance potential to conventional antibiotics. Protocol: Serial passage of bacteria in sub-MIC concentrations of compounds for 30 generations; monitor MIC changes; parallel passage with conventional antibiotics as controls; genome sequence resistant mutants to identify resistance mechanisms.

Production Scale-Up Strategies

Translating laboratory discoveries to clinically relevant quantities requires implementation of scalable production systems:

Metabolic Engineering in Heterologous Hosts: Optimize BGC expression in industrial production strains. Key considerations: Codon optimization; promoter engineering for balanced expression; precursor pathway enhancement; toxicity mitigation through compartmentalization; product secretion engineering.

Plant Cell and Tissue Culture Systems: Implement controlled bioreactor environments with optimized light regimes. Methodology: Establish dedifferentiated cell cultures or hairy root systems from high-producing genotypes; optimize medium composition (hormones, precursors, elicitors); implement controlled light quality, intensity, and photoperiod to enhance productivity [1]; scale up in photobioreactors with online monitoring.

Sustainable Production Integration: Combine metabolic engineering with agricultural optimization for field production. Strategy: Engineer high-yielding varieties via CRISPR-Cas9; optimize cultivation conditions with specific light regimens [1]; implement precision agriculture for consistent compound accumulation; develop extraction and purification protocols compliant with Good Manufacturing Practice.

The clinical translation from BGC discovery to anticancer and antimicrobial drugs represents an emerging paradigm that integrates plant science, synthetic biology, and drug development. The convergence of advanced BGC mining tools, sophisticated pathway engineering strategies, and comprehensive mechanistic studies creates a powerful framework for developing next-generation therapeutics from plant secondary metabolites. Future advancements will likely focus on AI-integrated pathway prediction and optimization, engineered biomolecular condensates for enhanced pathway flux, and personalized production systems tailored to specific clinical applications. As these technologies mature, plant natural products will continue to serve as an indispensable resource for addressing the dual challenges of antimicrobial resistance and cancer therapy refinement.

Overcoming Production Hurdles and Activating Silent Gene Clusters

Microbial secondary metabolites represent an immense reservoir of bioactive compounds that have yielded life-saving pharmaceuticals, including antibiotics, immunosuppressants, and anticancer agents [56]. The biochemical pathways responsible for these compounds—governed by enzymatic assemblies like polyketide synthases (PKS) and non-ribosomal peptide synthetases (NRPS)—are encoded in biosynthetic gene clusters (BGCs) [56]. Genomic sequencing has revealed a profound disparity: microbial genomes harbor a vast potential for natural product synthesis that far exceeds what is produced under standard laboratory monoculture conditions [57] [58]. A significant portion of these BGCs remain "silent" or "cryptic"—not transcribed or expressed under conventional fermentation settings [57] [59]. This silent genetic treasure trove presents a major bottleneck and opportunity for natural product discovery.

Activating these cryptic pathways requires mimicking the ecological and physiological cues that trigger secondary metabolism in nature. Within the context of the biosynthesis and biogenesis of secondary metabolites, two powerful, genetic-independent strategies have emerged as cornerstone methodologies: the One Strain Many Compounds (OSMAC) approach and Co-cultivation. This whitepaper provides an in-depth technical examination of these strategies, detailing their underlying mechanisms, experimental protocols, and applications in modern drug discovery pipelines aimed at addressing pressing global challenges such as antimicrobial resistance [60] [59].

The OSMAC Approach

The OSMAC approach is predicated on the metabolic plasticity of microorganisms, positing that systematic variation of simple cultivation parameters can dramatically alter secondary metabolite profiles [57] [61]. This methodology is technically straightforward, cost-effective, and does not require prior genetic knowledge of the producing strain, making it widely accessible [57]. Its power lies in perturbing the microbial system to trigger transcriptional reprogramming, which can lead to the activation of otherwise silent BGCs [57].

Core Mechanisms: Variations in culture conditions exert stress on the organism and alter its physiological state. This is interpreted as an environmental challenge, prompting the activation of defense and competition mechanisms, often mediated by the production of secondary metabolites [61]. For instance, modifying salt concentration can induce osmotic stress, while nutrient limitation can mimic natural competition for resources.

Co-cultivation Strategy

Co-cultivation, or mixed fermentation, involves growing two or more microorganisms in a shared environment. This strategy aims to replicate the complex biotic interactions—such as competition, antagonism, and mutualism—that microbes experience in their natural habitats [58]. These interactions are facilitated by chemical signals or physical contact, leading to the activation of silent BGCs as a defense or communication mechanism [62] [58].

Core Mechanisms: Microbial interactions in co-culture are diverse. They can be based on competition for nutrients and space, direct antagonism via the production of antimicrobials, or even more complex symbiotic relationships where one organism's metabolites trigger biosynthesis in another [58]. These interactions are mediated by soluble molecular signals, volatile organic compounds, or direct cell-to-cell contact, creating a dynamic environment that constantly challenges the organisms and stimulates metabolite production [62].

Table 1: Comparative Analysis of Silent BGC Activation Strategies

Feature	OSMAC Approach	Co-cultivation Strategy
Core Principle	Systematic variation of physical/chemical culture parameters [57]	Cultivating multiple microbes together to simulate ecological interactions [58]
Key Advantages	Simple, low-cost, no genetic manipulation required, easily scalable [57]	Mimics natural environment, can induce unique metabolites via biotic cues [62] [58]
Common Parameters	Culture media, temperature, aeration, pH, addition of elicitors (e.g., salts, enzyme inhibitors) [57] [61] [59]	Partner organism identity, inoculation ratio/timing, physical separation (e.g., mixed vs. separated culture) [58]
Typical Outcome	Increased diversity of metabolites from a single strain [57]	Production of novel metabolites not seen in monoculture [61] [58]
Mechanistic Basis	Transcriptional reprogramming in response to abiotic stress [57]	Pleiotropic metabolic induction via inter-microbial signaling [58]

Experimental Protocols and Workflows

Designing an OSMAC Experiment

A well-designed OSMAC screening involves the methodical alteration of key cultivation variables. The following protocol, adaptable for most filamentous fungi, is based on recent studies [57] [61] [59].

Step 1: Strain Selection and Preculture Preparation

• Select a genetically identified microbial strain. Preservation in a glycerol stock or on a silica gel bead at -80°C is recommended for long-term viability.
• Inoculate a small piece of mycelium or a spore suspension into a rich liquid medium (e.g., 50 mL of Potato Dextrose Broth (PDB) or JSA medium) in a 250 mL Erlenmeyer flask.
• Incubate at 28°C with shaking at 180 rpm for 2-4 days to generate a viable, active preculture [57].

Step 2: Variation of Culture Conditions

• Media Variation: Inoculate the preculture into a panel of different media. Common choices include PDB, Malt Extract Broth (MEB), Rice-based solid medium, and Czapek Yeast Autolysate (CYA) broth [57] [59].
• Addition of Elicitors: After an initial growth period (e.g., 48 hours), add chemical elicitors to the culture. Effective elicitors include:
  • 3% Sodium Bromide (NaBr) or 3% Sea Salt to induce osmotic stress and halogenate metabolites [57].
  • 5-Azacytidine (e.g., 5-10 µM), a DNA methyltransferase inhibitor that acts as an epigenetic modifier [61].
  • N-Acetyl-D-glucosamine, a component of fungal cell walls that can alter signaling pathways [61].
• Physical Parameters: Test static versus shaking conditions, different culture vessels, or variations in temperature and light [59].

Step 3: Harvest, Extraction, and Analysis

• Large-scale fermentation is typically carried out for 5-30 days. Both the mycelial mass and the broth are harvested separately [57] [63].
• The broth is extracted with a water-immiscible organic solvent like ethyl acetate (3x v/v). The mycelium is extracted with methanol or a methanol-dichloromethane mixture (1:1 v/v) [61].
• The combined organic extracts are concentrated under reduced pressure to yield a crude extract.
• The crude extract is analyzed by thin-layer chromatography (TLC) and liquid chromatography-mass spectrometry (LC-MS) to visualize and dereplicate metabolite profiles [59].
• Bioassay-guided fractionation using techniques like preparative HPLC with C18 columns is used to isolate active compounds [57].

Establishing a Co-cultivation System

The success of a co-culture experiment hinges on the choice of partner organisms and the setup of their interaction [58].

Step 1: Selection of Co-culture Partners

• Partners can be selected based on phylogenetic distance (e.g., a fungus and a bacterium), ecological relevance (e.g., organisms from the same habitat), or known antagonism [61] [58].
• A promising approach is to pair your target strain with a known strong antibiotic producer to induce a defensive response.

Step 2: Co-culture Setup Several physical setups can be employed, each offering different levels of interaction:

• Direct Mixed Fermentation: Both strains are inoculated simultaneously into the same liquid medium or on the same solid plate. This allows for full physical and chemical contact [61].
• Agar Plate Partitioning: Strains are inoculated at different points on a solid agar plate, allowing diffusion of signals and metabolites through the agar.
• Liquid-Based Separation: A system with two compartments separated by a semi-permeable membrane (e.g., a dialysis membrane) allows the exchange of soluble signals but prevents physical contact [58].

Step 3: Monitoring, Harvest, and Metabolite Analysis

• Monitor the co-culture for morphological changes (e.g., pigmentation, sporulation) compared to monocontrols, which often indicate metabolic induction [63] [58].
• Harvest and extract the culture as described in the OSMAC protocol.
• Use LC-MS to compare the metabolic fingerprints of the co-culture with the sum of the monocultures. New peaks in the co-culture chromatogram indicate induced compounds [61] [58].
• Subsequent isolation and structure elucidation follow standard natural product workflows (e.g., HRESIMS, 1D/2D NMR) [61].

Data Presentation and Quantitative Outcomes

The efficacy of OSMAC and co-cultivation strategies is demonstrated by quantitative data on BGC activation and novel metabolite discovery. The tables below summarize key findings from recent studies.

Table 2: Genome Mining Reveals Vast Silent BGC Potential

Microbial Strain	Total BGCs Predicted	Silent or Cryptic BGCs	Potential Novelty	Citation
Diaporthe kyushuensis ZMU-48-1	98	Majority	~60% showed no significant homology to known BGCs	[57]
Aspergillus nidulans	71+	>50%	More than half were uncharacterized prior to systematic TF OE	[63]
General Actinomycetales	N/A	N/A	45% of all bioactive microbial metabolites (approx. 10,000 compounds)	[60]

Table 3: Representative Metabolite Yields from OSMAC and Co-cultivation

Strain & Strategy	Culture Condition / Partner	Metabolite Outcome	Bioactivity (Minimum Inhibitory Concentration)	Citation
Pleotrichocladium opacum (OSMAC)	Rice solid medium	3 new compounds (e.g., 16–18) isolated	Not specified	[61]
Pleotrichocladium opacum (Co-cultivation)	With Echinocatena sp. on PDA	5 additional natural products (21–25) induced	Not specified	[61]
Diaporthe kyushuensis (OSMAC)	PDB + 3% NaBr	18 compounds; 2 novel pyrroles (Kyushuenines A & B)	Compound 8 vs. Bipolaris sorokiniana: MIC = 200 μg/mL; Compound 18 vs. Botryosphaeria dothidea: MIC = 50 μg/mL	[57]
Talaromyces pinophilus (OSMAC)	Variation across 5 media	Phenolic acids (Caffeic, Chlorogenic)	MIC range across extracts: 78–5000 μg/mL	[59]
Aspergillus nidulans (Systematic TF OE)	Over-expression of 51 TFs	Diverse pigment and metabolite profiles	Extracts from 8 strains showed >50% inhibition of S. aureus and B. subtilis	[63]

Visualization of Strategic Workflows

The following diagrams illustrate the logical workflow for implementing OSMAC and co-cultivation strategies, helping to guide researchers in experimental design.

OSMAC Experimental Workflow

Co-cultivation Experimental Workflow

The Scientist's Toolkit: Essential Research Reagents and Materials

Successful implementation of these strategies relies on a core set of laboratory reagents and materials. The following table details essential items for setting up these experiments.

Table 4: Research Reagent Solutions for BGC Activation Studies

Reagent/Material	Function/Application	Technical Notes
Potato Dextrose Broth (PDB) / Agar (PDA)	General-purpose fungal culture medium; base for OSMAC variations and co-culture.	Serves as a control and baseline for metabolic profiling [57] [59].
Rice or Wheat Grains	Solid fermentation substrate for OSMAC.	Provides a semi-solid, nutrient-rich matrix that often enhances metabolite diversity [57] [61].
Sodium Bromide (NaBr) / Sea Salt	Chemical elicitor for OSMAC.	Induces osmotic stress and can lead to biosynthesis of halogenated compounds [57].
5-Azacytidine	Epigenetic modifier for OSMAC.	DNA methyltransferase inhibitor that can alter gene expression and awaken silent BGCs [61].
Ethyl Acetate	Solvent for liquid-liquid extraction of culture broth.	Effectively extracts a broad range of medium-polarity secondary metabolites [61] [59].
Deuterated Solvents (CDCl₃, CD₃OD, DMSO-d₆)	NMR spectroscopy for structure elucidation.	Essential for determining the structure of novel compounds via 1D and 2D NMR experiments [57] [61].
C18 Reverse-Phase HPLC Columns	Chromatographic separation and purification of metabolites.	Used in analytical and preparative scale for final purification of compounds [57].
Semi-Permeable Membranes	Physical separation in co-culture systems.	Allows exchange of chemical signals while preventing physical contact between microbes [58].
Saralasin	Saralasin, CAS:34273-10-4, MF:C42H65N13O10, MW:912.0 g/mol	Chemical Reagent

The strategic activation of silent biosynthetic gene clusters through OSMAC and co-cultivation is a cornerstone of modern microbial natural product research. These methodologies effectively bridge the gap between genomic potential and observable chemical output by manipulating abiotic and biotic environmental cues. As the field advances, the integration of these strategies with genome mining, bioinformatics, and synthetic biology will be crucial for systematically exploring microbial dark matter. Sustained investment and interdisciplinary collaboration are imperative to fully leverage these strategies, ensuring a continuous pipeline of novel therapeutic molecules to combat the rising tide of antimicrobial resistance and meet emerging medical needs [60]. The untapped chemical diversity within microbial genomes remains vast, and OSMAC and co-cultivation are among the most practical and powerful keys to unlocking it.

Metabolic Engineering with Systems Biology Tools

Metabolic engineering, defined as the use of genetic engineering to modify the metabolism of an organism, has evolved from single-gene manipulations to sophisticated system-wide interventions [64]. In the context of secondary metabolite biosynthesis and biogenesis, this discipline faces a fundamental challenge: the immense structural diversity of these compounds is matched by equally complex metabolic networks that are tightly regulated in space and time [65]. Secondary metabolites, including phenolics, alkaloids, terpenoids, and flavonoids, possess diverse functionalities that attract pharmaceutical, food, and allied industries, yet their production in native plants often occurs in limited quantities, particularly under unfavorable ecological conditions [66] [65].

The integration of systems biology tools has transformed metabolic engineering from a largely empirical practice to a predictive science. This paradigm shift enables researchers to move beyond piecemeal pathway optimization toward holistic reprogramming of organismal metabolism [67]. For researchers and drug development professionals, this integration offers unprecedented capabilities to elucidate complex biosynthetic pathways, optimize metabolic flux, and ultimately achieve industrial-scale production of valuable secondary metabolites that would be economically unfeasible through traditional extraction or chemical synthesis [65] [67].

Core Principles: Integrating Systems Biology into Metabolic Engineering

The Multi-Omics Foundation

Systems biology provides a comprehensive analytical framework through the integration of multiple omics technologies, each contributing unique insights into metabolic networks:

• Genomics facilitates the identification of biosynthetic gene clusters (BGCs) and comprehensive gene cataloging [65] [67]. For example, genome sequencing has revealed metabolic gene clusters involved in the biosynthesis of complex compounds such as azadirone in Melia azedarach and QS-21 in Quillaja saponaria [65].

• Transcriptomics enables the identification of co-expressed genes through analyses of plant tissues where metabolite synthesis or storage occurs [65] [67]. This approach has been instrumental in elucidating jasmonate-induced expression patterns of artemisinin biosynthetic pathway genes in Artemisia annua [67].

• Proteomics characterizes the enzyme components and protein-level regulation that directly control metabolic flux [67].

• Metabolomics provides a comprehensive profile of pathway intermediates and end products, enabling functional validation of predicted pathways [65] [67].

The power of systems biology emerges from the integrative analysis of these complementary datasets, often employing computational tools such as GeNeCK, CoExpNetViz, and MapMan to identify candidate genes and reconstruct metabolic networks [65].

Computational Modeling and Prediction Tools

A key advantage of systems biology is its predictive capability. Computational models of metabolic networks enable in silico testing of engineering strategies before laboratory implementation. These models range from stoichiometric representations of metabolic pathways to kinetic models that simulate metabolite dynamics [67]. Machine learning approaches further enhance prediction accuracy for enzyme-substrate interactions and pathway optimization, gradually reducing the traditional trial-and-error approach in metabolic engineering [67].

Methodological Framework: Experimental Workflows

Pathway Elucidation and Validation

Elucidating complete biosynthetic pathways requires a systematic workflow that integrates computational predictions with experimental validation:

Figure 1: Integrated workflow for elucidating and engineering secondary metabolite pathways using multi-omics approaches

The process begins with comprehensive data collection through genomic sequencing, transcriptomic analysis of tissues with high metabolite production, and metabolomic profiling to identify intermediates and final products [65]. Computational analysis then identifies co-expressed genes, predicts biosynthetic pathways, and selects candidate genes for functional characterization [65]. Experimental validation typically employs heterologous expression systems, in vitro enzyme assays, and detailed metabolic profiling to confirm gene functions [65]. Successful validation enables pathway reconstruction in suitable production hosts followed by systematic optimization [65].

Host System Selection and Engineering Strategies

The choice of host organism significantly influences engineering strategy and potential success. Three primary platforms have emerged for secondary metabolite production:

Table 1: Comparison of Host Platforms for Secondary Metabolite Production

Platform	Maximum Achieved Yields	Key Advantages	Major Limitations	Ideal Applications
Native Medicinal Plants	Diosgenin: 2120 μg/g DW [65]	Preserves native regulatory machinery and compartmentalization	Challenging genetic manipulation; long growth cycles	Incremental yield improvements in established agricultural systems [67]
Microbial Chassis	Xanthommatin: Growth-coupled synthesis [64]	Rapid growth; well-established genetic tools; scalable fermentation	Limited post-translational modification capabilities; cytotoxicity of intermediates [67]	Production of precursors and simpler molecules at industrial scale [67]
Heterologous Plant Hosts	N-Formyldemecolcine: 6.3 μg/g DW [65]	Eukaryotic protein processing; transient expression capabilities; subcellular compartmentalization	Lower yields compared to optimized microbial systems; slower than microbial hosts [65]	Complex pathways requiring plant-specific modifications; rapid pathway prototyping [65]

Table 2: Representative Complex Pathway Engineering Achievements in Plants

Metabolite Class	Specific Metabolite	Host System	Number of Genes Expressed	Reported Yield	Key Technologies Employed
Terpenoid	Baccatin III	Taxus media var. hicksii	17	10-30 μg/g DW [65]	Single-cell transcriptomics, co-expression analysis, GC-MS
Phenolic compounds	(-)-deoxy-podophyllotoxin	Sinopodophyllum hexandrum	16	4300 μg/g DW [65]	Transcriptome data analysis, LC-MS, NMR
Tropane alkaloid	Cocaine	Erythroxylum novogranatense	8	398.3 ng/mg DW [65]	Transcriptome analysis, in vitro assays, yeast expression
Monoterpene Indole Alkaloids	Brucine	Strychnos nux-vomica	9	Not recorded [65]	In vitro assays, transcriptomics, co-expression analysis

Essential Research Reagent Solutions

Successful implementation of metabolic engineering strategies requires specialized research reagents and tools. The following table catalogizes essential solutions for systems biology-driven metabolic engineering:

Table 3: Essential Research Reagents and Tools for Metabolic Engineering

Reagent/Tool Category	Specific Examples	Function/Application	Technical Considerations
Bioinformatics Tools	GeNeCK, CoExpNetViz, MapMan [65]	Candidate gene selection and pathway prediction	Requires integration of multiple omics datasets for accurate predictions
Genome Editing Tools	CRISPR-Cas9, CRISPR-Cas12a [66] [67]	Targeted gene knockout, knockdown, or activation	Enables precise manipulation of regulatory genes and competing pathways
Heterologous Expression Systems	Nicotiana benthamiana transient expression [65]	Rapid pathway validation and small-scale production	Efficient for multi-gene co-expression; achieves high product levels
Analytical Platforms	LC-MS, GC-MS, NMR [65]	Metabolic profiling and structural elucidation	Essential for quantifying pathway intermediates and final products
Specialized Enzymes	Cytochrome P450s, Glycosyltransferases [67]	Introduction of functional groups and sugar moieties	Often require engineering for optimal activity in heterologous hosts
Synthetic Biology Parts	Synthetic promoters, regulatory elements [66]	Fine-tuning gene expression levels	Enables balanced expression of multiple pathway genes

Case Studies: Integrated Approaches in Secondary Metabolite Engineering

Terpenoid Biosynthesis Optimization

Terpenoids represent a particularly challenging class of secondary metabolites due to their complex structures and multi-compartmental biosynthesis. The integration of systems biology tools has enabled remarkable successes in this area:

Figure 2: Comprehensive terpenoid engineering strategy integrating multiple optimization approaches

Engineering terpenoid biosynthesis requires coordinated optimization of upstream precursor supply, mid-stream carbon skeleton formation, and downstream functionalization reactions [67]. In the case of artemisinin production in Artemisia annua, systems biology approaches revealed that 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) serves as the rate-limiting enzyme in the cytosolic mevalonate (MVA) pathway [67]. Targeted overexpression of HMGR from Catharanthus roseus (CrHMGR) increased artemisinin yield by 22.5% to 38.9% compared to non-transgenic controls [67]. Concurrently, activation of the plastidial methylerythritol phosphate (MEP) pathway through blue-light-mediated regulation of 1-deoxy-D-xylulose-5-phosphate synthase (DXS) further enhanced precursor supply [67]. These multipronged approaches demonstrate how systems biology identifies key regulatory nodes for targeted intervention.

Complex Alkaloid Pathway Reconstruction

The reconstruction of multi-step alkaloid biosynthesis pathways illustrates the power of integrated approaches for complex secondary metabolites. For example, the elucidation and reconstruction of the cocaine biosynthesis pathway in Erythroxylum novogranatense required expression of eight genes and coordination of multiple cell types and subcellular compartments [65]. Transcriptome analysis guided candidate gene identification, followed by functional validation through in vitro enzyme assays and heterologous expression in yeast [65]. The fully reconstructed pathway produced 398.3 ± 132.0 ng/mg dry weight of cocaine in the host system [65]. Similarly, the reconstruction of strictosidine biosynthesis in Catharanthus roseus required coordinated expression of 14 genes, leveraging CRISPR-Cas9 for precise regulation of endogenous genes [65]. These successes highlight the necessity of comprehensive pathway understanding before effective engineering.

Advanced Tools and Emerging Technologies

CRISPR-Based Metabolic Engineering

CRISPR technologies have expanded beyond simple gene editing to enable sophisticated metabolic network regulation. CRISPRi (interference) and CRISPRa (activation) systems allow fine-tuning of endogenous gene expression without permanent genetic alterations [66]. These approaches are particularly valuable for balancing flux through competing pathways and regulating the expression of toxic intermediate genes [67]. Synthetic promoters engineered with CRISPR-responsive elements further enable dynamic pathway control in response to metabolic status [66].

Protein and Enzyme Engineering

The functional expression of plant-derived enzymes in heterologous hosts often requires extensive protein engineering [67]. Cytochrome P450 enzymes, essential for terpenoid functionalization, present particular challenges due to their membrane association and specific electron transport requirements [67]. Structure-guided engineering, informed by AlphaFold predictions, enables optimization of these enzymes for improved activity, stability, and compatibility with heterologous cofactor systems [68] [67].

Subcellular Targeting and Compartmentalization

Metabolic engineering strategies increasingly incorporate precise subcellular targeting to leverage native compartmentalization or create engineered metabolic niches [64] [67]. For example, targeting terpenoid biosynthetic enzymes to peroxisomes has emerged as a strategy to isolate toxic intermediates from primary metabolism [64]. Similarly, engineered enzyme complexes through synthetic scaffolds enhance metabolic channeling and reduce intermediate diffusion [67].

Implementation Protocols

Protocol: Multi-Gene Pathway Assembly andN. benthamianaTransient Expression

Nicotiana benthamiana has emerged as a premier heterologous plant system for pathway validation and small-scale production [65]. The following protocol details robust methodology for complex pathway reconstruction:

• Modular Vector Assembly: Employ Golden Gate or Gibson assembly to construct expression units for each pathway gene, incorporating compatible overlapping sequences for rapid pathway assembly [65].

• Promoter and Terminator Selection: Utilize diverse promoter-terminator pairs to minimize homologous recombination and ensure balanced expression. Constitutive promoters like CaMV 35S are common, but tissue-specific or inducible promoters may be preferable for toxic intermediates [65].

• Agrobacterium tumefaciens Transformation: Introduce assembled constructs into A. tumefaciens strain GV3101 through electroporation or freeze-thaw transformation. Select transformed colonies on appropriate antibiotics [65].

• Plant Infiltration: Grow N. benthamiana plants for 4-5 weeks under standard conditions. Resuspend Agrobacterium cultures carrying pathway constructs in infiltration buffer (10 mM MES, 10 mM MgClâ‚‚, 150 μM acetosyringone) to OD₆₀₀ = 0.5-1.0 for each strain [65].

• Mixed Culture Infiltration: Combine equal volumes of each Agrobacterium strain carrying different pathway modules. Infiltrate into abaxial side of leaves using needleless syringe [65].

• Incubation and Harvest: Maintain infiltrated plants under standard growth conditions for 5-10 days. Harvest tissue by flash-freezing in liquid Nâ‚‚ for subsequent metabolite analysis [65].

• Metabolite Analysis: Extract metabolites using appropriate solvents (e.g., methanol:chloroform:water). Analyze via LC-MS/MS or GC-MS with multiple reaction monitoring for target compounds [65].

Protocol: Growth-Coupled Production in Microbial Systems

Growth-coupled production strategies, as demonstrated for xanthommatin synthesis in Pseudomonas putida, link target metabolite production to essential cellular functions, ensuring stable production without selective pressure [64]:

• Host Selection and Engineering: Choose microbial host with native metabolic capabilities aligned with target pathway. P. putida offers robust metabolism and stress tolerance advantageous for industrial applications [64].

• Essential Gene Knockdown: Identify essential genes whose expression can be controlled via inducible promoters or CRISPRi systems [64].

• Rescue Construct Design: Engineer rescue constructs that express the essential gene only when simultaneously expressing target pathway genes. This creates a genetic link between biomass formation and product synthesis [64].

• Fermentation Optimization: Develop fed-batch or continuous fermentation processes that maintain optimal growth conditions while maximizing product titers [64].

• Product Extraction and Quantification: Implement appropriate extraction protocols based on compound chemistry. Quantify yields using calibrated analytical standards [64].

Challenges and Future Perspectives

Despite significant advances, substantial challenges remain in the application of systems biology tools to metabolic engineering. Balancing metabolic flux in complex networks continues to present difficulties, particularly when engineering heterologous pathways that compete with essential host metabolism [65] [67]. Cytotoxicity of pathway intermediates often limits production, especially for oxidized terpenoids and alkaloids [67]. Incomplete knowledge of transport mechanisms between subcellular compartments hinders efficient channeling of intermediates [67]. Scaling engineered systems from laboratory to industrial production introduces additional challenges in process economics and regulatory compliance [67].

Future progress will likely focus on three key frontiers. First, the integration of machine learning and artificial intelligence will enhance predictive modeling of metabolic networks, enabling more rational design strategies [68] [67]. Second, the development of photoautotrophic chassis systems will reduce carbon dependency and improve sustainability of bioprocesses [67]. Third, novel bioprocessing approaches that integrate waste streams as feedstocks will support circular bioeconomy models while reducing production costs [68].

The continued integration of systems biology tools with metabolic engineering promises to accelerate the development of sustainable production platforms for valuable secondary metabolites. As these technologies mature, they will increasingly support the transition from discovery research to commercial-scale application, ultimately expanding access to complex natural products for pharmaceutical and industrial applications [65] [67].

Addressing Low Yield and Compound Purification Challenges

The biogenesis of plant secondary metabolites represents a cornerstone for developing therapeutic agents, with over 60% of FDA-approved small-molecule drugs originating from natural products or their derivatives [69]. However, the transition from discovery to commercial production faces significant hurdles in low yield and complex purification processes. These metabolites, including terpenoids, alkaloids, and phenolics, typically accumulate in minimal quantities within native plants and are challenging to purify from complex cellular matrices [70] [71]. This technical guide examines systematic strategies to overcome these bottlenecks, integrating advanced biotechnological approaches with cutting-edge analytical methodologies to enhance both the production and purification of valuable bioactive compounds within the broader context of biosynthesis and biogenesis research.

Foundational Concepts in Secondary Metabolite Biogenesis

Biosynthetic Pathways and Their Regulation

Secondary metabolites (SMs) are synthesized through distinct biosynthetic pathways that interconnect with primary metabolism. The major pathways include: the shikimic acid pathway, producing phenolic compounds like flavonoids and lignans; the mevalonic acid (MVA) and methylerythritol phosphate (MEP) pathways, generating terpenoids and steroids; and the amino acid pathways, constructing alkaloids and peptides [72] [69]. These SMs are not directly involved in growth and development but play crucial roles in plant defense and environmental interactions. Their synthesis is highly regulated by developmental stages, physiological conditions, and various environmental stresses, with production often activated through defense-related transcriptional factors in response to biotic and abiotic stressors [72].

Intrinsic Challenges in Production and Purification

The structural complexity of SMs makes total chemical synthesis economically unviable for commercial production, while extraction from wild plants faces limitations including low accumulation concentrations, long growth periods, and negative ecological impacts from overharvesting [70]. Furthermore, purifying desired compounds requires sophisticated separation from numerous structurally similar compounds, especially those with analogous yields [70]. These challenges necessitate the development of advanced biotechnological and purification strategies to achieve sustainable and efficient production.

Strategic Framework for Yield Enhancement

Genetic and Metabolic Engineering Approaches

Advanced genetic engineering provides powerful tools for enhancing secondary metabolite production by directly manipulating biosynthetic pathways:

• Pathway Gene Identification: Genomics, transcriptomics, and proteomics approaches identify genes, enzymes, and transcription factors involved in biosynthetic pathways. Genome-wide expression profiling analysis serves as a powerful discovery tool, with next-generation sequencing technologies providing extensive data for identifying biosynthetic genes in medicinal plants like Artemisia annua, Salvia miltiorrhiza, and Panax ginseng [70].

• Heterologous Expression Systems: Genetic transformation techniques enable the transfer of biosynthetic genes into cultured plant cells, tissues, or microorganisms for heterologous expression. For example, transforming the taxadiene synthase gene into Arabidopsis thaliana and tomato resulted in taxadiene accumulation, while tobacco plants transformed with methyltransferase genes successfully produced caffeine [70].

• Transcription Factor Engineering: Modulating transcription factors that control multiple biosynthetic genes can simultaneously upregulate entire pathway modules rather than individual enzymatic steps, providing a powerful approach to overcoming rate limitations [70].

Advanced Cultivation Systems and Optimization

In vitro culture systems provide controlled environments for consistent secondary metabolite production independent of environmental variations:

• Cell Suspension Cultures: Growing cell cultures in liquid medium enables selection of high-producing cell lines and scalable production. Optimization of media composition (carbon source, nutrients, growth regulators) and culture conditions (light, temperature, pH, agitation) significantly enhances yields [73].

• Hairy Root and Shoot Cultures: Utilizing biological vectors to deliver genes of interest into plant genomes enables the production of SMs not naturally synthesized by the plant, overexpression of rate-limiting enzymes, and blocking of competing pathways [73].

• Elicitation Strategies: Exposing in vitro cultures to trace levels of elicitors activates plant defense responses and consequent SM biosynthesis. Elicitors can be abiotic (jasmonic acid, heavy metals, UV light) or biotic (chitosan, yeast extract), representing one of the most effective approaches for altering both quantitative and qualitative production of SMs [72] [73].

• Precursor Feeding: Adding initiator or intermediary molecules at the start of biosynthesis enhances flux through metabolic pathways. Common precursors include shikimic acid, jasmonic acid, and amino acids like phenylalanine and tryptophan, which can be introduced during medium preparation or at specific growth intervals [73].

• Biotransformation: Leveraging tissue culture capacity to convert compounds provided in the medium into different compounds with new properties through plant enzyme activity. For example, scopolamine is produced in tobacco through biotransformation of hyoscyamine [73].

The following workflow illustrates the integrated approach to enhancing secondary metabolite production:

Evolution-Guided Optimization

Evolution-guided optimization represents a cutting-edge approach for enhancing metabolic pathway efficiency:

• Sensor-Selector Systems: Intracellular presence of target chemicals is converted into fitness advantages using sensor domains responsive to the chemical to control reporter genes necessary for survival under selective conditions. This couples chemical production to cellular fitness, allowing progressive enrichment of superior pathway designs [74].

• Toggled Selection Scheme: A negative selection scheme eliminates "cheater" cells that survive without producing the target molecule while preserving library diversity. This enables multiple rounds of evolution with minimal carryover of non-productive variants after each round [74].

• Targeted Genome-Wide Mutagenesis: Varying expression of pathway genes identified by flux balance analysis through targeted mutagenesis, followed by iterative evolution rounds, has increased production of naringenin and glucaric acid by 36- and 22-fold, respectively [74].

Computational and Analytical Tools for Pathway Design

Computational Pathway Design Platforms

Advanced computational tools are revolutionizing biosynthetic pathway design and optimization:

• BioNavi-NP: A deep learning-driven toolkit that predicts biosynthetic pathways for natural products through transformer neural networks and AND-OR tree-based planning algorithms. This system can identify biosynthetic pathways for 90.2% of test compounds and recovers reported building blocks with 1.7 times greater accuracy than conventional rule-based approaches [69].

• SubNetX: A computational algorithm that extracts reactions from biochemical databases and assembles balanced subnetworks to produce target biochemicals from selected precursor metabolites, energy currencies, and cofactors. These subnetworks integrate into whole-cell models, enabling reconstruction and ranking of alternative biosynthetic pathways based on yield, length, and other design parameters [75].

• Retrobiosynthesis Analysis: Rule-free deep learning models utilize transformer neural networks to predict candidate precursors for target natural products, demonstrating superior performance and generalization potential compared to rule-based models [69].

Biological Databases for Pathway Design

The effectiveness of computational methods depends on comprehensive biological databases:

Table 1: Essential Biological Databases for Biosynthetic Pathway Design

Database Category	Database Name	Key Features	Application in Pathway Design
Compound Information	PubChem [76]	119 million compound records with structures and properties	Foundation for reaction and pathway databases
	ChEBI [76]	Curated small molecules with detailed annotations	Focused chemical entity information
	NPAtlas [76]	Curated natural products with annotated structures	Natural product discovery and biosynthetic studies
Reaction/Pathway Information	KEGG [76]	Integrated genomic, chemical, and systemic functional information	Pathway analysis and reconstruction
	MetaCyc [76]	Metabolic pathways and enzymes across organisms	Studying metabolic diversity and evolution
	Rhea [76]	Biochemical reactions with detailed equations	Enzyme function and metabolic pathway studies
Enzyme Information	BRENDA [76]	Comprehensive enzyme function, structure, and mechanism data	Enzyme selection and characterization
	UniProt [76]	Protein information across organisms	Enzyme function and evolution studies
	AlphaFold DB [76]	Predicted protein structures through deep learning	Enzyme structure-function analysis

Advanced Purification and Characterization Techniques

Bioactivity-Guided Isolation Strategies

Efficient purification of bioactive secondary metabolites requires sophisticated separation techniques:

• Solvent Extraction and Fractionation: Freeze-dried biological samples undergo solvent extraction followed by liquid-liquid partitioning to separate compounds based on polarity [77].

• Chromatographic Separation: Sequential application of thin layer chromatography, vacuum liquid chromatography, column chromatography, and preparative high-performance reversed-phase liquid chromatography achieves progressive compound purification [77].

• Bioactivity Monitoring: Isolation of bioactive secondary metabolites is monitored through bioactivity assays such as antioxidant (DPPH) and cytotoxicity (MTT) assays, ultimately yielding active principles [77].

Structural Elucidation and Analytical Methods

Advanced spectroscopic techniques enable comprehensive structural characterization:

• 2D NMR Spectroscopy: Provides detailed information on molecular structure through correlation of nuclear spins, essential for determining complex natural product structures [77].

• Mass Spectrometry Analysis: Delivers molecular weight and fragmentation patterns, with LC-MS/MS systems enabling thorough profiling of plant extracts and identification of characteristic fragments [71].

• Metabolomics: Comprehensive analysis of global metabolite profiles in biological systems represents ultimate biochemical phenotypes, connecting functional entities at the genomic level [70].

Integrated Experimental Protocols

Objective: Increase secondary metabolite yield through optimized elicitor treatment in plant cell suspension cultures.

Materials:

• Sterile plant cell suspension culture (e.g., Catharanthus roseus for alkaloids)
• Jasmonic acid stock solution (100 µM prepared in ethanol)
• Yeast extract powder (biotic elicitor)
• Culture medium appropriate for the specific plant species
• Sterile Erlenmeyer flasks (250 mL)
• Orbital shaker incubator
• Laminar flow hood for aseptic techniques

Methodology:

• Initiate cell suspension cultures from established callus lines and maintain in appropriate liquid medium for 7 days to reach exponential growth phase [73].
• Prepare elicitor treatments: jasmonic acid (50-200 µM final concentration) and yeast extract (100-500 mg/L final concentration) in fresh culture medium [72] [73].
• Add elicitors to cultures under sterile conditions, with control cultures receiving equivalent volumes of sterile solvent.
• Incubate cultures on orbital shakers (100-120 rpm) at appropriate growth temperature for 24-96 hours.
• Harvest cells by filtration or centrifugation at predetermined time points.
• Extract metabolites using appropriate solvents (methanol, ethanol, or ethyl acetate) based on compound polarity.
• Analyze metabolite content using HPLC, LC-MS, or GC-MS systems with quantification against authentic standards.

Optimization Parameters:

• Elicitor concentration and combination
• Exposure duration and growth phase at treatment initiation
• Culture conditions (temperature, light, agitation)
• Precursor feeding simultaneous with elicitation [73]

Advanced Purification Protocol: Bioactivity-Guided Fractionation

Objective: Ispute and purify bioactive compounds from complex plant extracts through sequential fractionation monitored by bioassays.

Materials:

• Crude plant extract
• Solvents of varying polarity (hexane, dichloromethane, ethyl acetate, n-butanol, water)
• Chromatography equipment (VLC, CC, preparative HPLC)
• Stationary phases (silica gel, C18, Sephadex)
• TLC plates and visualization reagents
• Bioassay systems (antioxidant, antimicrobial, or enzyme inhibition assays)

Methodology:

• Perform initial liquid-liquid partitioning of crude extract using solvents of increasing polarity [77].
• Concentrate each fraction under reduced pressure and screen for bioactivity.
• Subject active fractions to vacuum liquid chromatography (VLC) on silica gel with stepwise gradient elution.
• Monitor fractionation by TLC with appropriate detection methods (UV, spraying reagents).
• Further purify active subfractions using column chromatography with optimized solvent systems.
• Apply final purification steps using preparative reversed-phase HPLC.
• Validate purity of isolated compounds by TLC and HPLC.
• Elucidate structures using spectroscopic methods (NMR, MS, IR) [77].

Critical Considerations:

• Adjust isolation procedures based on physicochemical characteristics of target compounds
• Maintain compound stability throughout purification process
• Implement rapid processing to prevent compound degradation
• Use appropriate controls in bioactivity assays to validate results

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 2: Key Research Reagent Solutions for Secondary Metabolite Research

Reagent/Material	Function	Application Examples
Jasmonic Acid	Signaling molecule and elicitor	Activates plant defense responses and enhances production of alkaloids, terpenoids, and phenolics [73]
Chitosan	Polysaccharide biotic elicitor	Derived from fungal cell walls, induces phytoalexin production and secondary metabolite accumulation [73]
Shikimic Acid	Pathway precursor	Fundamental precursor in shikimate pathway for aromatic amino acids and phenolic compounds [72] [73]
Methyl Jasmonate	Volatile signaling compound	Elicits secondary metabolite biosynthesis through defense-related gene expression in plants like Dendrobium officinale [71]
Silica Gel (Various Grades)	Chromatographic stationary phase	Separation of compounds based on polarity in column chromatography, VLC, and TLC [77]
C18 Reverse-Phase Material	HPLC stationary phase	Purification of medium to non-polar compounds in preparative separations [77]
Sephadex LH-20	Size exclusion chromatography matrix	Final purification steps, particularly for removal of pigments and polyphenols [77]
Deuterated Solvents	NMR spectroscopy	Solvent systems for structural elucidation of purified compounds (CDCl3, DMSO-d6, MeOD) [77]

The challenges of low yield and complex purification in secondary metabolite production are being systematically addressed through integrated biotechnological approaches. Genetic engineering, advanced cultivation systems, computational design tools, and evolution-guided optimization collectively enable significant enhancements in metabolite titers. Concurrently, sophisticated purification methodologies coupled with robust analytical techniques ensure efficient isolation and characterization of bioactive compounds. The continued integration of these strategies, particularly through AI-driven pathway design and multi-omics technologies, promises to accelerate the discovery and sustainable production of valuable plant-derived compounds for pharmaceutical and industrial applications. This technical framework provides researchers with comprehensive methodologies to overcome traditional bottlenecks in secondary metabolite research and development.

In the field of secondary metabolites research, the rediscovery of known compounds poses a significant bottleneck, consuming substantial time and resources [78]. Genetic dereplication has emerged as a powerful bioinformatic strategy that addresses this challenge by analyzing biosynthetic gene clusters (BGCs) in microbial genomes prior to chemical analysis [79] [80]. This approach enables researchers to rapidly identify strains that possess the greatest potential to produce new secondary metabolites while avoiding those that produce known compounds, thereby improving the efficiency of natural product discovery [78] [81].

This technical guide explores the core principles, methodologies, and applications of genetic dereplication, framed within the broader context of biosynthesis and biogenesis research. For researchers and drug development professionals, mastering these techniques is crucial for navigating the complex landscape of microbial secondary metabolism and prioritizing the most promising candidates for further investigation.

Core Principles and Significance

The Dereplication Challenge in Natural Product Discovery

The historical reduction in microbial natural products discovery stems largely from the high rediscovery rate of known metabolites [78]. Traditional methods involve cultivation, extraction, and chemical analysis, often leading to the repeated isolation of identical compounds. It is estimated that only 3% of the natural-product potential of even the well-studied genus Streptomyces has been realized, leaving considerable opportunity for new discovery [78]. Genetic dereplication addresses this inefficiency by leveraging genomic information to predict chemical output before undertaking laborious chemical analyses.

Fundamental Concepts

Genetic dereplication operates on the principle that the biosynthetic machinery for secondary metabolites is encoded by clustered genes in microbial genomes [80]. These biosynthetic gene clusters (BGCs) typically include genes for core biosynthetic enzymes such as polyketide synthases (PKS), non-ribosomal peptide synthetases (NRPS), terpene cyclases, and tailoring enzymes [79] [78]. Through bioinformatic analysis of these clusters, researchers can predict structural features of the corresponding metabolites and assess their novelty by comparison to databases of characterized pathways.

Table 1: Key Types of Biosynthetic Gene Clusters and Their Characteristics

BGC Type	Core Biosynthetic Enzymes	Representative Compounds	Genetic Features
Polyketides	Polyketide Synthases (PKS)	Aflatoxins, Statins	Ketosynthase (KS), Acyltransferase (AT), Acyl Carrier Protein (ACP) domains
Non-Ribosomal Peptides	Non-Ribosomal Peptide Synthetases (NRPS)	Penicillins, Vancomycin	Adenylation (A), Thiolation (T), Condensation (C) domains
Hybrid	PKS-NRPS	Equisetin, Bleomycin	Fusion of PKS and NRPS modules
Ribosomally Synthesized and Post-translationally Modified Peptides (RiPPs)	Various Modification Enzymes	Cyanobactins, Lantibiotics	Precursor peptide with modification enzymes

Biological Context for Dereplication

The tremendous diversity of secondary metabolites in fungi and actinobacteria reflects evolutionary adaptations to ecological challenges [81]. In Aspergillus species, considerable diversity exists in terms of morphological, functional, and genetic features, with sexual reproduction, parasexuality, and horizontal gene transfer (HGT) all contributing to the expansion and diversification of BGCs [81]. Bioinformatics analyses have revealed that Aspergillus flavus likely harbors more than 500 horizontally transferred genes, 41% of which reside in physically linked gene clusters [81]. This evolutionary perspective informs dereplication strategies by explaining the distribution and variation of BGCs across taxonomic groups.

Methodological Approaches

Gene Cluster Network Analysis

Network analysis approaches enable the categorization of secondary metabolite gene clusters (SMGCs) across multiple genomes into families predicted to produce similar compounds [79]. In a comprehensive study of Aspergillus section Nigri, researchers detected 2,622 gene clusters and categorized them into 435 families using an automated workflow, with 217 families containing only one unique cluster [79]. This approach facilitates the identification of homologous gene clusters and enables comparative analysis across strain collections.

The following workflow illustrates the genetic dereplication process using gene cluster network analysis:

Diagram 1: Genetic Dereplication via Network Analysis

PCR-Based Screening for Biosynthetic Genes

For rapid assessment of biosynthetic potential without full genome sequencing, PCR-based approaches using degenerate primers target conserved domains within BGCs [78]. This method has been successfully applied to screen marine-sediment-derived Actinobacteria, where two-thirds of strains yielded sequence-verified PCR products for at least one biosynthetic type [78].

Table 2: Degenerate Primers for Targeted BGC Amplification

Target Domain	Primer Name	Primer Sequence (5' to 3')	Target BGC Type
Ketosynthase (KS)	KS-F	CCSCAGSAGCGCSTSYTSCTSGA	Modular, iterative, hybrid type I PKS
Ketosynthase (KS)	KS-R	GTSCCSGTSCCGTGSGYSTCSA	Modular, iterative, hybrid type I PKS
Adenylation (A)	-	-	NRPS
Enediyne PKS	EdyA	CCCCCGCVCACATCACSGSCCTCGCSGTGAACATGCT	Enediyne PKS
Enediyne PKS	EdyE	GCAGGCKCCGTCSACSGTGTABCCGCCGCC	Enediyne PKS

Experimental Protocol: PCR-Based Screening for PKS/NRPS Genes

• Genomic DNA Extraction: Extract genomic DNA using modified DNeasy protocol with RNase A treatment (2 mg/ml) and proteinase K digestion [78].
• PCR Reaction Setup:
  • DNA template: 20-50 ng
  • Primers: 500-800 pmol each
  • PCR buffer II (Applied Biosciences)
  • MgClâ‚‚: 2.5 mM
  • AmpliTaq Gold DNA polymerase: 1.5 U
  • dNTP mixture: 400 μM
  • DMSO: 7%
• Amplification Conditions:
  • Initial denaturation: 95°C for 15 min
  • 1 cycle: 95°C for 1 min, 65°C for 1 min, 72°C for 1 min
  • 35 cycles: 95°C for 1 min, 62°C for 1 min, 72°C for 1 min
  • Final extension: 72°C for 10 min
• Product Analysis: Clone and sequence PCR products; perform phylogenetic analysis to assess similarity to characterized pathways.

Genetic Dereplication via Cluster Inactivation

An alternative approach involves the targeted inactivation of highly expressed BGCs to reduce metabolic background and facilitate detection of minor metabolites [80]. This method was successfully applied in Pestalotiopsis fici, where deletion of the pesthetic acid biosynthetic gene (PfptaA) simplified the metabolic profile and allowed identification of previously obscured compounds [80].

Experimental Protocol: Genetic Dereplication via Cluster Inactivation

• Identification of Target BGC: Select highly expressed gene clusters that dominate the metabolic profile.
• Vector Construction:
  • Amplify upstream and downstream homologous arms of target gene
  • Clone arms with antibiotic resistance gene (e.g., G418)
• Fungal Transformation:
  • Introduce deletion construct into wild-type strain
  • Select transformants on appropriate antibiotic media
• Mutant Verification:
  • Extract genomic DNA from transformants
  • Perform diagnostic PCR with designated primers
• Metabolic Profiling:
  • Culture wild-type and mutant strains on rice-based medium
  • Extract metabolites and analyze by HPLC and LC-MS
  • Compare metabolic profiles to identify newly detectable compounds

Epigenetic Manipulation for Cluster Activation

Many BGCs remain silent under standard laboratory conditions, limiting access to chemical diversity [80]. Manipulation of epigenetic regulators provides a strategy to activate these silent clusters by altering chromatin structure [80]. In Pestalotiopsis fici, deletion of histone methyltransferase gene PfcclA and histone deacetylase gene PfhdaA led to activation of silent BGCs and identification of 15 new structures [80].

Experimental Protocol: Epigenetic Dereplication

• Identification of Epigenetic Regulators: Target histone-modifying enzymes (deacetylases, methyltransferases).
• Strain Construction:
  • Create single and double mutants of epigenetic regulators
  • Consider combining with genetic dereplication mutants (e.g., ΔPfptaA ΔPfcclA)
• Phenotypic Assessment:
  • Evaluate effects on growth, sporulation, and stress response
  • Analyze global metabolic profiles via HPLC and LC-MS
• Compound Isolation: Isolate and characterize novel metabolites activated in mutants

Case Studies and Applications

Malformin Discovery in Aspergillus

Gene cluster network analysis enabled the prediction of the biosynthetic gene cluster responsible for malformin production in 18 Aspergillus strains [79]. Malformins exhibit anti-tobacco mosaic virus activity and act as potentiators of anti-cancer drugs in mouse and human colon carcinoma cells [79]. The predictions were validated by developing genetic engineering tools in Aspergillus brasiliensis, confirming the gene cluster responsible for malformin biosynthesis and demonstrating the predictive power of the approach [79].

Pestaloficiol Discovery in Pestalotiopsis fici

A combination strategy of genetic dereplication (deletion of PfptaA) and manipulation of epigenetic regulators (deletion of PfcclA and PfhdaA) led to the isolation of a novel compound, pestaloficiol X, along with 11 known compounds with obvious yield changes [80]. This study demonstrated that combinatorial approaches could be successfully applied to discover new natural products in filamentous fungi while also revealing phenotypic effects on conidial development and response to oxidative stressors [80].

Emerging Mycotoxins in Aspergillus flavus

Integrated metabolic and phylogenetic analysis of Aspergillus flavus populations revealed a high intra-species diversity, with unequal distribution of mycotoxin profiles across different strains [81]. Beyond aflatoxins, this fungus produces diverse toxic metabolites including indole-tetramates, non-ribosomal peptides, and indole-diterpenoids [81]. The study provided mass spectrometry fragmentation spectra for the most important classes of A. flavus metabolites, serving as identification cards for future dereplication studies [81].

Essential Research Reagents and Tools

Table 3: Key Research Reagent Solutions for Genetic Dereplication

Reagent/Tool	Function	Application Example
antiSMASH	Automated identification and analysis of BGCs	Annotation of secondary metabolite clusters in bacterial genomes [79]
SMURF	Fungal-specific BGC prediction	Identification of SMGCs in Aspergillus genomes [79]
MIBiG Database	Repository of known BGCs	Annotation of clusters producing known compounds [79]
DNeasy Kit	Genomic DNA extraction	Preparation of template for PCR-based screening [78]
Degenerate Primers	Amplification of conserved BGC domains	Targeted amplification of PKS/NRPS genes [78]
G418 Antibiotic	Selection of fungal transformants	Selection of P. fici mutants with deleted BGCs [80]
HPLC-MS Systems	Metabolic profiling	Comparative analysis of metabolite production in mutants [80]

Integration with Metabolomic Dereplication

Genetic dereplication is most powerful when integrated with metabolomic approaches that combine chemical analysis with database searching [81]. Advanced visualization strategies for untargeted metabolomics data facilitate the interpretation of complex datasets and enhance dereplication efficiency [82]. The implementation of robust data visualization techniques is particularly crucial given the complexity of LC-MS/MS-based untargeted metabolomics data and its importance in validating genetic dereplication predictions [82].

The following diagram illustrates the integrated approach combining genetic and metabolomic dereplication:

Diagram 2: Integrated Genetic & Metabolomic Dereplication

Genetic dereplication represents a paradigm shift in natural products discovery, moving the point of dereplication from the chemical stage to the initial strain selection phase [79] [78] [80]. By leveraging genomic information to predict chemical output, researchers can prioritize strains with the greatest potential to produce novel compounds while avoiding redundant rediscovery of known metabolites [78] [81]. As genomic sequencing becomes increasingly accessible and BGC databases expand, these techniques will continue to enhance the efficiency and effectiveness of secondary metabolite research and drug discovery pipelines.

The integration of genetic dereplication with complementary strategies—including epigenetic manipulation, metabolomic analysis, and advanced data visualization—provides a powerful framework for navigating the complex landscape of microbial secondary metabolism and unlocking its full potential for pharmaceutical applications [82] [80].

The escalating demand for plant secondary metabolites (PSMs) for pharmaceutical, nutraceutical, and cosmetic applications necessitates the development of sustainable and controllable production systems [83]. These compounds, which include terpenes, steroids, phenolics, and alkaloids, exhibit a wide spectrum of biological activities but are often produced in low quantities within intact plants, constrained by ecological, political, and geographical factors [83] [72]. Traditional extraction from field-grown plants faces challenges such as environmental variability, seasonal fluctuations, and risk of overharvesting endangered species [83] [84].

In vitro culture technologies have emerged as a compelling alternative, offering a controlled environment independent of geographical and seasonal constraints [83] [85]. These systems provide uncontaminated plant material free from pesticides and enable the production of complex compounds from rare species that resist domestication [83]. However, a persistent limitation of many in vitro systems is low productivity of the target metabolites [83] [86].

Among the most effective strategies to enhance the biotechnological production of secondary compounds is elicitation [83] [84] [86]. Elicitation involves the introduction of specific chemical or biological agents (elicitors) that mimic stress signals, thereby activating plant defense responses and subsequently promoting the biosynthesis and accumulation of valuable secondary metabolites [83] [87]. This technical guide explores the mechanistic basis of elicitation, provides detailed experimental protocols, and synthesizes quantitative data on its efficacy, framing this discussion within the broader context of biosynthesis and biogenesis research for a scientific audience.

Definition and Classification of Elicitors

In plant cell cultures, an elicitor is defined as a compound introduced in small concentrations to a living system to promote the biosynthesis of a target metabolite [83]. Elicitors are broadly classified based on their origin and nature.

Table 1: Classification of Elicitors with Examples and Mechanisms

Category	Subcategory	Examples	Typical Mechanisms/Effects
Biotic Elicitors	Microbial-derived	Yeast extract, chitosan, chitin, glucans [83] [84]	Recognition as Microbe-Associated Molecular Patterns (MAMPs); activation of defense genes [83] [84].
	Plant-derived	Pectin, pectic acid, cellulose [84]	Act as endogenous signaling molecules (Danger-Associated Molecular Patterns) [84].
Abiotic Elicitors	Hormonal signaling compounds	Methyl Jasmonate (MeJA), Salicylic Acid (SA), Jasmonic Acid (JA) [83] [84] [88]	Key players in signal transduction pathways; modulate transcriptional networks [84] [85].
	Inorganic chemicals & salts	Vanadyl sulphate, AgNO₃, CdCl₂, CuCl₂ [83] [84] [85]	Induce oxidative stress; modulate ion fluxes; can inhibit ethylene action (e.g., AgNO₃) [83] [85].
	Physical factors	UV light, ozone, cold shock, osmotic stress [84]	Generate reactive oxygen species (ROS); alter membrane permeability and enzyme activity [84].
Novel Elicitors		Coronatine, cyclodextrins, nanoparticles [83] [84]	Coronatine is a potent JA mimic; cyclodextrins can complex and sequester metabolites, potentially facilitating excretion [83].

Molecular Mechanisms of Elicitor Action

The elicitor-induced activation of secondary metabolism is a multi-step process initiated by signal perception and culminating in gene expression and metabolic re-routing. The general sequence of events is as follows [83] [84] [86]:

• Elicitor Recognition: Elicitors are perceived by specific receptors located on the plasma membrane [83] [84].
• Early Signaling Events: This perception triggers immediate responses including:
  • Ion fluxes (Ca²⁺ influx, K⁺/Cl⁻ efflux, H⁺ influx) leading to cytoplasmic acidification and extracellular alkalinization [83] [84] [86].
  • Activation of NADPH oxidase and production of Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS) [83] [84].
  • Phosphorylation and dephosphorylation of plasma membrane and cytosolic proteins, activating Mitogen-Activated Protein Kinase (MAPK) cascades [83] [84] [86].
• Activation of Secondary Messengers and Transcription: The initial signals are amplified by secondary messengers, leading to the activation of transcription factors (e.g., WRKY, MYB, AP2/ERF). This results in the expression of defense-related genes, including those encoding key enzymes of secondary metabolic pathways [84] [85] [88].
• Metabolic Reprogramming and Metabolite Accumulation: The transcriptional activation leads to the biosynthesis and accumulation of defensive secondary metabolites such as phytoalexins and pathogenesis-related (PR) proteins [83] [84].

The following diagram illustrates the core signaling pathway activated by elicitors.

This section provides a generalized, yet detailed, methodology for implementing elicitation in plant in vitro cultures. The protocol must be optimized for each specific plant species, culture type, and target metabolite.

Establishing In Vitro Cultures

Objective: To generate sterile, uniform biomass as a platform for elicitation.

Materials:

• Plant Material: Sterile seedlings, explants (leaf, stem, root), or established callus lines.
• Culture Vessels: Petri dishes for solid cultures; Erlenmeyer flasks or bioreactors for suspension cultures.
• Growth Media: Basal medium (e.g., MS, B5) supplemented with appropriate plant growth regulators (PGRs) like auxins (2,4-D, NAA) and cytokinins (BAP, kinetin) [85].
• Sterilization Equipment: Laminar flow hood, autoclave, 70% (v/v) ethanol, sodium hypochlorite solution.

Procedure:

• Surface Sterilization: Treat explants with 70% ethanol for 30-60 seconds, followed by immersion in a sodium hypochlorite solution (1-2% available chlorine) for 10-20 minutes. Rinse thoroughly 3-5 times with sterile distilled water [85].
• Callus Induction: Place sterilized explants on solid culture medium containing a balance of auxin and cytokinin. Seal plates with parafilm and incubate in the dark or under a light/dark cycle at 25±2°C for 2-4 weeks until callus forms.
• Cell Suspension Culture: Transfer friable callus to liquid medium of the same composition. Maintain cultures on an orbital shaker (e.g., 110-120 rpm) at 25±2°C. Subculture every 7-14 days to maintain log-phase growth [89].

Elicitor Preparation and Treatment

Objective: To prepare elicitor stock solutions and apply them to cultures at the optimal time and concentration.

Materials:

• Elicitors: e.g., Methyl Jasmonate (MeJA), Salicylic Acid (SA), Chitosan, Yeast Extract, AgNO₃.
• Solvents: Ethanol, DMSO, or sterile distilled water depending on elicitor solubility.
• Culture System: Established cell suspension or tissue cultures in their exponential or early stationary growth phase.

Procedure:

• Elicitor Stock Solution:
  • Biotic Elicitors (e.g., Chitosan): Prepare a 1 mg/mL stock by dissolving chitosan in dilute acetic acid solution (e.g., 0.1-1.0% v/v) and adjust pH to 5.5-5.8. Sterilize by autoclaving or filtration [84].
  • Abiotic Elicitors (e.g., MeJA, SA): Prepare concentrated stocks in ethanol or DMSO. For example, dissolve MeJA in ethanol to make a 100 mM stock solution. Sterilize by filtration (0.22 μm) [84].
  • Salt Elicitors (e.g., AgNO₃): Prepare an aqueous stock solution (e.g., 10-100 mM) and sterilize by autoclaving or filtration [85].
• Determining Treatment Timing: For a two-stage culture, transfer cells to a production medium or treat cultures during the late exponential or early stationary phase, as secondary metabolite production is often decoupled from growth [83] [85].
• Elicitor Application: Add the sterile stock solution directly to the culture medium to achieve the desired final concentration. For example:
  • MeJA: Typical final concentrations range from 50 to 200 μM [84].
  • AgNO₃: A study on Artemisia annua callus used 1 mg/L in a medium containing specific PGRs [85].
  • Include control treatments with the solvent vehicle alone.
• Post-Elicitation Incubation: Continue incubation of cultures under standard growth conditions (temperature, light, shaking) for a predetermined period (typically 24 hours to several days) before harvesting for analysis.

Metabolite Analysis and Evaluation

Objective: To quantify the yield of the target secondary metabolite(s) and assess the effectiveness of the elicitation.

Materials:

• Harvested biomass (filtered or centrifuged)
• Liquid Nitrogen
• Extraction solvents (e.g., methanol, ethanol, hexane)
• Analytical equipment: HPLC, LC-MS, GC-MS, or a rapid ES-MS system for screening [89].

Procedure:

• Biomass Harvesting and Extraction:
  • Separate biomass from the culture medium by filtration or centrifugation.
  • Record fresh and dry weight (after drying at 40-60°C) to calculate biomass yield.
  • Homogenize the biomass in liquid nitrogen. Extract metabolites using an appropriate solvent (e.g., methanol, ethanol) via sonication or agitation. A study on actinomycetes used ethanol extraction with 2h agitation followed by 16h settling [89].
  • Filter the extract (e.g., through a 0.22 μm membrane) before analysis.
• Metabolite Quantification:
  • High-Performance Liquid Chromatography (HPLC): The gold standard for quantifying specific metabolites. Use a C18 column and a gradient elution system with UV-Vis or Diode Array Detection (DAD). Compare peak areas of samples to those of authentic standards [89] [84].
  • Evaporative Light Scattering Detection (ELSD): A quasi-universal, non-selective detection method useful for estimating the number of secondary metabolites when coupled with HPLC [89].
  • Electrospray Mass Spectrometry (ES-MS): Can be used for rapid profiling and estimation of secondary metabolite productivity. Direct-infusion ES-MS can process samples in ~1 minute and correlates well with HPLC-based methods [89].

The overall workflow, from culture establishment to analysis, is summarized below.

Elicitation has proven highly effective in enhancing the production of a diverse range of valuable PSMs across numerous plant species and culture systems. The table below summarizes documented fold-increases in metabolite yield following elicitor treatment.

Table 2: Efficacy of Elicitation for Enhanced Metabolite Production

Target Metabolite	Plant Species	Culture Type	Elicitor(s) Used	Fold-Increase / Yield	Reference Source
Artemisinin	Artemisia annua	Callus	AgNO₃ (1 mg/L) with specific PGRs	0.83-fold of wild plant content	[85]
Hypericins	Hypericum perforatum	Seedlings, Shoot cultures	Various biotic & abiotic elicitors	Significant induction (naphthodianthrones mainly in dark nodules)	[84]
Flavonoids & Xanthones	Hypericum perforatum	Cell suspensions, Calli, Roots	Various biotic & abiotic elicitors	Significant induction (compounds formed in all culture types)	[84]
General Secondary Metabolites	Various Actinomycetes	Fermentation Broth	N/A (comparison of conditions)	Up to 400-fold difference between conditions	[89]
General Secondary Metabolites	Various plant species	In vitro cultures	N/A (across studies)	1 to 2230-fold enhancement reported	[86]

A 2025 study on A. annua callus cultures provides a nuanced view of elicitation outcomes [85]. Treatment with 1 mg/L AgNO₃ in a medium containing 5 mg/L BAP and 1 mg/L NAA resulted in:

• Biomass Enhancement: Fresh and dry biomass increased by 182% and 227%, respectively.
• Metabolic Decoupling: Despite massive biomass growth, artemisinin content reached only 0.83-fold that of wild plants, indicating that the elicitor combination decoupled growth from the target secondary metabolism.
• Context-Dependent Oxidative Stress: The role of silver ions was highly context-specific, attenuating oxidative stress under some PGR conditions (2,4-D) while exacerbating it under others (NAA).

This case highlights the critical importance of fine-tuning elicitor and PGR combinations to direct metabolic flux toward the desired compound rather than just maximizing biomass.

The Scientist's Toolkit: Essential Reagents and Materials

Successful implementation of elicitation strategies requires a suite of key reagents and materials. The following table details essential components for a research program in this field.

Table 3: Research Reagent Solutions for Elicitation Studies

Category	Item	Typical Function / Application
Culture Media & Supplements	Murashige and Skoog (MS) Basal Salt Mixture	Provides essential macro and micronutrients for in vitro plant growth.
	Plant Growth Regulators (PGRs): Auxins (2,4-D, NAA, IAA) and Cytokinins (BAP, Kinetin)	Control cell division, differentiation, and callus/organ formation [85].
	Gelling Agent (Agar, Gelzan)	Solidifies media for callus and plantlet culture.
Common Elicitors	Methyl Jasmonate (MeJA)	Key hormonal signaling molecule; potent inducer of defense pathways and terpenoid/alkaloid biosynthesis [84] [87].
	Salicylic Acid (SA)	Defense signaling hormone; often induces pathways related to phenolic compound and phytoalexin production [84] [88].
	Chitosan	Biotic elicitor derived from chitin; activates broad-spectrum defense responses and secondary metabolism [83] [84].
	Silver Nitrate (AgNO₃)	Abiotic elicitor; inhibits ethylene action, induces oxidative stress, and can enhance metabolite production in specific contexts [83] [85].
	Yeast Extract	Complex biotic elicitor containing a mixture of potential MAMPs; provides a strong, non-specific stimulus [83].
Analysis & Quantification	Solid-Phase Extraction (SPE) Cartridges (e.g., C18)	Pre-concentrate and clean up samples prior to analysis, improving detection limits [89].
	HPLC/LC-MS Grade Solvents (Acetonitrile, Methanol, Water)	Required for high-resolution chromatographic separation and mass spectrometric detection of metabolites.
	Analytical Standards for Target Metabolites (e.g., Artemisinin, Hypericin)	Essential for creating calibration curves and quantifying specific compounds in complex extracts.

Elicitation stands as a powerful and versatile strategy within the plant biotechnology toolkit, capable of dramatically enhancing the sustainable production of high-value secondary metabolites through in vitro cultures. Its effectiveness is rooted in the sophisticated innate immune and stress response systems of plants. By understanding the molecular mechanisms—from initial elicitor recognition to the transcriptional activation of biosynthetic genes—researchers can rationally design elicitation protocols.

The successful application of this technology requires careful optimization of multiple variables, including the choice of elicitor, its concentration, the timing of application, and the type of culture system used. As demonstrated by recent research, the interaction between elicitors and plant growth regulators is particularly critical and can lead to complex outcomes, such as the decoupling of growth and product formation. Future advances will likely integrate elicitation with other strategies, such as metabolic engineering and multi-omics analysis, to further unravel and manipulate the complex regulatory networks governing the biogenesis of secondary metabolites, paving the way for more predictable and efficient plant cell factories.

Validating Function and Assessing Diversity through Comparative Genomics

Genetic Dereplication using Gene Cluster Networks (e.g., SMGC Families)

The genomic era has revealed a fundamental challenge in secondary metabolite research: the number of biosynthetic gene clusters in microbial genomes vastly outnumbers the detected compounds under standard laboratory conditions. This discrepancy challenges efficient resource allocation in natural product discovery, necessitating advanced computational methods for genetic dereplication—the process of identifying and grouping homologous gene clusters to avoid redundant characterization efforts. Focusing on Secondary Metabolite Gene Clusters (SMGCs), particularly in prolific producers like fungi, genetic dereplication enables researchers to prioritize novel biosynthetic pathways and understand the evolutionary dynamics of secondary metabolism [79] [90].

The concept of SMGC families represents a cornerstone approach in this field, categorizing evolutionarily related clusters that potentially produce structurally similar compounds. This methodology has demonstrated remarkable utility in navigating the complex landscape of fungal secondary metabolism. For instance, within the genus Aspergillus, studies have revealed that SMGC diversity within a single section (Nigri) can equal the diversity observed across the entire genus, highlighting both the extensive genetic repertoire and the pressing need for efficient categorization systems [79]. By implementing gene cluster networks, researchers can systematically elucidate biosynthetic pathways for medically relevant compounds while gaining insights into the gain, loss, and horizontal transfer of secondary metabolite genes across phylogenetic boundaries.

Theoretical Framework and Significance

The Genomic Potential of Secondary Metabolites

Secondary metabolites represent a rich reservoir of bioactive compounds with significant pharmaceutical, agricultural, and industrial applications. These specialized molecules are encoded by biosynthetic gene clusters (BGCs) that bring together all necessary enzymes for a particular metabolite's construction. In fungi, these clusters typically involve several key enzyme classes: polyketide synthases (PKSs), non-ribosomal peptide synthetases (NRPSs), terpene cyclases (TCs), and various tailoring enzymes that modify the core scaffold [79]. The disparity between genomic potential and expressed metabolites is substantial; comparative genomic studies across 23 Aspergillus species revealed an average of 73 secondary metabolite gene clusters per genome, indicating vast untapped chemical diversity [91].

Genetic dereplication addresses this disparity through computational approaches that group homologous SMGCs into families based on sequence similarity and gene content. This methodology operates on the principle of "guilt by association," where clusters sharing significant homology likely produce structurally related compounds [79]. The organization into SMGC families enables researchers to quickly identify novel clusters distinct from known pathways, prioritize strains for further investigation, and predict chemical scaffolds based on genetic signatures. This approach has proven particularly valuable in studying taxa with rich secondary metabolisms, such as Aspergillus section Nigri, where the dynamic gain and loss of SMGCs contributes to substantial metabolic diversity between closely related species [79].

Evolutionary Dynamics of Gene Clusters

Comparative analyses of SMGC families across phylogenetic boundaries reveal fascinating evolutionary patterns in secondary metabolism. Studies demonstrate that while some SMGC families are conserved across broad taxonomic groups, others exhibit a patchy distribution consistent with horizontal gene transfer or differential gene loss. Within Aspergillus section Nigri, SMGC similarity between species ranges from 80-100% among isolates of the same species to as low as 20-30% between distantly related clades—a diversity magnitude comparable to that observed across the entire genus [79].

These evolutionary dynamics have practical implications for drug discovery. Clusters encoding valuable pharmaceuticals often display restricted phylogenetic distributions, while core SMGC families maintained across diverse taxa may represent pathways producing fundamental ecological mediators. The malformin biosynthetic pathway, a potentiator of anti-cancer drugs, exemplifies how SMGC family analysis can identify homologous clusters across multiple strains (18 Aspergillus strains in one study), enabling targeted genetic manipulation and heterologous expression strategies [79] [90]. Understanding these distribution patterns allows researchers to strategically select microbial strains that maximize the probability of discovering novel chemistries while avoiding redundant rediscovery of known compounds.

Methodological Workflow for Genetic Dereplication

Genome Mining and Cluster Identification

The genetic dereplication workflow begins with comprehensive genome mining to identify all potential secondary metabolite biosynthetic gene clusters. This initial step employs specialized bioinformatics tools designed to detect signature domains and architectures associated with different classes of secondary metabolites.

Table 1: Key Software Tools for SMGC Identification

Tool Name	Primary Function	Applications	References
antiSMASH	Identifies secondary metabolite gene clusters with module prediction	Comprehensive cluster detection and boundary prediction	[79]
SMURF	Fungal-specific SMGC annotation	Specialized for fungal genomes	[79]
MIBiG	Repository of known BGCs	Reference database for cluster annotation	[79]

The methodology requires standardized parameters across all genomes to ensure comparable results. For a typical analysis, genomic sequences are first annotated using standardized gene prediction algorithms. Subsequently, SMGC detection pipelines scan these annotations for hallmark biosynthetic domains—such as ketosynthase (KS) domains for polyketides and condensation (C) domains for non-ribosomal peptides—along with associated tailoring enzymes. This process generates a comprehensive catalog of SMGCs for each strain, including information on cluster boundaries, core biosynthetic genes, and putative regulatory elements [79].

Cluster Family Construction Using Network Analysis

Following identification, SMGCs are categorized into families through network analysis based on protein sequence similarity and gene content. This process involves systematic comparison of all encoded enzymes within each cluster, typically using BLAST-based algorithms with carefully optimized thresholds for homology detection [79].

The construction of SMGC families employs a distance metric based on shared gene content, often using relative risk (RR) calculations, followed by clustering algorithms such as hierarchical clustering or k-means to group related clusters [92]. The optimal number of clusters can be determined using silhouette analysis and the elbow method [92]. To address challenges posed by duplicated gene sets across multiple analyses, the "Unique Gene-Sets" methodology detects repeated gene-sets with identical identifiers and merges them into unified entries containing the union of all associated genes, thus eliminating analytical bias caused by redundancies [92].

Table 2: SMGC Family Distribution in Aspergillus Section Nigri

Taxonomic Level	SMGC Family Similarity Range	Number of Unique Families	Notable Patterns
Intraspecies (A. niger isolates)	80-100%	None unique	Limited diversity among isolates
A. niger clade species	60-80%	Varies by species	A. eucalypticola distinct
A. heteromorphus clade	50-60%	Multiple unique	High divergence
Section Nigri overall	≥30% (within biseriates/uniseriates)	435 total families	217 families unique to single species

Advanced implementations incorporate tools like GeneSetCluster 2.0, which provides enhanced clustering through seriation-based algorithms and sub-clustering capabilities via the BreakUpCluster module, allowing researchers to iteratively refine clusters for greater biological interpretability [92]. This approach facilitates identification of nuanced relationships between gene clusters that might be obscured in initial broad analyses.

Annotation and Cross-Referencing with Known Compounds

The final methodological stage involves annotating SMGC families by cross-referencing with databases of characterized gene clusters. The Minimum Information about a Biosynthetic Gene cluster (MIBiG) database serves as the primary resource, containing comprehensive information on experimentally verified biosynthetic pathways and their molecular products [79].

Annotation employs protein BLAST analysis to identify significant similarities between predicted enzymes in novel SMGC families and characterized enzymes in MIBiG. This process facilitates "genetic dereplication" by identifying SMGC families that correspond to known compounds, allowing researchers to focus efforts on truly novel pathways. In practice, this approach has successfully identified 36 known compound-associated gene clusters within Aspergillus section Nigri SMGC families, including universal clusters like those for fungisporin and siderophores such as ferrichrome [79].

For clusters without direct matches to characterized pathways, additional bioinformatics analyses—including substrate specificity prediction for adenylation domains and phylogenetic analysis of key biosynthetic enzymes—provide insights into potential chemical outputs. This systematic annotation strategy transforms raw genomic data into biologically meaningful hypotheses about metabolic capabilities that can guide subsequent experimental validation.

Experimental Protocols and Validation

In Silico Analysis Pipeline

The computational pipeline for genetic dereplication requires methodical execution of sequential analytical steps with careful parameter optimization at each stage:

Step 1: Data Acquisition and Quality Control

• Obtain genome sequences in FASTA format and verify assembly quality using BUSCO benchmarks to ensure ≥95% completeness for core genes [91]
• Annotate genomes using standardized pipelines (e.g., AUGUSTUS, GeneMark) with consistent parameters across all samples
• Store annotations in GFF3 format for downstream compatibility with SMGC prediction tools

Step 2: SMGC Detection and Annotation

• Process annotated genomes through antiSMASH with fungal-specific settings for comprehensive cluster detection [79]
• Supplement with SMURF analysis for improved fungal cluster prediction
• Extract protein sequences for all enzymes within predicted clusters and annotate functional domains using Pfam and InterProScan

Step 3: Cluster Comparison and Family Construction

• Perform all-vs-all BLASTP comparison of core biosynthetic enzymes using an E-value threshold of 1e-10 and minimum 30% sequence identity
• Calculate pairwise similarity scores between clusters based on shared gene content using relative risk (RR) metrics [92]
• Construct similarity matrix and perform hierarchical clustering with average linkage method
• Determine optimal cluster number using silhouette width analysis and implement sub-clustering with BreakUpCluster for refined resolution [92]

Step 4: Database Integration and Annotation

• Cross-reference cluster families with MIBiG database using BLASTP of key biosynthetic enzymes
• Annotate families with known compound associations where significant homology exists (E-value < 1e-20, identity > 40%)
• Export results in standardized formats for visualization and downstream analysis

Experimental Validation Framework

Computational predictions require experimental validation to confirm functional accuracy. The following protocol outlines a standardized approach for verifying SMGC family predictions:

Genetic Validation Protocol:

• Strain Selection: Prioritize representative strains from distinct phylogenetic lineages containing the target SMGC family to assess conservation and variability
• Gene Inactivation: For candidate clusters, design knockout constructs targeting core biosynthetic genes using fusion PCR or CRISPR-Cas9 systems
• Metabolite Profiling: Culture wild-type and mutant strains under multiple conditions (varying media, temperature, aeration) to elicit secondary metabolite production
• Chemical Analysis: Employ LC-MS/MS for metabolite detection and compare chemical profiles between wild-type and mutant strains to identify absent compounds in mutants
• Structure Elucidation: Purify target compounds using preparative chromatography and determine structures via NMR spectroscopy and HR-MS

This methodology was successfully implemented for the malformin biosynthetic cluster, where predictions from SMGC family analysis were confirmed through gene inactivation in Aspergillus brasiliensis, followed by chemical analysis demonstrating the absence of malformins in knockout strains [79] [90]. The experimental validation serves as the critical bridge between in silico predictions and confirmed biological function, ensuring that SMGC families accurately represent functional biosynthetic units.

Visualization of Methodological Workflow

The following diagram illustrates the comprehensive workflow for genetic dereplication using gene cluster networks, integrating both computational and experimental components:

Genetic Dereplication Workflow from Genomes to Validation

Successful implementation of genetic dereplication strategies requires specialized computational tools and biological resources. The following table catalogues essential reagents and their applications in SMGC family analysis:

Table 3: Essential Research Reagents and Resources for Genetic Dereplication

Resource Category	Specific Tools/Reagents	Function/Application	Implementation Notes
Genome Annotation	AUGUSTUS, GeneMark-ES	Structural gene prediction	Fungal-specific parameters recommended
SMGC Detection	antiSMASH, SMURF	Identify biosynthetic gene clusters	antiSMASH for broad detection, SMURF for fungi
Cluster Analysis	GeneSetCluster 2.0, ClustScan	Group related SMGCs into families	Handles redundancies via Unique Gene-Sets method [92]
Reference Databases	MIBiG, GenBank	Annotate with known compounds	Essential for dereplication [79]
Sequence Analysis	BLAST+, HMMER	Identify homologous sequences	Custom thresholds for domain detection
Visualization	Cytoscape, iTOL	Display networks and phylogenies	Integrate with cluster family data
Genetic Manipulation	CRISPR-Cas9, PEG-mediated transformation	Experimental validation	Species-specific protocols required

These resources collectively enable researchers to transition from raw genomic data to biologically meaningful insights about secondary metabolic potential. The integration of multiple tools creates a robust pipeline that balances sensitivity (comprehensive cluster detection) with specificity (accurate family assignment), ultimately supporting informed decisions about which gene clusters warrant further experimental investigation.

Genetic dereplication using gene cluster networks represents a transformative approach in secondary metabolite research, effectively addressing the challenge of prioritizing biosynthetic pathways from genomic data. The SMGC family framework enables systematic categorization of chemical potential across strains and species, revealing evolutionary patterns while accelerating novel compound discovery. As genomic sequencing continues to expand, these computational strategies will grow increasingly essential for navigating the vast landscape of microbial secondary metabolism and unlocking its potential for pharmaceutical and industrial applications.

Comparative Genomics to Reveal BGC Phylogenetic Distribution

The biosynthesis of secondary metabolites (SMs) represents a critical adaptive strategy across life forms, from bacteria and fungi to plants. These compounds, while not essential for basic growth, provide organisms with significant competitive advantages and are the source of many clinically valuable compounds, including antibiotics, antifungals, and anticancer agents [93]. The genetic blueprint for their production is typically organized into biosynthetic gene clusters (BGCs)—groups of co-localized genes encoding the enzymes, regulators, and transporters required for SM assembly [94].

In the context of a broader thesis on the biosynthesis and biogenesis of secondary metabolites, understanding the evolutionary forces that shape the distribution of these BGCs is paramount. Comparative genomics has emerged as a powerful discipline for elucidating the phylogenetic distribution patterns of BGCs across related species and strains. This approach reveals how vertical inheritance, horizontal gene transfer, and local adaptation have collectively shaped the modern landscape of metabolic potential [93] [95]. This technical guide outlines the core concepts, methodologies, and analytical frameworks for conducting research into the phylogenetic distribution of BGCs, providing a foundational resource for scientists and drug development professionals engaged in natural product discovery.

Core Concepts and Definitions

• Biosynthetic Gene Cluster (BGC): A set of physically close genes in a genome that collectively encode the biosynthesis of a secondary metabolite. Key classes include:
  • Polyketide Synthases (PKS): Megasynthases that produce polyketides through a multimodular assembly line [93].
  • Non-Ribosomal Peptide Synthetases (NRPS): Large enzymes that assemble peptides without ribosomal translation [93].
  • Ribosomally synthesized and post-translationally modified peptides (RiPPs) [93].
  • Terpenes [93].
• Gene Cluster Family (GCF): A group of BGCs from different organisms that share a common set of core biosynthetic genes and are predicted to produce structurally similar chemical compounds [93] [95]. Categorizing BGCs into GCFs is essential for prioritizing novel compounds and predicting their structural scaffolds.
• Phylogenetic Distribution: The pattern of presence or absence of a BGC or GCF across a phylogenetic tree constructed from housekeeping genes or whole genomes. This distribution indicates the evolutionary history of the cluster—whether it was conserved through vertical descent, acquired via horizontal transfer, or lost in certain lineages [93].
• Pan-genome: The entire set of genes found across all strains of a taxonomic group, comprising the core genome (shared by all strains) and the accessory/dispensable genome (present in a subset of strains). BGCs are frequently located in the accessory, hypervariable regions of the genome, which are influenced by horizontal gene transfer [93] [96].

Methodological Framework: An Experimental Workflow

The following section details the standard protocols for a comparative genomics study aimed at revealing BGC phylogenetic distribution.

Genome Sequencing, Assembly, and Annotation

Objective: To generate high-quality, comparable genomic data for all taxa in the study.

Detailed Protocol:

• Genome Sequencing: Utilize a combination of sequencing technologies to overcome assembly challenges.

  • Long-Read Sequencing (PacBio or Oxford Nanopore): Generates reads spanning thousands of base pairs, crucial for resolving repetitive regions and obtaining complete BGC sequences [97] [98]. For example, Kutzneria chonburiensis was sequenced using both Oxford Nanopore and Illumina technologies to achieve a complete circular chromosome [97].
  • Short-Read Sequencing (Illumina): Provides high-accuracy reads to correct errors in long-read data [97] [99]. A hybrid assembly approach is often the most effective strategy.

• Genome Assembly & Quality Assessment:

  • Perform de novo assembly using appropriate tools (e.g., SPAdes [94], HGAP for PacBio [99]).
  • Assess assembly quality and completeness using tools like QUAST (to filter out genomes with excessive gaps or inconsistent size) [94] and BUSCO (to benchmark universal single-copy orthologs) [97].

• Gene Prediction and Annotation:

  • Employ a unified, automated pipeline for consistent gene prediction across all genomes. The funannotate pipeline is a specialized tool for fungal genomes that integrates masking, prediction, and functional annotation [94].
  • For prokaryotes, the NCBI's Prokaryotic Genome Annotation Pipeline is a standard [99].
  • Critical Consideration: Re-annotating all genomes with the same pipeline is necessary to remove technical bias when comparing BGCs from genomes originally annotated with different methods [94].

Phylogenomic Analysis

Objective: To reconstruct the evolutionary relationships among the strains/species under study.

Detailed Protocol:

• Dataset Selection: Extract a set of conserved, single-copy housekeeping genes from the annotated genomes. For bacteria, a common approach is Multi-Locus Sequence Analysis (MLSA) using genes such as atpD, gyrB, and rpoB [93]. For phylogenomics, hundreds of universal single-copy orthologs can be used.
• Alignment and Tree Construction:
  • Align the amino acid or nucleotide sequences of each gene using tools like MAFFT or MUSCLE.
  • Concatenate the alignments into a supermatrix.
  • Construct a Maximum Likelihood phylogenetic tree using software such as RAxML or IQ-TREE. Use outgroup taxa to root the tree [93] [100].

BGC Identification and Classification into GCFs

Objective: To catalog and categorize the biosynthetic potential of each genome.

Detailed Protocol:

• BGC Detection:

  • Run all genomes through the antiSMASH software [97]. antiSMASH is the industry standard for identifying BGCs of all major classes (PKS, NRPS, RiPPs, terpenes, etc.) in bacterial and fungal genomes [97].
  • Outputs include the genomic location of each BGC and a preliminary classification.

• GCF Analysis:

  • Use the BiG-SCAPE tool to compare all detected BGCs against each other and group them into Gene Cluster Families (GCFs) based on sequence similarity and shared protein domains [93] [95].
  • BiG-SCAPE calculates pairwise distances between BGCs and generates networks or clusters, grouping BGCs that likely produce structurally related metabolites.

Correlation of GCF and Phylogenetic Patterns

Objective: To determine the evolutionary history of BGCs by comparing GCF distributions with the species phylogeny.

Detailed Protocol:

• Create a Presence/Absence Matrix: Generate a matrix where rows represent GCFs, columns represent genomes, and cells indicate the presence (1) or absence (0) of that GCF in that genome.
• Visualize and Compare Patterns:
  • Construct a heatmap of the GCF presence/absence matrix and compare it to the phylogenomic tree.
  • GCFs whose distribution perfectly correlates with the phylogeny (e.g., found exclusively in one monophyletic clade) are likely vertically inherited [93].
  • GCFs with a patchy distribution, present in distantly related taxa but absent in close relatives, are strong candidates for horizontal gene transfer [93].
  • Statistical tests, such as Mantel tests, can be used to formally correlate phylogenetic distance with BGC profile dissimilarity.

The following diagram illustrates the integrated workflow of this methodology.

Key Findings from Model Systems

Comparative genomics studies across diverse taxa have yielded fundamental insights into the principles governing BGC distribution.

BGC Distribution is Shaped by Both Vertical and Horizontal Evolution

• Vertical Inheritance: In the actinobacterial genus Amycolatopsis, the distribution of certain GCFs strongly correlated with the phylogeny of four major lineages, indicating that vertical descent plays a major role in the evolution of secondary metabolites [93].
• Horizontal Gene Transfer (HGT): The same study found that BGCs acquired via HGT were often located in non-conserved, hypervariable genomic regions, distinguishing them from the core genome [93]. This pattern of HGT facilitating metabolic diversification is also observed in fungi. In Alternaria, while GCF patterns generally correlated with phylogeny at higher taxonomic levels, individuals within the same species could differ in their toxicological potential, suggesting recent HGT or loss [95] [94].

Phylogeny and Ecology are Both Key Drivers

• Phylotype Correlation: A study of 87 marine Streptomyces genomes found that phylogenomic clades (Clades I, II, and III) harbored distinct sets of specific BGCs [100]. This demonstrates that evolutionary history is a strong predictor of BGC repertoire.
• Ecotype Correlation: The same study found that the habitat (ecotype) was also a significant factor. Streptomyces derived from marine sediments possessed different BGCs than those derived from marine invertebrates, independent of their phylogeny [100]. This suggests that ecological niche adaptation selectively maintains specific metabolic pathways.

Strain-Level Diversity is a Rich Resource for Discovery

• Strain-Specific BGCs: Comparative analysis of Kutzneria species revealed that K. chonburiensis possesses six strain-specific BGCs predicted to produce metabolites like virginiamycin S1 and rakicidin, which are absent in closely related species [97]. This highlights that valuable and novel BGCs can be highly specific, even below the species level.
• Differential Regulation: In Streptomyces venezuelae, three strains sharing over 85% of their genes and most BGCs nevertheless produced vastly different amounts of chloramphenicol and jadomycin. Genomic comparisons revealed sequence variations in regulatory regions and non-coding RNAs, explaining the antagonistic production of these metabolites [99]. This underscores that strain-level comparisons are essential for understanding the complex regulation of secondary metabolism.

Table 1: Quantitative Insights from Key Comparative Genomic Studies

Study System	Number of Genomes Analyzed	Average BGCs per Genome	Number of GCFs Identified	Key Finding on Phylogenetic Distribution
Amycolatopsis [93]	43	Not Specified	Not Specified	Four major phylogenetic lineages differed in secondary metabolite potential; both vertical and horizontal transfer are key.
Marine Streptomyces [100]	87	Not Specified	Not Specified	BGC distribution patterns were associated with both phylotype (clade) and ecotype (sediment vs. invertebrate).
Alternaria & Relatives [95] [94]	187	34 (all), 29 (Alternaria)	548	GCF presence/absence patterns were generally well-correlated with phylogenomic patterns at higher taxonomic levels.
Kutzneria [97]	7	Not Specified	322 (Total BGCs)	High BGC diversity was observed among species; K. chonburiensis contained 6 unique, strain-specific BGCs.
Pediococcus [96]	616	Not Specified	Not Specified	Pan-genome analysis revealed remarkable genomic flexibility and a diverse arsenal of bacteriocin BGCs.

The Scientist's Toolkit: Essential Research Reagents and Solutions

Successful execution of a comparative genomics study relies on a suite of bioinformatics tools and databases. The following table details essential resources for the core analytical steps.

Table 2: Key Bioinformatics Tools for BGC Phylogenetic Distribution Analysis

Tool Name	Primary Function	Application in the Workflow	Key Feature
antiSMASH [97]	BGC Identification & Prediction	Detects and annotates BGCs in genomic sequences.	The comprehensive standard for identifying all major classes of BGCs in bacteria and fungi.
BiG-SCAPE [93]	GCF Analysis	Groups predicted BGCs into Gene Cluster Families (GCFs).	Enables prioritization of BGCs based on novelty and evolutionary relationships.
funannotate [94]	Genome Annotation (Fungi)	Unified pipeline for gene prediction and functional annotation in fungal genomes.	Removes technical bias by providing consistent annotation across a dataset.
QUAST [94]	Genome Assembly Quality Assessment	Evaluates the quality of genome assemblies pre-analysis.	Filters out low-quality genomes with excessive gaps or inconsistent sizes.
BUSCO [97]	Genome Completeness Assessment	Benchmarks assembly and annotation completeness based on universal single-copy orthologs.	Ensures the genomic data is of sufficient quality for comparative analysis.
MIBiG [94]	BGC Database	Repository of experimentally characterized BGCs for comparison.	Allows researchers to compare their putative BGCs against a database of known compounds.

The integration of comparative genomics and phylogenetics provides a powerful, systematic framework for deciphering the evolutionary history and distribution of biosynthetic gene clusters. The methodologies outlined in this guide—from high-quality genome sequencing and unified annotation to phylogenomic reconstruction and GCF analysis—enable researchers to move beyond single-genome mining to a holistic, evolutionary-informed perspective. The consistent finding that BGC distribution is shaped by a complex interplay of vertical descent, horizontal gene transfer, and ecological adaptation has profound implications for natural product discovery. It argues that a combined strategy—targeting both specific phylogenetic lineages and unique ecological niches—will be most fruitful for discovering novel bioactive metabolites. Furthermore, the prevalence of strain-specific BGCs underscores the need to sequence multiple strains within a species to fully access its biosynthetic potential. As genomic technologies continue to advance and datasets expand, these comparative approaches will become increasingly central to guiding the effective prioritization of BGCs and accelerating the discovery of the next generation of natural products.

Linking BGCs to Known Compounds with MIBiG Database

Biosynthetic Gene Clusters (BGCs) are sets of co-located genes in microbial and plant genomes that encode the molecular machinery for producing specialized metabolites [101]. These metabolites, often called secondary metabolites, are a rich source of pharmaceutically relevant compounds, including antibiotics, antifungals, and anticancer agents. The Minimum Information about a Biosynthetic Gene Cluster (MIBiG) repository was established to provide a standardized, centralized resource for experimentally characterized BGCs, enabling researchers to connect gene clusters to their chemical products systematically [101]. As genomic sequencing data has exploded, MIBiG has become an essential resource for interpreting the function and novelty of newly identified BGCs, accelerating genome-mining efforts in drug discovery and microbial ecology [101].

The repository's significance stems from its role as a reference dataset for comparative analysis. When a new BGC is identified computationally in a genome or metagenome, researchers can compare it against MIBiG's curated entries to predict its product, understand its biosynthetic logic, and assess its potential for producing novel chemistry [101]. This process is fundamental to linking genes to compounds on a large scale. As of MIBiG version 2.0, the repository contained 2,021 manually curated BGCs with known functions, a 73% increase from the initial release [101]. These entries are predominantly of bacterial and fungal origin, with Streptomyces (568 BGCs) and Aspergillus (79 BGCs) being the most prominent genera [101].

The MIBiG Data Standard and Access

Data Structure and Annotation Completeness

The MIBiG standard captures detailed information about each BGC, its enzymatic components, and its molecular products. The data schema is designed to capture the architectural and enzymatic diversity of known BGCs while remaining flexible enough to accommodate future discoveries [101]. Key information captured for each entry includes:

• Cluster and Compound Information: BGC name, biosynthetic class, key publications, genomic loci, and compound structures.
• Gene Information: Gene identifiers, positions, predicted functions, and experimental evidence.
• Biosynthesis Details: Information on the biosynthetic pathway and enzymatic steps.

The annotation completeness of entries varies. MIBiG entries begin with a "minimal" annotation, which is enhanced through community submissions and dedicated "Annotathons" [101]. The repository utilizes a JSON schema description and validation technology to ensure data quality and consistency across entries [101].

Accessing and Querying the Repository

The MIBiG repository is accessible online at https://mibig.secondarymetabolites.org/. The web interface provides several ways to explore its contents [101]:

• Browsing and Search: Users can browse the repository overview or use a simple search form to find specific BGCs by compound name, organism, or other metadata.
• Advanced Querying: An interactive query builder allows for constructing complex Boolean queries to filter BGCs based on multiple criteria.
• REST-like API: For programmatic access, a web API (https://github.com/mibig-secmet/mibig-api/) handles access to the underlying database [101].

Table: MIBiG BGC Distribution by Biosynthetic Class (Representative Examples)

Biosynthetic Class	Number of BGCs	Example Compound	Producing Organism
Polyketide (PK)	825	Novofumigatonin	Aspergillus novofumigatus [102]
Non-Ribosomal Peptide (NRP)	627	Mycoplanecin A	Actinoplanes awajinensis [103]
Terpene	Information missing	Carotenoid	Streptomyces avermitilis [104]
Ribosomally synthesized and Post-translationally modified Peptide (RiPP)	Information missing	Information missing	Information missing
Saccharide	Information missing	Information missing	Information missing
Alkaloid	Information missing	Information missing	Information missing
Other	Information missing	Information missing	Information missing
Hybrid (e.g., PK-NRP)	Information missing	Information missing	Information missing

A Step-by-Step Guide to Linking BGCs and Compounds

Linking a BGC to its chemical product using MIBiG involves a multi-step process that integrates genomic and chemical data. The following diagram illustrates the core workflow for this identification and comparison process.

Protocol: Comparative Analysis of a BGC Using MIBiG

This protocol details the key steps for connecting a BGC of interest to known compounds.

Step 1: BGC Identification and Delineation

• Objective: Obtain the DNA sequence of the BGC to be studied.
• Methods:
  • For a sequenced microbial genome, use computational tools like antiSMASH to identify and extract the BGC sequence [101].
  • The BGC coordinates within a public nucleotide database (e.g., GenBank) are often reported in the primary literature. For example, the novofumigatonin BGC is located at coordinates 103,246 - 136,242 nt on the GenBank entry MSZS01000014.1 [102].
• Output: A FASTA file containing the nucleotide sequence of the putative BGC.

Step 2: In-depth Analysis with antiSMASH

• Objective: Annotate the BGC's core biosynthetic machinery and predict its biosynthetic class.
• Methods:
  • Input the BGC FASTA sequence into the antiSMASH web server or standalone tool.
  • antiSMASH will identify and annotate key biosynthetic genes (e.g., Polyketide Synthase (PKS), Non-Ribosomal Peptide Synthetase (NRPS)) and their domains [101].
• Output: A detailed annotation of the BGC, including a graphical map of genes and domains, which serves as the basis for comparison.

Step 3: Comparative Analysis via KnownClusterBlast

• Objective: Identify known BGCs in MIBiG that are similar to the query cluster.
• Methods:
  • Within the antiSMASH results, locate the KnownClusterBlast module. This function automatically compares the query BGC against the entire MIBiG repository [101].
  • Analyze the results, which include:
    • Alignment Scores: Percent identity and query coverage for homologous genes.
    • Visual Comparison: A side-by-side graphical representation of the query BGC and reference BGCs from MIBiG, with homologous genes color-coded [102].
• Output: A ranked list of MIBiG BGCs with significant similarity to the query.

Step 4: Functional Assessment and Homology Evaluation

• Objective: Determine if the genetic similarity is strong enough to infer production of a similar compound.
• Methods:
  • High Homology: If the core biosynthetic genes show high sequence identity and synteny (gene order conservation) with a MIBiG entry, the BGC likely produces the same or a very similar compound. For example, a query cluster with genes highly homologous to the Aspergillus novofumigatus novofumigatonin BGC would be a strong candidate for a related polyketide-terpene hybrid [102].
  • Partial Homology: Lower similarity may indicate a novel variant of a known compound family. Focus on the conservation of key catalytic residues in enzymatic domains.
• Output: A hypothesis about the chemical structure of the metabolite based on genetic homology.

Step 5: Connecting to Chemical Structure and Validation

• Objective: Access chemical data for the predicted compound and design experiments for validation.
• Methods:
  • From the matched MIBiG entry (e.g., BGC0001708 for novofumigatonin), use the provided cross-links to chemical databases like PubChem or the Natural Products Atlas to access the compound's structure (SMILES, InChI), mass, and spectroscopic data [102] [101].
  • Use this information to guide experimental validation:
    • Heterologous Expression: Clone and express the BGC in a model host (e.g., Streptomyces coelicolor) and analyze the metabolites.
    • Gene Knockout: Inactivate a core biosynthetic gene in the native host and compare the metabolite profile to the wild type.
• Output: A confirmed link between the BGC and its metabolic product.

Biosynthetic Pathways of Secondary Metabolites

Fundamental Metabolic Pathways

The biosynthesis of secondary metabolites originates from primary metabolic pathways, which supply the essential precursors. The major biosynthetic routes are interconnected within the plant cell, as shown in the following simplified pathway diagram.

The diagram illustrates three primary routes for secondary metabolite biosynthesis [72] [88]:

• The Shikimate Pathway: This pathway combines phosphoenolpyruvate (from glycolysis) and erythrose-4-phosphate (from the pentose phosphate pathway) to produce the aromatic amino acids phenylalanine, tyrosine, and tryptophan [88]. These serve as precursors for a vast array of metabolites, including phenolic compounds, flavonoids, lignans, and alkaloids [72] [88]. The pathway involves seven steps to generate chorismate, a key branch-point intermediate regulated by enzymes like chorismate mutase and isochorismate synthase [88].

• The Terpenoid Pathways: Terpenes are built from isoprenoid precursors isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). These precursors are synthesized via two independent pathways [72]:

  • The Mevalonic Acid (MVA) Pathway, occurring in the cytosol, produces sesquiterpenes, triterpenes, and sterols [72].
  • The Methylerythritol Phosphate (MEP) Pathway, occurring in plastids, produces isoprene, monoterpenes, diterpenes, and carotenoids [72]. The universal building blocks DMADP and IPP are then condensed by terpene synthases to form the diverse skeletons of terpene natural products [72].

• Alkaloid and Nitrogen-Containing Compound Pathways: Amino acids such as lysine, tyrosine, and tryptophan act as precursors for nitrogenous secondary metabolites like alkaloids [72]. Biosynthesis is often regulated by enzymes like tryptophan decarboxylase and hyoscyamine 6β-hydroxylase, whose expression can be induced by environmental stresses such as UV exposure or salt stress [72].

Regulation by Transcription Factors

The biosynthesis of secondary metabolites is highly regulated at the transcriptional level. Key transcription factor families that respond to environmental stresses and regulate SM biosynthetic genes include WRKY, MYB, AP2/ERF, bZIP, bHLH, and NAC [88]. These transcription factors bind to promoter regions of biosynthetic genes, activating or repressing their expression in response to biotic and abiotic stresses, thereby modulating the accumulation of specific SMs [88].

Table: Essential Reagents and Databases for BGC-Compound Linking

Resource Name	Type	Primary Function	Application in BGC Research
antiSMASH	Software Tool	BGC Identification & Analysis	Predicts BGCs in genomic sequences and performs comparative analysis with MIBiG via KnownClusterBlast [101].
MIBiG Repository	Curated Database	Reference BGC Repository	Provides a curated set of experimentally characterized BGCs for comparison and functional prediction [101].
NCBI GenBank	Public Database	Nucleotide Sequence Archive	Source of genomic sequences containing BGCs; MIBiG entries link to their source GenBank accessions [102] [105].
PubChem	Public Database	Chemical Structure Database	Provides chemical information (structures, properties, bioactivity) for compounds linked from MIBiG entries [102] [101].
Natural Products Atlas	Curated Database	Natural Product Database	Contains data on known natural products structures; cross-referenced from MIBiG for similar compounds [101].
GNPS Spectral Library	Public Database	Tandem Mass Spectrometry Library	Used to validate compound identity by matching experimental mass spectra against reference data [101].

Advanced Applications and Future Directions

The integration of MIBiG into research workflows has enabled several advanced applications beyond basic compound identification. In metagenomics, MIBiG serves as a reference to assess the novelty of BGCs recovered from complex environmental samples (e.g., soil or marine microbiomes), revealing that many environmental bacteria possess BGCs with little homology to known clusters [101]. For ecological studies, researchers can use homology searches against MIBiG to identify BGCs associated with specific activities, such as correlating the abundance of antibacterial BGCs in soils with the presence of antimicrobial resistance genes [101].

The repository also supports synthetic biology and pathway engineering. Tools like ClusterCAD use MIBiG-sourced BGC data as a starting point for computer-aided design of new biochemical pathways, enabling the rational engineering of natural product biosynthesis [101]. Future advancements will likely focus on enhancing the integration of MIBiG with other data types, such as metabolomics and proteomics, and improving automated annotation pipelines to keep pace with the rapidly growing number of sequenced genomes.

Analyzing Horizontal vs. Vertical Gene Transfer in BGC Evolution

The biosynthesis of secondary metabolites, which includes many compounds of pharmaceutical importance, is directed by Biosynthetic Gene Clusters (BGCs). Understanding the evolutionary pathways of these BGCs is critical for advancing research in drug discovery and microbial ecology [106]. The two principal mechanisms driving BGC evolution are vertical gene transfer (VGT), the inheritance of genetic material from a parent organism, and horizontal gene transfer (HGT), the movement of genes between unrelated organisms [107]. While HGT has historically been emphasized for its role in rapidly expanding metabolic diversity, a nuanced understanding reveals that vertical inheritance and the subsequent species-specific diversification are equally critical in shaping the secondary metabolome of bacteria [108] [109]. This guide provides researchers with a technical framework for analyzing these evolutionary processes, complete with quantitative data, experimental protocols, and essential research tools.

Evolutionary Dynamics of BGCs

The distribution and diversity of BGCs across bacterial lineages are shaped by a complex interplay of evolutionary forces. A study on the marine actinobacterial genus Salinispora, encompassing 118 strains across nine species, provides a powerful model to quantify these dynamics [108].

The Overlooked Role of Vertical Inheritance

While HGT is often highlighted, genomic analyses reveal a strong phylogenetic signal in BGC distributions. In Salinispora, species designation explains 43.6% of the variation in BGC composition, demonstrating that specialized metabolism is a conserved phylogenetic trait [108]. An analysis of 3,041 predicted BGCs showed that only 3.6% were singletons (found in a single strain), equating to an average of 0.9 recently acquired BGCs per genome out of an average of 25.8 total BGCs. This indicates that most BGCs are maintained and diversified through vertical descent over evolutionary timescales [108].

Quantifying Horizontal Transfer and Its Consequences

HGT, though less frequent than once thought, remains a potent evolutionary force. Analysis of nine experimentally characterized BGCs in Salinispora revealed that interspecies HGT events were relatively rare, with an average of 0.9 ± 1.1 HGT events per BGC, while constrained intraspecific recombination was more frequent (18.7 ± 14.7 events per BGC) [108]. The success of an HGT event depends on the host's metabolic capacity. Transfer of the micrococcin P1 BGC to Staphylococcus aureus RN4220 enabled immediate production but imposed a significant metabolic burden, reducing growth. This burden was relieved through adaptive evolution that enhanced TCA cycle activity, underscoring that genetic acquisition alone is insufficient without metabolic integration [110].

Table 1: Evolutionary Processes in Nine Characterized Salinispora BGCs

Evolutionary Process	Frequency (Mean ± SD)	Impact on BGC Diversification
Vertical Inheritance with Diversification	N/A (Primary mode)	Major contributor; leads to species-specific patterns in metabolites.
Intraspecific Recombination	18.7 ± 14.7 events per BGC	Maintains species-level coherence and drives sequence variation.
Interspecific Horizontal Transfer	0.9 ± 1.1 events per BGC	Introduces novel BGCs but is a relatively rare event.
Gene Gain/Loss Events	Identified in all nine BGCs	Fine-tunes BGC content and function, affecting final metabolite output.

Methodologies for Analyzing Gene Transfer in BGCs

Genomic and Phylogenetic Analysis

Core Genome Phylogeny: Establish a robust species phylogeny using core genes to serve as a reference for identifying phylogenetic incongruences [108]. BGC Identification and Classification: Identify BGCs in genome assemblies using tools like antiSMASH. Group BGCs into Gene Cluster Families (GCFs) based on sequence similarity to track homologous clusters across strains [108] [106]. Phylogenetic Reconciliation: Compare the phylogenetic tree of a BGC or its key genes (e.g., Ketosynthase domains in PKS) to the core genome phylogeny. Significant discrepancies suggest potential HGT events [108] [107]. Average Nucleotide Identity (ANI): Calculate ANI for BGCs between strains. BGCs with ANI values significantly lower than the whole-genome ANI may be candidates for horizontal acquisition [108] [111].

Experimental Validation with Metabolomics

Genomic predictions require validation through metabolite detection. Strain Cultivation and Metabolite Extraction: Grow bacterial strains under standardized conditions. Perform whole-cell extraction using solvents like methanol [110]. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): Analyze extracts using LC-MS/MS. This targets the small molecule products of the BGCs under investigation [108] [109]. Metabolite Detection and Quantification: Identify compounds based on their mass and fragmentation patterns. Compare production levels across species to correlate genetic differences with metabolic output, as demonstrated with salinosporamide production in Salinispora [108].

Investigating HGT Adaptation with Multi-Omics

Experimental Evolution: After transferring a BGC (e.g., via conjugation or electroporation), serially passage the recipient strain for many generations [110]. Whole-Genome Sequencing (WGS): Sequence evolved clones to identify mutations that confer a fitness advantage, such as mutations in core metabolic genes like citrate synthase [110]. Transcriptome and Metabolome Analysis: Use RNA-Seq to profile gene expression changes and targeted metabolomics to measure central metabolite levels (e.g., citrate, α-ketoglutarate). This reveals the metabolic basis of adaptation to BGC acquisition [110].

Table 2: Key Reagent Solutions for BGC Evolutionary Analysis

Research Reagent / Tool	Primary Function	Technical Notes
antiSMASH	In silico identification & analysis of BGCs in genomic data.	The antiSMASH database provides a curated resource of BGCs from finished bacterial genomes [112].
LC-HR ESI/MS (Liquid Chromatography-High-Resolution Electrospray Ionization Mass Spectrometry)	Detects and characterizes small molecule metabolites from BGCs.	Confirms compound production and structure; enables relative quantification [108] [110].
Conjugative Plasmids / Electroporation	Experimental horizontal transfer of BGCs into recipient strains.	Used to study the immediate physiological impact and adaptation requirements of new BGC acquisition [110].
MIBiG Database	Repository for experimentally characterized BGCs.	Used as a reference for annotating and comparing newly discovered BGCs [112].
AcCNET / ANI Analysis	Bioinformatic pipeline for comparing plasmid & accessory genomes.	Helps determine plasmid host range and identify genetically coherent plasmid groups (PTUs) [111].

Visualization of Evolutionary Pathways and Host Ranges

The following diagram synthesizes the core concepts of how VGT and HGT contribute to BGC diversity and the documented host ranges for mobile genetic elements.

A comprehensive understanding of BGC evolution requires moving beyond simplistic models that overemphasize either horizontal or vertical transfer. The evidence shows that vertical inheritance is a dominant force facilitating interspecies diversification of BGCs over evolutionary timescales, creating a distinct phylogenetic fingerprint in specialized metabolism [108] [109]. Meanwhile, HGT acts as a critical, though less frequent, source of innovation, with its success contingent upon the genetic and metabolic integration into the new host [110]. For researchers in biosynthesis and drug development, these insights are transformative. They suggest that targeting closely related species within a phylogeny can yield novel, yet structurally related, natural products. Furthermore, successfully harnessing HGT for synthetic biology requires engineering not just the transfer of BGCs, but also the recipient's metabolic network to support production without a fitness cost.

Within the genomes of microorganisms, biosynthetic gene clusters (BGCs) serve as encoded blueprints for producing secondary metabolites, which represent an invaluable source of pharmaceuticals, agrochemicals, and industrially relevant compounds. The declining discovery rate of novel scaffolds through traditional approaches has shifted research toward genome mining, leveraging the wealth of genomic data to uncover this hidden metabolic potential [113] [93]. This in-depth technical guide examines the phylogenetic distribution, diversity, and research methodologies for BGCs in two prolific genera: the actinobacterium Amycolatopsis and the fungus Aspergillus.

Amycolatopsis, a high-GC Gram-positive actinobacterium, is renowned for producing clinically vital antibiotics such as vancomycin and rifamycin [114] [93]. Aspergillus, a genus of filamentous fungi, contributes to industrial enzyme production and synthesizes diverse metabolites, from the toxic aflatoxin to the pivotal antibiotic penicillin [115]. Despite their taxonomic distance, both genera possess extensive, underexplored biosynthetic capacities, with most BGCs remaining "silent" under standard laboratory conditions [113] [93]. This guide provides researchers and drug development professionals with a comparative analysis of their BGC diversity and the advanced genomic and experimental methodologies used to activate and characterize these pathways.

Comparative Genomics of BGC Diversity

BGC Landscape in Amycolatopsis

The genus Amycolatopsis exhibits remarkable genomic potential for secondary metabolite production. Comparative genomics of 43 Amycolatopsis genomes revealed a phylogeny comprising four major lineages (A-D), with BGC distribution demonstrating strong correlation to this phylogenetic structure [93].

Table 1: BGC Diversity and Genomic Features in Amycolatopsis

Phylogenetic Lineage	Representative Species/Strains	Genomic Features	Notable Characterized BGCs/Compounds
Lineage A	A. japonica DSM 44213, A. orientalis HCCB10007	Large genomes, high BGC diversity	Ristomycin A (NRP/Saccharide) [114]
Lineage B	A. keratiniphila subsp. nogabecina	Moderately sized genomes	-
Lineage C	A. orientalis DSM 46075, A. lurida DSM 43134	Diverse BGC repertoire	Ristocetin (NRP), Vancomycin (NRP) [114]
Lineage D	A. mediterranei S699	Large genomes	Rifamycin (Polyketide) [114]
Distinct Clades	A. marina, A. halophila	Unique BGC complements adapted to marine/saline niches	-

This phylogenetic distribution indicates that vertical gene transfer is a significant driver in the evolution of secondary metabolite gene clusters within this genus. However, the majority of BGCs are strain-specific and unique compared to databases of known compounds, highlighting a vast reservoir for novel natural product discovery [93]. Genomic analysis shows that BGCs acquired via horizontal gene transfer are often located in non-conserved, hypervariable genomic regions, providing insights for targeted genome mining [93].

BGC Landscape in Aspergillus

Aspergillus species possess a rich and diverse secondary metabolome, with their BGCs encoding for a wide array of polyketides, non-ribosomal peptides, terpenoids, and other compounds. Comparative genomics of sections Cavernicolus and Usti reveals that these sections harbor "mainly unique" secondary metabolite gene clusters (SMGCs) [116]. Section Usti, in particular, contains "very large and information-rich genomes," which are highly enriched in carbohydrate-active enzymes (CAZymes), making it an underutilized source for industrial enzyme production and novel metabolite discovery [116].

Table 2: BGC Diversity and Research Focus in Key Aspergillus Species

Aspergillus Species	Research & Clinical Significance	Notable BGCs/Compounds	Application as a Heterologous Host
A. niger	Industrial enzyme (CAZyme) producer; GRAS status [115]	-	High-protein secretion host; used for homologous expression of glucoamylase, xylanase, and heterologous proteins like lysozyme [115]
A. oryzae	Food fermentation (sake, soy sauce); GRAS status [115]	-	Preferred host for heterologous terpenoid production (e.g., pleuromutilin); used for antibody (adalimumab) expression [115]
A. nidulans	Eukaryotic model organism [115]	-	Model chassis for elucidating biosynthetic pathways of bioactive natural products [115]
A. flavus	Agricultural pathogen & clinical relevance in Saudi Arabia [117]	Aflatoxin	-
A. fumigatus	Major human pathogen [118]	Gliotoxin	-
A. terreus	Industrial and clinical relevance [117]	Lovastatin	-

The biosynthetic potential of Aspergillus is further leveraged through its use as a heterologous expression chassis. Species like A. niger, A. oryzae, and A. nidulans* are engineered to express biosynthetic pathways from other organisms, enabling the characterization of cryptic BGCs and the large-scale production of valuable compounds [115].

Methodologies for BGC Discovery and Activation

Genomic Sequencing and In Silico Prediction

The initial step in modern natural product discovery involves sequencing the target organism's genome and using computational tools to identify BGCs.

• Genome Sequencing: For bacteria like Amycolatopsis, Illumina HiSeq technology is commonly used to obtain draft or complete genomes [113] [114]. For complex fungal genomes, long-read sequencing technologies (e.g., PacBio) have been instrumental in generating high-quality assemblies [119].
• BGC Prediction: The antiSMASH (Antibiotics & Secondary Metabolite Analysis Shell) platform is the standard tool for identifying BGCs in bacterial genomes. For example, antiSMASH analysis of Amycolatopsis lurida TRM64739 identified a silent iodinin-like BGC (Region 33.2) responsible for phenazine production [113]. Similar genome mining tools are applied to fungal genomes.
• Phylogenomic Analysis: Following prediction, BGCs are compared to known clusters in databases like the Minimum Information about a Biosynthetic Gene cluster (MIBiG) repository. Phylogenetic analysis of core biosynthetic genes helps prioritize novel BGCs for experimental work [113] [114].

Activation of Silent BGCs: A Case Study of Co-culture

Most predicted BGCs are silent under standard laboratory monoculture conditions. A key strategy to activate them is co-culture, which mimics ecological interactions by cultivating the target strain with another microorganism.

Detailed Protocol: Activation of a Silent Phenazine BGC via Co-culture [113]

• Strain Preparation and Culture Conditions:

  • The target strain, Amycolatopsis lurida TRM64739, is cultured on ISP4 solid medium at 30°C for 8 days to generate spores.
  • A seed culture is prepared by inoculating a bacterial cake into liquid ISP4 medium and incubating at 30°C with shaking at 120 rpm for 5 days.
  • The inducing strain, Bacillus haynesii, is cultured in LB medium at 37°C.

• Drug Sensitivity Test (Optional but Strategic):

  • To selectively inhibit the inducing strain after it has initiated the interaction, a drug sensitivity test is performed.
  • Antibiotics like rifamycin, chloramphenicol, kanamycin, and streptomycin are tested against both strains using the filter paper diffusion method.
  • An antibiotic that inhibits B. haynesii but not A. lurida is selected. The semi-inhibitory concentration of this antibiotic on B. haynesii is determined for use in the co-culture.

• Co-culture Fermentation:

  • The activated seed culture of A. lurida TRM64739 and B. haynesii are inoculated into a co-culture system using ISP3 liquid medium.
  • The culture is incubated under appropriate conditions (e.g., 30°C with shaking) to allow microbial interaction.

• Metabolite Extraction and Analysis:

  • After fermentation, the culture broth is extracted with organic solvents (e.g., ethyl acetate).
  • The crude extract is subjected to chromatographic separation, including silica gel column chromatography (100-200 mesh), Sephadex LH-20 gel filtration, and finally, purification by preparative High-Performance Liquid Chromatography (HPLC).

• Compound Identification:

  • The structure of purified compounds is elucidated using spectroscopic techniques, primarily Nuclear Magnetic Resonance (NMR) and UPLC-HRESI-MS/MS (Ultra-Performance Liquid Chromatography-High Resolution ElectroSpray Ionization Tandem Mass Spectrometry) [113].

This protocol successfully activated the silent phenazine BGC in A. lurida TRM64739, leading to the isolation of five compounds, including a novel antimicrobial, 1,6-p-chlorophenylphenazine, which showed activity against clinically drug-resistant strains like A. baumannii and P. aeruginosa [113].

Heterologous Expression in Fungal Chassis

For fungi and actinobacteria with genetic intractability, heterologous expression is a powerful alternative. This involves cloning and transferring a target BGC into a genetically amenable host.

• Host Selection: Common fungal chassis include A. niger, A. oryzae, and A. nidulans, chosen for their GRAS status, efficient protein secretion, and robust precursor supply [115].
• Genetic Engineering: CRISPR-Cas9 technology has revolutionized genetic manipulation in Aspergillus species. It enables precise gene knock-outs, promoter engineering, and targeted integration of heterologous pathways [115].
• Application: This approach is widely used to elucidate biosynthetic pathways and produce complex terpenoids, polyketides, and non-ribosomal peptides. For instance, A. oryzae has been engineered for the efficient production of the diterpenoid antibiotic pleuromutilin and the triterpenoid cephalosporin P1 [115].

Research Workflow and Pathway Visualization

The following diagram illustrates the integrated genomics- and co-culture-based workflow for discovering novel natural products, as demonstrated in the Amycolatopsis case study.

Integrated Workflow for Novel Natural Product Discovery

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 3: Key Reagent Solutions for BGC Discovery and Characterization

Reagent/Material	Function/Application	Example from Case Studies
antiSMASH Software	In silico prediction and annotation of BGCs from genomic data.	Identifying the iodinin-like BGC in Amycolatopsis lurida TRM64739 [113].
ISP Media Series	Cultivation, sporulation, and fermentation of actinomycetes.	ISP4 for spore production; ISP3 for co-culture fermentation [113].
LB Medium	Routine cultivation of fast-growing bacteria like Bacillus.	Culturing the inducing strain Bacillus haynesii [113].
Sephadex LH-20	Gel filtration chromatography for desalting and fractionation based on molecular size.	Purification of phenazine compounds from co-culture extract [113].
Preparative HPLC	High-resolution purification of individual compounds from complex mixtures.	Final purification step for phenazine compounds 1-5 [113].
NMR Spectroscopy	Elucidating the planar structure and stereochemistry of purified compounds.	Structural identification of the novel 1,6-p-chlorophenylphenazine [113].
LC-HRMS/MS	Determining molecular formula and fragmentation patterns for structural confirmation.	Used alongside NMR for compound identification [113].
CRISPR-Cas9 System	Genetic engineering of fungal hosts for heterologous BGC expression.	Used in A. niger and A. oryzae for gene editing and pathway engineering [115].

The comparative analysis of Amycolatopsis and Aspergillus reveals distinct yet complementary paradigms for BGC diversity and exploitation. In Amycolatopsis, BGC distribution is strongly linked to phylogeny, providing a roadmap for targeted bioprospecting. In Aspergillus, the combination of rich, unique SMGCs and advanced heterologous expression systems creates a powerful platform for synthetic biology. The integrated approach of genome mining to identify novel genetic blueprints, coupled with innovative activation strategies like co-culture and heterologous expression, is paramount for unlocking the vast reservoir of silent secondary metabolites. As genomic and synthetic biology technologies continue to advance, the systematic exploration of BGC diversity in these and other genera will undoubtedly accelerate the discovery of novel compounds to address pressing challenges in drug development and biotechnology.

Conclusion

The systematic investigation of secondary metabolite biosynthesis, from foundational pathways to advanced genomic applications, is revolutionizing natural product discovery. The integration of genome mining, multi-omics, and comparative genomics has not only expanded our understanding of chemical diversity but also provided powerful tools to overcome traditional production bottlenecks. These advancements are directly contributing to the pipeline of novel therapeutics, particularly in oncology and anti-infectives. Future directions will be shaped by the continued decoding of complex BGCs from underexplored taxa, the refinement of heterologous expression platforms, and the application of artificial intelligence to predict chemical structures from genetic blueprints. For biomedical research, this promises a new era of rationally designed, natural product-inspired medicines to address pressing clinical challenges.

References

• 1. Light regulates the synthesis and accumulation of plant ... [https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2025.1644472/full]
• 2. Statistical experimental designs for the production of ... [https://pubmed.ncbi.nlm.nih.gov/27623794/]
• 3. Microbial secondary metabolites: advancements to ... [https://pubmed.ncbi.nlm.nih.gov/39824928/]
• 4. Systems and synthetic biology for plant natural product ... [https://www.sciencedirect.com/science/article/pii/S2211124725004863]
• 5. Qualitative and Quantitative Analysis of Secondary ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8840654/]
• 6. Exploring novel secondary metabolites from natural ... [https://www.nature.com/articles/s41598-019-54078-1]
• 7. Shikimate pathway [https://en.wikipedia.org/wiki/Shikimate_pathway]
• 8. Mevalonate pathway [https://en.wikipedia.org/wiki/Mevalonate_pathway]
• 9. Acetate-Malonate Pathway | PPTX [https://www.slideshare.net/slideshow/acetatemalonate-pathway/154833057]
• 10. Metabolic Engineering of Shikimic Acid Biosynthesis Pathway ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9332510/]
• 11. The Acetate Pathway Supports Flavonoid and Lipid ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6997690/]
• 12. Secondary metabolite biosynthetic diversity in the fungal ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8403587/]
• 13. Branching and converging pathways in fungal natural product ... [https://fungalbiolbiotech.biomedcentral.com/articles/10.1186/s40694-022-00135-w]
• 14. Combinatorial biosynthesis for the engineering of novel ... [https://www.nature.com/articles/s42004-024-01172-9]
• 15. Characterization of NRPS and PKS genes involved in the ... [https://www.nature.com/articles/s41598-022-11896-0]
• 16. Genome Mining of Alkaloidal Terpenoids from a Hybrid ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7000236/]
• 17. Terpenoid Biosynthesis Dominates among Secondary ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8070225/]
• 18. Terpenoid Biosynthesis Dominates among Secondary ... [https://www.mdpi.com/2309-608X/7/4/285]
• 19. Integrative Multi-Omics Identify Key Secondary Metabolites ... [https://www.mdpi.com/2076-2607/13/11/2493]
• 20. Environmental stress induced biosynthesis of plant ... [https://www.sciencedirect.com/science/article/pii/S2772899425000060]
• 21. Production of secondary metabolites under challenging ... [https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2025.1569014/full]
• 22. Plant Secondary Metabolites—Central Regulators Against ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12029941/]
• 23. Isolation and Characterization of Secondary Metabolites from ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12300214/]
• 24. Comprehensive multivariate analysis of secondary ... [https://www.sciencedirect.com/science/article/pii/S0926669025017364]
• 25. Secondary metabolites and biodiversity of actinomycetes - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC8116480/]
• 26. Biological activity of secondary metabolites of actinomycetes ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12095151/]
• 27. Endophytic actinobacteria of medicinal plants: diversity and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4491368/]
• 28. Genomes of 211 Actinomycete Strains from Diverse ... [https://www.nature.com/articles/s41597-025-05567-8]
• 29. Discovery of novel secondary metabolites encoded in ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9113425/]
• 30. Genomic basis for natural product biosynthetic diversity in the ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3063060/]
• 31. Isolation, abundance and phylogenetic affiliation of ... [https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2015.00273/full]
• 32. Biological activity of secondary metabolites ... [https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1550516/full]
• 33. Mining and unearthing hidden biosynthetic potential | Nature Communications [https://www.nature.com/articles/s41467-021-24133-5]
• 34. Genome Mining as New Challenge in Natural Products ... [https://www.mdpi.com/1660-3397/18/4/199]
• 35. Computational advances in biosynthetic gene cluster discovery and prediction - PubMed [https://pubmed.ncbi.nlm.nih.gov/39924008/]
• 36. Mining Silent Biosynthetic Gene Clusters for Natural Products in Filamentous Fungi - PubMed [https://pubmed.ncbi.nlm.nih.gov/39817799/]
• 37. A Machine Learning Bioinformatics Method to Predict ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8243324/]
• 38. Sequence modeling tools to decode the biosynthetic diversity ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12282076/]
• 39. Genome Annotation / Secondary metabolite discovery ... [https://training.galaxyproject.org/training-material/topics/genome-annotation/tutorials/secondary-metabolite-discovery/tutorial.html]
• 40. “Genome-based in silico assessment of biosynthetic gene ... [https://www.sciencedirect.com/science/article/pii/S0888754324001861]
• 41. Targeted genome mining for natural product discovery [https://pubmed.ncbi.nlm.nih.gov/40651827/]
• 42. MEANtools integrates multi-omics data to identify metabolites ... [https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003307]
• 43. MEANtools integrates multi-omics data to identify ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12327601/]
• 44. Metabolomics and transcriptomics based multi-omics ... [https://www.nature.com/articles/s41540-023-00305-5]
• 45. Multiomic analysis of the synthetic pathways of secondary ... [https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2025.1615756/full]
• 46. Algorithms and tools for data-driven omics integration to ... [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-025-06446-x]
• 47. Comparative analysis of statistical and deep learning-based ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12210783/]
• 48. Comprehensive prediction of secondary metabolite ... [https://www.nature.com/articles/s41467-020-19986-1]
• 49. Network-based multi-omics integrative analysis methods in ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11954193/]
• 50. Multi-omics profiling of Curcuma Wenyujin under salt-alkali ... [https://bmcplantbiol.biomedcentral.com/articles/10.1186/s12870-025-07376-y]
• 51. Identification of Secondary Metabolites by Multi-Omics ... [https://www.mdpi.com/2218-1989/14/11/597]
• 52. Tracer techniques, General techniques for biosynthetic ... [https://www.slideshare.net/slideshow/tracer-techniques-229084291/229084291]
• 53. Secondary Metabolic Pathway-Targeted Metabolomics [https://pmc.ncbi.nlm.nih.gov/articles/PMC5049693/]
• 54. Cluster mining tools - SMBP - SecondaryMetabolites.org [https://www.secondarymetabolites.org/mining/]
• 55. Studies on Anticancer Activities of Antimicrobial Peptides - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC2238813/]
• 56. BIOCHEMICAL PATHWAYS IN DRUG DISCOVERY [https://pakjmcr.com/index.php/1/article/view/260]
• 57. Genome mining and OSMAC strategies unveil diverse ... [https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1604639/full]
• 58. Enhancing chemical and biological diversity by co-cultivation [https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2023.1117559/full]
• 59. An OSMAC Strategy for the Production of Antimicrobial ... [https://www.mdpi.com/2079-6382/14/8/756]
• 60. Strategies Used for the Discovery of New Microbial ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12251386/]
• 61. OSMAC Approach and Cocultivation for the Induction of ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10601420/]
• 62. Strategies to enhance production of metabolites in ... [https://www.sciencedirect.com/science/article/abs/pii/S0960852424007533]
• 63. Systematic over-expression of secondary metabolism ... [https://www.nature.com/articles/s42003-025-08840-z]
• 64. Metabolic engineering - Latest research and news [https://www.nature.com/subjects/metabolic-engineering]
• 65. Navigating the challenges of engineering composite ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11910955/]
• 66. Synthetic and systems biology strategies for enhanced ... [https://ui.adsabs.harvard.edu/abs/2025ESust.tmp...36R/abstract]
• 67. Metabolic Engineering of Terpenoid Biosynthesis in ... [https://www.mdpi.com/1467-3045/47/9/723]
• 68. Metabolic engineering and synthetic biology for the environment [https://biotechforenvironment.biomedcentral.com/articles/10.1186/s44314-025-00029-2]
• 69. Deep learning driven biosynthetic pathways navigation for ... [https://www.nature.com/articles/s41467-022-30970-9]
• 70. Strategies on biosynthesis and production of bioactive ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10874775/]
• 71. Editorial: Biosynthesis, purification, characterization and ... [https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2023.1162676/full]
• 72. A Review of Secondary Metabolite Biosynthetic Pathways ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10456650/]
• 73. Techniques for secondary metabolite production [https://labassociates.com/techniques-for-secondary-metabolite-production]
• 74. Evolution-guided optimization of biosynthetic pathways - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC4273373/]
• 75. Designing pathways for bioproducing complex chemicals ... [https://www.nature.com/articles/s41467-025-59827-7]
• 76. computational methods for biosynthetic pathway design [https://pmc.ncbi.nlm.nih.gov/articles/PMC12159830/]
• 77. Methods for isolation, purification and structural elucidation ... [https://pubmed.ncbi.nlm.nih.gov/18989260/]
• 78. Sequence-Based Analysis of Secondary-Metabolite ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC2849207/]
• 79. Uncovering secondary metabolite evolution and ... [https://www.nature.com/articles/s41598-018-36561-3]
• 80. Combination Strategy of Genetic Dereplication and ... [https://www.mdpi.com/1422-0067/23/7/3686]
• 81. Secondary Metabolite Dereplication and Phylogenetic ... [https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2019.00667/full]
• 82. Effective data visualization strategies in untargeted ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11610048/]
• 83. Elicitation, an Effective Strategy for the Biotechnological ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6273650/]
• 84. Elicitation as a tool to improve the profiles of high‐value ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6585710/]
• 85. Engineered elicitation in Artemisia annua L. callus cultures ... [https://www.nature.com/articles/s44383-025-00009-1]
• 86. Elicitation, A Mechanistic Approach to Change the ... [https://irispublishers.com/gjes/fulltext/elicitation-a-mechanistic-approach-to-change-the-metabolic-pathway-of-plants.ID.000678.php]
• 87. Synthesis of plant secondary metabolites under the ... [https://www.sciencedirect.com/science/article/abs/pii/S0885576525003443]
• 88. Plant Secondary Metabolite Biosynthesis and ... [https://www.mdpi.com/2073-4395/11/5/968]
• 89. Rapid Method To Estimate the Presence of Secondary ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC92588/]
• 90. Uncovering secondary metabolite evolution and ... [https://pubmed.ncbi.nlm.nih.gov/30560908/]
• 91. A comparative genomics study of 23 Aspergillus species ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7046712/]
• 92. GeneSetCluster 2.0: a comprehensive toolset for summarizing ... [https://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-025-06249-3]
• 93. Comparative genomics reveals phylogenetic distribution ... [https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-018-4809-4]
• 94. Genome mining reveals the distribution of biosynthetic gene ... [https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-025-11754-z]
• 95. Genome mining reveals the distribution of biosynthetic ... [https://pubmed.ncbi.nlm.nih.gov/40691532/]
• 96. Comparative Genomic Analysis of the Pediococcus Genus ... [https://www.sciencedirect.com/science/article/pii/S2001037025004520]
• 97. Comparative genome features and secondary metabolite ... [https://www.nature.com/articles/s41598-023-36039-x]
• 98. Unraveling the specialized metabolic pathways in ... [https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2024.1459533/full]
• 99. Comparative Genomics Determines Strain-Dependent ... [https://www.mdpi.com/2218-273X/10/6/864]
• 100. Comparative Genomic Insights into Secondary Metabolism ... [https://pubmed.ncbi.nlm.nih.gov/31454987/]
• 101. MIBiG 2.0: a repository for biosynthetic gene clusters of known ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7145714/]
• 102. BGC0001708 - MIBiG [https://mibig.secondarymetabolites.org/go/BGC0001708.3]
• 103. BGC0002957 - MIBiG [https://mibig.secondarymetabolites.org/repository/BGC0002957.1/]
• 104. BGC0000633 - MIBiG [https://mibig.secondarymetabolites.org/go/BGC0000633/1]
• 105. A standardized workflow for submitting data to the Minimum ... [https://environmentalmicrobiome.biomedcentral.com/articles/10.1186/s40793-018-0318-y]
• 106. Diversity of Bacterial Secondary Metabolite Biosynthetic Gene ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9864124/]
• 107. Horizontal gene transfer [https://en.wikipedia.org/wiki/Horizontal_gene_transfer]
• 108. Vertical Inheritance Facilitates Interspecies Diversification ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8609351/]
• 109. Vertical Inheritance Facilitates Interspecies Diversification in ... [https://pubmed.ncbi.nlm.nih.gov/34809466/]
• 110. Horizontal Transfer of Bacteriocin Biosynthesis Genes ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9927498/]
• 111. Pathways for horizontal gene transfer in bacteria revealed ... [https://www.nature.com/articles/s41467-020-17278-2]
• 112. BGC databases - SMBP - SecondaryMetabolites.org [https://www.secondarymetabolites.org/databases/]
• 113. The taxonomy of Amycolatopsis lurida TRM64739 and ... [https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1571458/full]
• 114. Comparative Genomics and Biosynthetic Potential Analysis of ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5859366/]
• 115. Recent Advances in Heterologous Protein Expression and ... [https://www.mdpi.com/2309-608X/11/7/534]
• 116. Section-level genome sequencing and comparative ... [https://pubmed.ncbi.nlm.nih.gov/40371420/]
• 117. Unveiling the distribution and research patterns of Aspergillus ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12401964/]
• 118. Comparison of the Equivalence of Aspergillus Antigen and ... [https://pubmed.ncbi.nlm.nih.gov/39900777/]
• 119. understanding and harnessing plant metabolic diversity [https://pmc.ncbi.nlm.nih.gov/articles/PMC12361408/]